Publications
Selected publications
- Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis (Journal article - 2021)
- The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. (Journal article - 2016)
- Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation (Journal article - 2021)
- Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives (Journal article - 2021)
- European position statement on lung cancer screening (Journal article - 2017)
- Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study (Journal article - 2012)
- Mortality Reduction with Low-Dose CT Screening for Lung Cancer (Journal article - 2020)
- The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals (Journal article - 2017)
- Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme (Journal article - 2019)
- Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls (Journal article - 2020)
2024
Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2024). Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.. The Lancet regional health. Europe, 42, 100936. doi:10.1016/j.lanepe.2024.100936
Novel Transcriptional and DNA Methylation Abnormalities of SORT1 Gene in Non-Small Cell Lung Cancer.
Acha-Sagredo, A., Wilson, C. M., Garcia Bediaga, N., Kalirai, H., Davies, M. P. A., Coupland, S. E., . . . Liloglou, T. (2024). Novel Transcriptional and DNA Methylation Abnormalities of SORT1 Gene in Non-Small Cell Lung Cancer.. Cancers, 16(11), 2154. doi:10.3390/cancers16112154
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.
Filippi, A. R., Bar, J., Chouaid, C., Christoph, D. C., Field, J. K., Fietkau, R., . . . Girard, N. (2024). Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R.. ESMO open, 9(6), 103464. doi:10.1016/j.esmoop.2024.103464
Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationships.
Ohlander, J., Kromhout, H., Vermeulen, R., Portengen, L., Kendzia, B., Savary, B., . . . Peters, S. (2024). Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationships.. Scandinavian journal of work, environment & health, 50(3), 178-186. doi:10.5271/sjweh.4140
Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studies.
Xu, M., Ho, V., Lavoué, J., Olsson, A., Schüz, J., Richardson, L., . . . Siemiatycki, J. (2024). Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studies.. American journal of industrial medicine, 67(3), 200-213. doi:10.1002/ajim.23562
CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.
Du, M., Xin, J., Zheng, R., Yuan, Q., Wang, Z., Liu, H., . . . Christiani, D. C. (2024). CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility.. Cancer research, 84(4), 616-625. doi:10.1158/0008-5472.can-23-0900
Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification
Wang, X., Zhang, Z., Ding, Y., Chen, T., Mucci, L., Albanes, D., . . . Christiani, D. C. (n.d.). Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification. Genome Medicine, 16(1). doi:10.1186/s13073-024-01298-4
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Yarmolinsky, J., Robinson, J. W., Mariosa, D., Karhunen, V., Huang, J., Dimou, N., . . . Martin, R. M. (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.. EBioMedicine, 100, 104991. doi:10.1016/j.ebiom.2024.104991
Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
Li, Y., Xiao, X., Li, J., Han, Y., Cheng, C., Fernandes, G. F., . . . Amos, C. I. (2024). Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. doi:10.1158/1055-9965.epi-23-0613
Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY).
Olsson, A., Bouaoun, L., Schüz, J., Vermeulen, R., Behrens, T., Ge, C., . . . Peters, S. (2024). Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY).. Environmental health perspectives, 132(1), 17005. doi:10.1289/ehp13380
Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies.
Wan, W., Peters, S., Portengen, L., Olsson, A., Schüz, J., Ahrens, W., . . . Vermeulen, R. (2024). Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies.. American journal of respiratory and critical care medicine, 209(2), 185-196. doi:10.1164/rccm.202306-0942oc
2023
Investigating iRHOM2-Associated Transcriptional Changes in Tylosis With Esophageal Cancer
Murtough, S., Babu, D., Webb, C. M., Louis dit Picard, H., McGinty, L. A., Chao-Chu, J., . . . Kelsell, D. P. (2023). Investigating iRHOM2-Associated Transcriptional Changes in Tylosis With Esophageal Cancer. Gastro Hep Advances, 3(3), 385-395. doi:10.1016/j.gastha.2023.12.007
Road map to improve the quality of lung cancer risk data.
Field, J. K. (2023). Road map to improve the quality of lung cancer risk data.. Thorax, 79(1), 11-12. doi:10.1136/thorax-2023-220784
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Zhao, X., Yang, M., Fan, J., Wang, M., Wang, Y., Qin, N., . . . Dai, J. (2023). Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.. Cancer. doi:10.1002/cncr.35130
OA17.03 Real-World Outcomes with Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC (PACIFIC-R)
Peters, S., Christoph, D. C., Field, J. K., Fietkau, R., Filippi, A. R., Garassino, M., . . . Girard, N. (2023). OA17.03 Real-World Outcomes with Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC (PACIFIC-R). Journal of Thoracic Oncology, 18(11), S83. doi:10.1016/j.jtho.2023.09.088
P1.17-01 Lung Cancer Screening in Low- and Middle-income Countries - Report on Status, Challenges and Perspectives from WCLC2022 and LALCA2023
Cavic, M., Viola, L., Kerpel-Fronius, A., Ventura, L., Jiang, L., Sales dos Santos, R., . . . Huber, R. M. (2023). P1.17-01 Lung Cancer Screening in Low- and Middle-income Countries - Report on Status, Challenges and Perspectives from WCLC2022 and LALCA2023. Journal of Thoracic Oncology, 18(11), S222. doi:10.1016/j.jtho.2023.09.362
Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer.
Xu, J., Xu, W., Choi, J., Brhane, Y., Christiani, D. C., Kothari, J., . . . Briollais, L. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer.. PLoS genetics, 19(9), e1010902. doi:10.1371/journal.pgen.1010902
Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies
Fares, A. F., Li, Y., Jiang, M., Brown, M. C., Lam, A. C. L., Aggarwal, R., . . . Liu, G. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. LANCET PUBLIC HEALTH, 8(9), E691-E700. Retrieved from https://www.webofscience.com/
The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World
Avila, R. S., Krishnan, K., Wynes, M., Connolly, C., McWilliams, A., Logan, J., . . . Lam, S. (2023). The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World. In JOURNAL OF THORACIC ONCOLOGY Vol. 17 (pp. S82). Retrieved from https://www.webofscience.com/
The IASLC Early Lung Imaging Confederation (ELIC) Open-Source Deep Learning and Quantitative Measurement Initiative.
Lam, S., Wynes, M. W., Connolly, C., Ashizawa, K., Atkar-Khattra, S., Belani, C. P., . . . Avila, R. (2023). The IASLC Early Lung Imaging Confederation (ELIC) Open-Source Deep Learning and Quantitative Measurement Initiative.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, S1556-0864(23)00736-0. doi:10.1016/j.jtho.2023.08.016
Current and Future Perspectives on CT Screening for Lung Cancer: A Road Map for 2023-2027 from the IASLC.
Lam, S., Bai, C., Baldwin, D., Chen, Y., Connolly, C., de Koning, H., . . . Field, J. (2023). Current and Future Perspectives on CT Screening for Lung Cancer: A Road Map for 2023-2027 from the IASLC.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, S1556-0864(23)00687-1. doi:10.1016/j.jtho.2023.07.019
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.
Luyapan, J., Bossé, Y., Li, Z., Xiao, X., Rosenberger, A., Hung, R. J., . . . Amos, C. I. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.. Human molecular genetics, ddad095. doi:10.1093/hmg/ddad095
Plasma protein biomarkers for early prediction of lung cancer
Davies, M. P. A., Sato, T., Ashoor, H., Hou, L., Liloglou, T., Yang, R., & Field, J. K. (2023). Plasma protein biomarkers for early prediction of lung cancer. EBIOMEDICINE, 93. doi:10.1016/j.ebiom.2023.104686
Circulating Proteome for Pulmonary Nodule Malignancy.
Khodayari Moez, E., Warkentin, M. T., Brhane, Y., Lam, S., Field, J. K., Liu, G., . . . Hung, R. J. (2023). Circulating Proteome for Pulmonary Nodule Malignancy.. Journal of the National Cancer Institute, djad122. doi:10.1093/jnci/djad122
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population.
Shi, J., Shiraishi, K., Choi, J., Matsuo, K., Chen, T. -Y., Dai, J., . . . Lan, Q. (2023). Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population.. Nature communications, 14(1), 3043. doi:10.1038/s41467-023-38196-z
Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis.
Cheng, C., Hong, W., Li, Y., Xiao, X., McKay, J., Han, Y., . . . INTEGRAL-ILCCO lung cancer consortium. (2023). Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, S1556-0864(23)00527-0. doi:10.1016/j.jtho.2023.05.001
Defining the road map to a UK national lung cancer screening programme
O'Dowd, E. L., Lee, R. W., Akram, A. R., Bartlett, E. C., Bradley, S. H., Brain, K., . . . Crosbie, P. (2023). Defining the road map to a UK national lung cancer screening programme. LANCET ONCOLOGY, 24(5), E207-E218. Retrieved from https://www.webofscience.com/
Data from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Data from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.c.6567223
Data from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Data from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.c.6567223.v1
Supplementary Figures and Table legends from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Supplementary Figures and Table legends from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.22569163
Supplementary Figures and Table legends from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Supplementary Figures and Table legends from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.22569163.v1
Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.22569160.v1
Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2023). Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. doi:10.1158/0008-5472.22569160
Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY)
Behrens, T., Ge, C., Vermeulen, R., Kendzia, B., Olsson, A., Schuez, J., . . . Bruening, T. (2023). Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY). INTERNATIONAL JOURNAL OF CANCER, 152(4), 645-660. doi:10.1002/ijc.34272
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
Girard, N., Bar, J., Garrido, P., Garassino, M. C., McDonald, F., Mornex, F., . . . Solomon, B. (2023). Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study. JOURNAL OF THORACIC ONCOLOGY, 18(2), 181-193. doi:10.1016/j.jtho.2022.10.003
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Robbins, H. A., Alcala, K., Moez, E. K., Guida, F., Thomas, S., Zahed, H., . . . Hung, R. J. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. ANNALS OF EPIDEMIOLOGY, 77, 1-12. doi:10.1016/j.annepidem.2022.10.014
On the Non-Linearity of Radon-Induced Lung Cancer
2022
58O Real-world overall survival (OS) with durvalumab (D) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): Interim analysis from the PACIFIC-R study
Girard, N., Christoph, D. C. C., Garassino, M. C., McDonald, F., Mornex, F., Field, J. K., . . . Filippi, A. R. R. (2022). 58O Real-world overall survival (OS) with durvalumab (D) after chemoradiotherapy (CRT) in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): Interim analysis from the PACIFIC-R study. Immuno-Oncology and Technology, 16, 100163. doi:10.1016/j.iotech.2022.100163
On the non-linearity of radon-induced lung cancer
On the non-linearity of radon-induced lung cancer
Circulating Proteome for Pulmonary Nodule Malignancy
EP01.04-005 Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment
Avila, R. S., Krishnan, K., Wynes, M., Connolly, C., McWilliams, A., Logan, J., . . . Lam, S. (2022). EP01.04-005 Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment. Journal of Thoracic Oncology, 17(9), S180-S181. doi:10.1016/j.jtho.2022.07.300
EP01.06-006 Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2022). EP01.06-006 Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups. Journal of Thoracic Oncology, 17(9), S190. doi:10.1016/j.jtho.2022.07.318
MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World
Avila, R. S., Krishnan, K., Wynes, M., Connolly, C., McWilliams, A., Logan, J., . . . Lam, S. (2022). MA11.07 The ELIC Distributed Database and Computation Environment for Analyses of Lung Cancer Screening LDCTs Across the World. Journal of Thoracic Oncology, 17(9), S82. doi:10.1016/j.jtho.2022.07.140
P1.02-02 Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries
Cavic, M., Kerpel-Fronius, A., Viola, L., Ventura, L., Jiang, L., Sales dos Santos, R., . . . Huber, R. (2022). P1.02-02 Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries. Journal of Thoracic Oncology, 17(9), S98-S99. doi:10.1016/j.jtho.2022.07.163
Selection of eligible participants for screening for lung cancer using primary care data
O'Dowd, E. L., Ten Haaf, K., Kaur, J., Duffy, S. W., Hamilton, W., Hubbard, R. B., . . . Baldwin, D. R. (2022). Selection of eligible participants for screening for lung cancer using primary care data. THORAX, 77(9), 882-890. doi:10.1136/thoraxjnl-2021-217142
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk.
Li, Y., Xiao, X., Li, J., Byun, J., Cheng, C., Bosse, Y., . . . Amos, C. I. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. HUMAN MOLECULAR GENETICS, 31(16), 2831-2843. doi:10.1093/hmg/ddac030
On the non-linearity of radon-induced lung cancer
A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians
Zhang, R., Shen, S., Wei, Y., Zhu, Y., Li, Y., Chen, J., . . . Christiani, D. C. (2022). A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. JOURNAL OF THORACIC ONCOLOGY, 17(8), 974-990. doi:10.1016/j.jtho.2022.04.011
Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend
Groves, S., McCutchan, G., Quaife, S. L., Murray, R. L., Ostroff, J. S., Brain, K., . . . McWilliams, L. (2022). Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend. HEALTH EXPECTATIONS, 25(4), 1703-1716. doi:10.1111/hex.13513
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer.
Byun, J., Han, Y., Li, Y., Xia, J., Long, E., Choi, J., . . . Amos, C. I. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. NATURE GENETICS, 54(8), 1167-+. doi:10.1038/s41588-022-01115-x
Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)
Olsson, A., Guha, N., Bouaoun, L., Kromhout, H., Peters, S., Siemiatycki, J., . . . Straif, K. (2022). Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 31(7), 1433-1441. doi:10.1158/1055-9965.EPI-21-1428
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Impact of risk-based low dose CT screening on different socio-economic groups
Davies, M., Vulkan, D., Gabe, R., Duffy, S., & Field, J. (2022). Impact of risk-based low dose CT screening on different socio-economic groups. Lung Cancer, 165, S20. doi:10.1016/s0169-5002(22)00088-5
Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants.
Loong, L., Cubuk, C., Choi, S., Allen, S., Torr, B., Garrett, A., . . . CanVIG-UK. (2022). Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants.. Genetics in medicine : official journal of the American College of Medical Genetics, 24(3), 552-563. doi:10.1016/j.gim.2021.11.011
Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report
Huber, R. M., Cavic, M., Kerpel-Fronius, A., Viola, L., Field, J., Jiang, L., . . . Lam, S. (2022). Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report. JOURNAL OF THORACIC ONCOLOGY, 17(2), 228-238. doi:10.1016/j.jtho.2021.11.008
Gene-gene interaction of <i>AhR</i>with and within the <i>Wnt</i>cascade affects susceptibility to lung cancer
Rosenberger, A., Muttray, N., Hung, R. J., Christiani, D. C., Caporaso, N. E., Liu, G., . . . Bickeboeller, H. (2022). Gene-gene interaction of <i>AhR</i>with and within the <i>Wnt</i>cascade affects susceptibility to lung cancer. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 27(1). doi:10.1186/s40001-022-00638-7
Iam hiQ-a novel pair of accuracy indices for imputed genotypes
Rosenberger, A., Tozzi, V., Bickeboeller, H., & Consortium, I. N. T. E. G. R. A. L. -I. L. C. C. O. (2022). Iam hiQ-a novel pair of accuracy indices for imputed genotypes. BMC BIOINFORMATICS, 23(1). doi:10.1186/s12859-022-04568-3
Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.
Schmid, S., Jiang, M., Brown, M. C., Fares, A., Garcia, M., Soriano, J., . . . Liu, G. (2022). Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. doi:10.1158/1055-9965.epi-21-0747
Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries
Cavic, M., Kerpel-Fronius, A., Viola, L., Ventura, L., Jiang, L., dos Santos, R. S., . . . Huber, R. (2022). Current Status, Challenges and Perspectives of Lung Cancer Screening in Low- and Middle-Income Countries. In JOURNAL OF THORACIC ONCOLOGY Vol. 17 (pp. S98-S99). Retrieved from https://www.webofscience.com/
Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2022). Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups. In JOURNAL OF THORACIC ONCOLOGY Vol. 17 (pp. S190). Retrieved from https://www.webofscience.com/
Impact of risk-based low dose CT screening on different socio-economic groups
Davies, M., Vulkan, D., Gabe, R., Duffy, S., & Field, J. (2022). Impact of risk-based low dose CT screening on different socio-economic groups. In LUNG CANCER Vol. 165 (pp. S20). Retrieved from https://www.webofscience.com/
Pacific-R Real-World Study: Treatment Duration and Interim Analysis of Progression-Free Survival in Unresectable Stage III NSCLC Patients Treated with Durvalumab After Chemoradiotherapy
Christoph, D., Girard, N., Smit, H. J. M., Sibille, A., Mcdonald, F., Mornex, F., . . . Fietkau, R. (2022). Pacific-R Real-World Study: Treatment Duration and Interim Analysis of Progression-Free Survival in Unresectable Stage III NSCLC Patients Treated with Durvalumab After Chemoradiotherapy. In ONCOLOGY RESEARCH AND TREATMENT Vol. 45 (pp. 151). Retrieved from https://www.webofscience.com/
Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment
Avila, R. S., Krishnan, K., Wynes, M., Connolly, C., McWilliams, A., Logan, J., . . . Lam, S. (2022). Quantitative Characteristics in Global CT Lung Cancer Screening Populations Using the ELIC Distributed Database and Computation Environment. In JOURNAL OF THORACIC ONCOLOGY Vol. 17 (pp. S180-S181). Retrieved from https://www.webofscience.com/
Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' reply
Duffy, S. W., & Field, J. K. (2022). Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' reply. LANCET REGIONAL HEALTH-EUROPE, 12. doi:10.1016/j.lanepe.2021.100259
2021
Clonal Hematopoiesis Mutations in Lung Cancer Patients are Associated with Lung Cancer Risk Factors.
Hong, W., Li, A., Liu, Y., Xiao, X., Christiani, D. C., Hung, R. J., . . . Cheng, C. (2021). Clonal Hematopoiesis Mutations in Lung Cancer Patients are Associated with Lung Cancer Risk Factors.. Cancer research. doi:10.1158/0008-5472.can-21-1903
Analysis of the baseline performance of five UK lung cancer screening programmes
Balata, H., Ruparel, M., O'Dowd, E., Ledson, M., Field, J. K., Duffy, S. W., . . . Crosbie, P. A. J. (2021). Analysis of the baseline performance of five UK lung cancer screening programmes. LUNG CANCER, 161, 136-140. doi:10.1016/j.lungcan.2021.09.012
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., . . . Duffy, S. W. (2021). Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. LANCET REGIONAL HEALTH-EUROPE, 10. doi:10.1016/j.lanepe.2021.100179
OA19.02 The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis
Field, J., Vulkan, D., Davies, M., Gabe, R., & Duffy, S. (2021). OA19.02 The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis. Journal of Thoracic Oncology, 16(10), S882. doi:10.1016/j.jtho.2021.08.098
Gene-gene Interaction of AhR with and within the Wnt Cascade Affects Susceptibility to Lung Cancer
Application of two job indices for general occupational demands in a pooled analysis of case-control studies on lung cancer
Hovanec, J., Siemiatycki, J., Conway, D. I., Olsson, A., Guenel, P., Luce, D., . . . Behrens, T. (2021). Application of two job indices for general occupational demands in a pooled analysis of case-control studies on lung cancer. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 47(6), 475-481. doi:10.5271/sjweh.3967
PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Girard, N., Smit, H. J. M., Sibille, A., McDonald, F., Mornex, F., Garassino, M. C. C., . . . Garrido, P. (2021). PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. In ANNALS OF ONCOLOGY Vol. 32 (pp. S939-S940). doi:10.1016/j.annonc.2021.08.1775
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
Gene-gene Interaction of AhR With and Within the Wnt Cascade Affects Susceptibility to Lung Cancer
A multi-omics study links <i>TNS3</i> and <i>SEPT7</i> to long-term former smoking NSCLC survival
Shen, S., Wei, Y., Li, Y., Duan, W., Dong, X., Lin, L., . . . Christiani, D. C. (2021). A multi-omics study links <i>TNS3</i> and <i>SEPT7</i> to long-term former smoking NSCLC survival. NPJ PRECISION ONCOLOGY, 5(1). doi:10.1038/s41698-021-00182-3
A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?"
Liu, G., Brenner, H., Chen, C., Christiani, D., Field, J. K., Hung, R., . . . Xu, W. (2021). A reply to "Lung cancer outcomes: Are BMI and race clinically relevant?". LUNG CANCER, 154, 225-226. doi:10.1016/j.lungcan.2021.02.019
Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma
Qin, N., Li, Y., Wang, C., Zhu, M., Dai, J., Hong, T., . . . Shen, H. (2021). Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. FRONTIERS OF MEDICINE, 15(2), 275-291. doi:10.1007/s11684-020-0779-4
Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model
Hung, R. J., Warkentin, M. T., Brhane, Y., Chatterjee, N., Christiani, D. C., Landi, M. T., . . . Amos, C. I. (2021). Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. CANCER RESEARCH, 81(6), 1607-1615. doi:10.1158/0008-5472.CAN-20-1237
Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers
Lesseur, C., Ferreiro-Iglesias, A., McKay, J. D., Bosse, Y., Johansson, M., Gaborieau, V., . . . Brennan, P. (2021). Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLOS GENETICS, 17(3). doi:10.1371/journal.pgen.1009254
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization
Zhou, W., Liu, G., Hung, R. J., Haycock, P. C., Aldrich, M. C., Andrew, A. S., . . . Amos, C. I. (2021). Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. INTERNATIONAL JOURNAL OF CANCER, 148(5), 1077-1086. doi:10.1002/ijc.33292
FP07.02 Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC
Haragan, A., Nekolla, K., Kapil, A., Brieu, N., Widmaier, M., Budco, A., . . . Gosney, J. (2021). FP07.02 Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC. Journal of Thoracic Oncology, 16(3), S203. doi:10.1016/j.jtho.2021.01.102
FP09.02 Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People
Field, J., Vulkan, D., Davies, M., Duffy, S., & Gabe, R. (2021). FP09.02 Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People. Journal of Thoracic Oncology, 16(3), S212. doi:10.1016/j.jtho.2021.01.119
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
Oudkerk, M., Liu, S., Heuvelmans, M. A., Walter, J. E., & Field, J. K. (n.d.). Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives. Nature Reviews Clinical Oncology. doi:10.1038/s41571-020-00432-6
I’am hiQ – A Novel Accuracy Index for Imputed Genotypes
Rare deleterious germline variants and risk of lung cancer
Liu, Y., Xia, J., McKay, J., Tsavachidis, S., Xiao, X., Spitz, M. R., . . . Amos, C. I. (2021). Rare deleterious germline variants and risk of lung cancer. NPJ PRECISION ONCOLOGY, 5(1). doi:10.1038/s41698-021-00146-7
Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer
Sun, R., Xu, M., Li, X., Gaynor, S., Zhou, H., Li, Z., . . . Lin, X. (2021). Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. GENETIC EPIDEMIOLOGY, 45(1), 99-114. doi:10.1002/gepi.22358
Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation
Field, J. K., Vulkan, D., Davies, M. P. A., Duffy, S. W., & Gabe, R. (2021). Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation. THORAX, 76(2), 161-168. doi:10.1136/thoraxjnl-2020-215158
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients
Jiang, M., Fares, A. F., Shepshelovich, D., Yang, P., Christiani, D., Zhang, J., . . . Liu, G. (2021). The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer, 152, 58-65. doi:10.1016/j.lungcan.2020.11.029
Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People
Field, J., Vulkan, D., Davies, M., Duffy, S., & Gabe, R. (2021). Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People. In JOURNAL OF THORACIC ONCOLOGY Vol. 16 (pp. S212). Retrieved from https://www.webofscience.com/
Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC
Haragan, A., Nekolla, K., Kapil, A., Brieu, N., Widmaier, M., Budco, A., . . . Gosney, J. (2021). Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC. In JOURNAL OF THORACIC ONCOLOGY Vol. 16 (pp. S203). Retrieved from https://www.webofscience.com/
I'am hiQ - A Novel Accuracy Index for Imputed Genotypes
Rosenberger, A., Viola, T., Hung, R. J., Amos, C. I., & Bickeboelle, H. (2021). I'am hiQ - A Novel Accuracy Index for Imputed Genotypes. In HUMAN HEREDITY Vol. 85 (pp. 90). Retrieved from https://www.webofscience.com/
Pacific-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with Durvalumab after chemoradiotherapy
Christoph, D. C., Girard, N., Smit, H. J. M., Sibille, A., McDonald, F., Mornex, F., . . . Fietkau, R. (2021). Pacific-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with Durvalumab after chemoradiotherapy. In ONCOLOGY RESEARCH AND TREATMENT Vol. 44 (pp. 53). Retrieved from https://www.webofscience.com/
The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis
Field, J., Vulkan, D., Davies, M., Gabe, R., & Duffy, S. (2021). The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis. In JOURNAL OF THORACIC ONCOLOGY Vol. 16 (pp. S882). Retrieved from https://www.webofscience.com/
2020
Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank
McCarthy, C. E., Bonnet, L. J., Marcus, M. W., & Field, J. K. (2020). Development and validation of a multivariable risk prediction model for head and neck cancer using the UK Biobank. INTERNATIONAL JOURNAL OF ONCOLOGY, 57(5), 1192-1202. doi:10.3892/ijo.2020.5123
Trans-ethnic genome-wide meta-analysis of 35,732 cases and 34,424 controls identifies novel genomic cross-ancestry loci contributing to lung cancer susceptibility
Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium
Brhane, Y., Yang, P., Christiani, D. C., Liu, G., McLaughlin, J. R., Brennan, P., . . . Hung, R. J. (2020). Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 29(10), 1983-1992. doi:10.1158/1055-9965.EPI-20-0248
Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy
Girard, N., Fietkau, R., Garassino, M., Garrido, P., Field, J. K., Peters, S., . . . Christoph, D. (2020). Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. In ANNALS OF ONCOLOGY Vol. 31 (pp. S805-S806). doi:10.1016/j.annonc.2020.08.115
Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks A Pooled Exposure-Response Analysis of 14 Case-Control Studies
Ge, C., Peters, S., Olsson, A., Portengen, L., Schuz, J., Almansa, J., . . . Vermeulen, R. (2020). Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks A Pooled Exposure-Response Analysis of 14 Case-Control Studies. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 202(3), 402-411. doi:10.1164/rccm.201911-2101OC
Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks A Pooled Analysis of Case-Control Studies
Ge, C., Peters, S., Olsson, A., Portengen, L., Schuz, J., Almansa, J., . . . Vermeulen, R. (2020). Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks A Pooled Analysis of Case-Control Studies. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 202(3), 412-421. doi:10.1164/rccm.201910-1926OC
Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls
Wang, Y., Gorlova, O. Y., Gorlov, I. P., Zhu, M., Dai, J., Albanes, D., . . . Shen, H. (2020). Association Analysis of Driver Gene–Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 29(7), 1423-1429. doi:10.1158/1055-9965.epi-19-1085
Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe.
Veronesi, G., Baldwin, D. R., Henschke, C. I., Ghislandi, S., Iavicoli, S., Oudkerk, M., . . . Pelosi, G. (2020). Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe.. Cancers, 12(6). doi:10.3390/cancers12061672
Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk
Dai, J., Huang, M., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., . . . Shen, H. (2020). Genome-wide association study of INDELs identified four novel susceptibility loci associated with lung cancer risk. INTERNATIONAL JOURNAL OF CANCER, 146(10), 2855-2864. doi:10.1002/ijc.32698
Protein-altering germline mutations implicate novel genes related to lung cancer development
Ji, X., Mukherjee, S., Landi, M. T., Bosse, Y., Joubert, P., Zhu, D., . . . Amos, C. I. (2020). Protein-altering germline mutations implicate novel genes related to lung cancer development. NATURE COMMUNICATIONS, 11. doi:10.1038/s41467-020-15905-6
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
Song, Y., Hu, C., Xie, Z., Wu, L., Zhu, Z., Rao, C., . . . Grp, A. M. E. L. C. C. (2020). Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort. TRANSLATIONAL LUNG CANCER RESEARCH, 9(2), 269-+. doi:10.21037/tlcr.2020.03.17
Transcriptome-wide association study reveals candidate causal genes for lung cancer
Bosse, Y., Li, Z., Xia, J., Manem, V., Carreras-Torres, R., Gabriel, A., . . . McKay, J. D. (2020). Transcriptome-wide association study reveals candidate causal genes for lung cancer. INTERNATIONAL JOURNAL OF CANCER, 146(7), 1862-1878. doi:10.1002/ijc.32771
Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis
Acha-Sagredo, A., Uko, B., Pantazi, P., Bediaga, N., Moschandrea, C., Rainbow, L., . . . Liloglou, T. (2020). Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. British Journal of Cancer, 122(7), 1050-1058. doi:10.1038/s41416-020-0742-9
<i>Lung cancer: a potential role for dentists</i>
Field, E. A., & Field, J. K. (2020). <i>Lung cancer: a potential role for dentists</i>. BRITISH DENTAL JOURNAL, 228(6), 413-414. doi:10.1038/s41415-020-1418-9
Mortality Reduction with Low-Dose CT Screening for Lung Cancer
Duffy, S. W., & Field, J. K. (2020). Mortality Reduction with Low-Dose CT Screening for Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE, 382(6), 572-573. doi:10.1056/NEJMe1916361
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Kachuri, L., Johansson, M., Rashkin, S. R., Graff, R. E., Bosse, Y., Manem, V., . . . Hung, R. J. (2020). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. NATURE COMMUNICATIONS, 11(1). doi:10.1038/s41467-019-13855-2
Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme (vol 134, pg 66, 2019)
Ghimire, B., Maroni, R., Vulkan, D., Shah, Z., Gaynor, E., Timoney, M., . . . Field, J. K. (2020). Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme (vol 134, pg 66, 2019). LUNG CANCER, 139, 224. doi:10.1016/j.lungcan.2019.10.007
2019
PREVALENCE AND OUTCOMES OF UNEXPECTED FINDINGS IN THE LIVERPOOL HEALTHY LUNG PROJECT (LHLP)
Cheng, Y., Field, J. K., Gaynor, E., Timoney, M., Arvanitis, R., McCann, C., . . . Ledson, M. (2019). PREVALENCE AND OUTCOMES OF UNEXPECTED FINDINGS IN THE LIVERPOOL HEALTHY LUNG PROJECT (LHLP). In THORAX Vol. 74 (pp. A128). doi:10.1136/thorax-2019-BTSabstracts2019.215
THE LIVERPOOL HEALTHY LUNG PROJECT - RAISING THE IMPORTANCE OF LUNG HEALTH
Ledson, M. J., Ahmed, M., Arvanitis, R., Timoney, M., Gaynor, E., & Field, J. (2019). THE LIVERPOOL HEALTHY LUNG PROJECT - RAISING THE IMPORTANCE OF LUNG HEALTH. In THORAX Vol. 74 (pp. A14). doi:10.1136/thorax-2019-BTSabstracts2019.28
Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review
Cheng, Y. I., Gan, Y. C., Liu, D., Davies, M. P. A., Li, W. M., & Field, J. K. (2019). Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review. BMC CANCER, 19(1). doi:10.1186/s12885-019-6317-6
Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening
Soo, E., Edey, A. J., Mak, S. M., Moser, J., Mohammadi, S., Rodrigues, T., . . . Devaraj, A. (2019). Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening. EUROPEAN JOURNAL OF RADIOLOGY, 120. doi:10.1016/j.ejrad.2019.108646
Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion.
Field, J. K., deKoning, H., Oudkerk, M., Anwar, S., Mulshine, J., Pastorino, U., . . . Prosch, H. (2019). Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion.. ESMO open, 4(5). doi:10.1136/esmoopen-2019-000577
Implementation Planning of Lung Cancer Screening in China
Cheng, Y., Davies, M., Liu, D., Li, W., & Field, J. (2019). Implementation Planning of Lung Cancer Screening in China. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S1008). doi:10.1016/j.jtho.2019.08.2223
Introductions & Welcome
Mulshine, J., & Field, J. (2019). Introductions & Welcome. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S196). doi:10.1016/j.jtho.2019.08.388
Liverpool Health Lung Project: Significant Incidental Findings in a Smoker-Predominant Cohort
Ledson, M., Cheng, Y., Gaynor, E., & Field, J. (2019). Liverpool Health Lung Project: Significant Incidental Findings in a Smoker-Predominant Cohort. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S524). doi:10.1016/j.jtho.2019.08.1094
Pathogenic Germline Rare Variants and Risk of Lung Cancer
Liu, Y., Mckay, J., Xiao, X., Field, J., Davies, M., Brennan, P., . . . Amos, C. (2019). Pathogenic Germline Rare Variants and Risk of Lung Cancer. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S689-S690). doi:10.1016/j.jtho.2019.08.1465
Session I: 2019 Status of the International Maturity of CT Trial Outcomes and Their Implications
Field, J., & Mulshine, J. (2019). Session I: 2019 Status of the International Maturity of CT Trial Outcomes and Their Implications. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S196-S197). doi:10.1016/j.jtho.2019.08.389
The Liverpool Healthy Lung Project - Championing the Importance of Lung Health
Ledson, M., Ahmed, M., Arvanitis, R., Timoney, M., Gaynor, E., & Field, J. (2019). The Liverpool Healthy Lung Project - Championing the Importance of Lung Health. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S530-S531). doi:10.1016/j.jtho.2019.08.1107
The UKLS Nodule Risk Model (UKLS-NRM): Utilising Nodule Volumetry
Marcus, M., Duffy, S., Devaraj, A., Oudkerk, M., Baldwin, D., & Field, J. (2019). The UKLS Nodule Risk Model (UKLS-NRM): Utilising Nodule Volumetry. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S529). doi:10.1016/j.jtho.2019.08.1105
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium
Shepshelovich, D., Xu, W., Lu, L., Fares, A., Yang, P., Christiani, D., . . . Hung, R. J. (2019). Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium. JOURNAL OF THORACIC ONCOLOGY, 14(9), 1594-1607. doi:10.1016/j.jtho.2019.05.031
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
Alcala, N., Leblay, N., Gabriel, A. A. G., Mangiante, L., Hervas, D., Giffon, T., . . . Fernandez-Cuesta, L. (2019). Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. NATURE COMMUNICATIONS, 10. doi:10.1038/s41467-019-11276-9
Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme
Ghimire, B., Maroni, R., Vulkan, D., Shah, Z., Gaynor, E., Timoney, M., . . . Field, J. K. (2019). Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme. LUNG CANCER, 134, 66-71. doi:10.1016/j.lungcan.2019.05.026
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response
Haragan, A., Field, J. K., Davies, M. P. A., Escriu, C., Gruver, A., & Gosney, J. R. (2019). Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response. Lung Cancer, 134, 79-84. doi:10.1016/j.lungcan.2019.06.005
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5<sub>p</sub>15.33 <i>TERT-CLPTM1Ll</i> Region
Hung, R. J., Spitz, M. R., Houlston, R. S., Schwartz, A. G., Field, J. K., Ying, J., . . . Gorlova, O. Y. (2019). Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5<sub>p</sub>15.33 <i>TERT-CLPTM1Ll</i> Region. JOURNAL OF THORACIC ONCOLOGY, 14(8), 1360-1369. doi:10.1016/j.jtho.2019.04.008
Abstract LB-053: Familial studies identify variants in the E2A transcription factor as putative risk factors for lung cancer
Pikielny, C. W., Musolf, A. M., Andrade, M. D., Mandal, D., Gaba, C., Yang, P., . . . Amos, C. I. (2019). Abstract LB-053: Familial studies identify variants in the E2A transcription factor as putative risk factors for lung cancer. Cancer Research, 79(13_Supplement). doi:10.1158/1538-7445.am2019-lb-053
Familial studies identify variants in the E2A transcription factor as putative risk factors for lung cancer
Pikielny, C. W., Musolf, A. M., de Andrade, M., Mandal, D., Gaba, C., Yang, P., . . . Amos, C. I. (2019). Familial studies identify variants in the E2A transcription factor as putative risk factors for lung cancer. In CANCER RESEARCH Vol. 79. doi:10.1158/1538-7445.SABCS18-LB-053
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer
Kachuri, L., Helby, J., Bojesen, S. E., Christiani, D. C., Su, L., Wu, X., . . . Hung, R. J. (2019). Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 28(7), 1228-1237. doi:10.1158/1055-9965.EPI-18-1215
Presentation of lung cancer in primary care
Weller, D. P., Peake, M. D., & Field, J. K. (2019). Presentation of lung cancer in primary care. NPJ PRIMARY CARE RESPIRATORY MEDICINE, 29. doi:10.1038/s41533-019-0133-y
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Kachuri, L., Johansson, M., Rashkin, S., Graff, R., Bossé, Y., Manem, V., . . . Hung, R. (2019). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility: bioRxiv. doi:10.1101/635318
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis
Zhu, Y., Wei, Y., Zhang, R., Dong, X., Shen, S., Zhao, Y., . . . Christiani, D. C. (2019). Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 28(5), 935-942. doi:10.1158/1055-9965.EPI-18-0356
Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial
Marcus, M. W., Duffy, S. W., Devaraj, A., Green, B. A., Oudkerk, M., Baldwin, D., & Field, J. K. (2019). Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial. Thorax, 74(08), 761-767. doi:10.1136/thoraxjnl-2018-212263
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy
Girard, N., Mornex, F., Christoph, D. C., Fietkau, R., Filippi, A. R., Field, J., . . . Garassino, M. C. (2019). PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy. Annals of Oncology, 30, ii37. doi:10.1093/annonc/mdz067.017
PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits
Haragan, A. K., Field, J. K., Davies, M. P. A., Escriu, C., Gruver, A., & Gosney, J. R. (2019). PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits. In JOURNAL OF PATHOLOGY Vol. 248 (pp. S11). Retrieved from https://www.webofscience.com/
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases
Haragan, A., Gosney, J., Field, J., Davies, M., Escriu, C., & Gruver, A. (2019). PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases. In Journal of Pathology Vol. 248 (pp. S11). Wiley-Blackwell.
Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.
Li, Y., Xiao, X., Bossé, Y., Gorlova, O., Gorlov, I., Han, Y., . . . Amos, C. I. (2019). Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.. Oncotarget, 10(19), 1760-1774. doi:10.18632/oncotarget.26678
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Seijo, L. M., Peled, N., Ajona, D., Boeri, M., Field, J. K., Sozzi, G., . . . Montuenga, L. M. (2019). Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. JOURNAL OF THORACIC ONCOLOGY, 14(3), 343-357. doi:10.1016/j.jtho.2018.11.023
Implementation planning for lung cancer screening in China
Cheng, Y. I., Davies, M. P. A., Liu, D., Li, W., & Field, J. K. (2019). Implementation planning for lung cancer screening in China. PRECISION CLINICAL MEDICINE, 2(1), 13-44. doi:10.1093/pcmedi/pbz002
Lung cancer screening programmes: landscape in China
Cheng, Y., Davies, M. P. A., Li, W., & Field, J. K. (2019). Lung cancer screening programmes: landscape in China. In LUNG CANCER Vol. 127 (pp. S60-S61). doi:10.1016/S0169-5002(19)30188-6
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.
Dai, J., Li, Z., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., . . . Shen, H. (2019). Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.. Carcinogenesis. doi:10.1093/carcin/bgy187
Liverpool Healthy Lung Project second year evaluation: deaths prevented and significant other findings
Hill, S., Ledson, M., Grundy, S., Gaynor, E., Fidoe, D., Mason, S., . . . Duffy, S. (2019). Liverpool Healthy Lung Project second year evaluation: deaths prevented and significant other findings. In LUNG CANCER Vol. 127 (pp. S92). doi:10.1016/S0169-5002(19)30264-8
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy
Girard, N., Mornex, F., Christoph, D. C., Fietkau, R., Filippi, A. R., Field, J., . . . Garassino, M. C. (2019). PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy. In ANNALS OF ONCOLOGY Vol. 30. Retrieved from https://www.webofscience.com/
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases
Haragan, A., Gosney, J., Field, J. K., Davies, M., Escriu, C., & Gruver, A. (2019). PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases. In LUNG CANCER Vol. 127 (pp. S25). doi:10.1016/S0169-5002(19)30106-0
The International Association for the Study of Lung Cancer Early Lung Imaging Confederation
Mulshine, J. L., Avila, R. S., Conley, E., Devaraj, A., Ambrose, L. F., Flanagan, T., . . . Field, J. K. (2020). The International Association for the Study of Lung Cancer Early Lung Imaging Confederation. JCO CLINICAL CANCER INFORMATICS, 4, 89-99. doi:10.1200/CCI.19.00099
2018
EARLY DIAGNOSIS OF LUNG CANCER THROUGH CASE FINDING - THE LIVERPOOL HEALTHY LUNG PROGRAM TWO YEARS ON
Ledson, M. J., Tippett, V., Arvanitis, R., Timoney, M., Gaynor, E., & Field, J. (2018). EARLY DIAGNOSIS OF LUNG CANCER THROUGH CASE FINDING - THE LIVERPOOL HEALTHY LUNG PROGRAM TWO YEARS ON. In THORAX Vol. 73 (pp. A254). doi:10.1136/thorax-2018-212555.435
EARLY OUTCOMES OF LUNG CANCER REFERRALS FROM THE LIVERPOOL HEALTHY LUNG PROJECT, A COMMUNITY BASED TARGETED LUNG CANCER SCREENING PILOT
Mason, S., Fidoe, D., Hill, S., Frost, F., Ledson, M. J., & Field, J. K. (2018). EARLY OUTCOMES OF LUNG CANCER REFERRALS FROM THE LIVERPOOL HEALTHY LUNG PROJECT, A COMMUNITY BASED TARGETED LUNG CANCER SCREENING PILOT. In THORAX Vol. 73 (pp. A256). doi:10.1136/thorax-2018-212555.440
LIVERPOOL HEALTHY LUNG PROJECT: DETECTION OF UNDIAGNOSED AIRWAYS DISEASE AND SIGNIFICANT OTHER FINDINGS IN A RISK STRATIFIED LUNG HEALTH CHECK
Fidoe, D., Hill, S., Gaynor, E., Field, J., Duffy, S., Ledson, M., & Grundy, S. (2018). LIVERPOOL HEALTHY LUNG PROJECT: DETECTION OF UNDIAGNOSED AIRWAYS DISEASE AND SIGNIFICANT OTHER FINDINGS IN A RISK STRATIFIED LUNG HEALTH CHECK. In THORAX Vol. 73 (pp. A201). doi:10.1136/thorax-2018-212555.342
Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners
Rosenberger, A., Hung, R. J., Christiani, D. C., Caporaso, N. E., Liu, G., Bojesen, S. E., . . . Gomolka, M. (2018). Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 91(8), 937-950. doi:10.1007/s00420-018-1334-3
Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?
Field, J. K., & Duffy, S. W. (2018). Lung cancer CT screening: are we ready to consider screening biennially in a subgroup of low-risk individuals?. THORAX, 73(11), 1006-1007. doi:10.1136/thoraxjnl-2018-211814
Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy
Haragan, A., Field, J., Davies, M., Escriu, C., Gruver, A., & Gosney, J. (2018). Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S534-S535). doi:10.1016/j.jtho.2018.08.739
Germline Mutation in ATM Affect Lung Cancer Risk with High Effect
Ji, X., Zhu, D., Pikielny, C., Gorlova, O., Landi, M., Field, J., . . . Amos, C. (2018). Germline Mutation in ATM Affect Lung Cancer Risk with High Effect. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S377-S378). doi:10.1016/j.jtho.2018.08.365
Liverpool Identifies the Hard to Reach Population at Risk of Developing Lung Cancer.
Ledson, M., Gaynor, E., Grundy, S., Hill, S., Fidoe, D., Mason, S., . . . Field, J. (2018). Liverpool Identifies the Hard to Reach Population at Risk of Developing Lung Cancer.. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S963-S964). doi:10.1016/j.jtho.2018.08.1809
Polygenic Risk Score for Risk Assessment
Hung, R., Brhane, Y., Chatterjie, N., Christiani, D., Caporaso, N., Landi, M., . . . Amos, C. (2018). Polygenic Risk Score for Risk Assessment. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S301-S302). doi:10.1016/j.jtho.2018.08.198
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer
Liu, Y., Lusk, C. M., Cho, M. H., Silverman, E. K., Qiao, D., Zhang, R., . . . Spitz, M. R. (2018). Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 13(10), 1483-1495. doi:10.1016/j.jtho.2018.06.016
Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment
Haragan, A., Field, J., Davies, M., Escriu, C., Gruver, A., & Gosney, J. (2018). Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S768). doi:10.1016/j.jtho.2018.08.1316
Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity
Ferreiro-Iglesias, A., Lesseur, C., McKay, J., Hung, R. J., Han, Y., Zong, X., . . . Brennan, P. (2018). Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. NATURE COMMUNICATIONS, 9, 12 pages. doi:10.1038/s41467-018-05890-2
Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.
Field, J. K. (2018). Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.. Nature Communications, 9. doi:10.1038/s41467-018-05074-y
Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers.
Kachuri, L., Saarela, O., Bojesen, S. E., Davey Smith, G., Liu, G., Landi, M. T., . . . Hung, R. J. (2018). Mendelian Randomization and mediation analysis of leukocyte telomere length and risk of lung and head and neck cancers.. International journal of epidemiology. doi:10.1093/ije/dyy140
Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma
Leblay, N., Alcala, N., Marin, D. H., Delhomme, T. M., Giffon, T., Ghantous, A., . . . Fernandez-Cuesta, L. (2018). Multi-omics comparative analyses of pulmonary typical carcinoids, atypical carcinoids, and large-cell neuroendocrine carcinoma. In CANCER RESEARCH Vol. 78. doi:10.1158/1538-7445.AM2018-5358
Multi-Omics Analysis Reveals a HIF Network and Hub Gene <i>EPAS1</i> Associated with Lung Adenocarcinoma
Wang, Z., Wei, Y., Zhang, R., Su, L., Gogarten, S. M., Liu, G., . . . Christiani, D. C. (2018). Multi-Omics Analysis Reveals a HIF Network and Hub Gene <i>EPAS1</i> Associated with Lung Adenocarcinoma. EBIOMEDICINE, 32, 93-101. doi:10.1016/j.ebiom.2018.05.024
Utilizing Lung Cancer Risk Prediction Models to Promote Smoking Cessation: Two Randomized Controlled Trials
Sherratt, F. C., Marcus, M. W., Robinson, J., & Field, J. K. (2018). Utilizing Lung Cancer Risk Prediction Models to Promote Smoking Cessation: Two Randomized Controlled Trials. AMERICAN JOURNAL OF HEALTH PROMOTION, 32(5), 1196-1205. doi:10.1177/0890117116673820
THE ROLE OF IMAGING IN SCREENING SPECIAL FEATURE: COMMENTARY EUPS-argues that lung cancer screening should be implemented in 18 months
Field, J. K., Baldwin, D. R., Devaraj, A., & Oudkerk, M. (2018). THE ROLE OF IMAGING IN SCREENING SPECIAL FEATURE: COMMENTARY EUPS-argues that lung cancer screening should be implemented in 18 months. BRITISH JOURNAL OF RADIOLOGY, 91(1090). doi:10.1259/bjr.20180243
Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial
Field, J. K., Duffy, S. W., & Baldwin, D. R. (2018). Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial. TRANSLATIONAL LUNG CANCER RESEARCH, 7(Suppl 2), S114-S116. doi:10.21037/tlcr.2018.03.12
Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population
Li, Y., Xiao, X., Han, Y., Gorlova, O., Qian, D., Leighl, N., . . . Amos, C. I. (2018). Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. CARCINOGENESIS, 39(3), 336-346. doi:10.1093/carcin/bgx113
Low-dose CT for lung cancer screening Reply
Field, J. K., Heuvelmans, M. A., Devaraj, A., Heussel, C. P., Baldwin, D. R., Vliegenthart, R., . . . Oudkerk, M. (2018). Low-dose CT for lung cancer screening Reply. LANCET ONCOLOGY, 19(3), E135-E136. doi:10.1016/S1470-2045(18)30122-0
Lung cancer and socioeconomic status in a pooled analysis of case-control studies.
Hovanec, J., Siemiatycki, J., Conway, D. I., Olsson, A., Stücker, I., Guida, F., . . . Behrens, T. (2018). Lung cancer and socioeconomic status in a pooled analysis of case-control studies.. PloS one, 13(2), e0192999. doi:10.1371/journal.pone.0192999
The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial
Nair, A., Screaton, N. J., Holemans, J. A., Jones, D., Clements, L., Barton, B., . . . Devaraj, A. (2018). The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial. EUROPEAN RADIOLOGY, 28(1), 226-234. doi:10.1007/s00330-017-4903-z
2017
Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium
Lohavanichbutr, P., Sakoda, L. C., Amos, C. I., Arnold, S. M., Christiani, D. C., Davies, M. P. A., . . . Chen, C. (2017). Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. CLINICAL CANCER RESEARCH, 23(24), 7550-7557. doi:10.1158/1078-0432.CCR-17-1401
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., . . . Field, J. K. (2017). European position statement on lung cancer screening. The Lancet Oncology, 18(12), E754-E766. doi:10.1016/S1470-2045(17)30861-6
THE LIVERPOOL HEALTHY LUNG PROJECT (LHLP) - SEEKING OUT LUNG DISEASE
Ledson, M. J., Grundy, S., Arvanitis, R., Timoney, M., Gaynor, E., & Field, J. (2017). THE LIVERPOOL HEALTHY LUNG PROJECT (LHLP) - SEEKING OUT LUNG DISEASE. In THORAX Vol. 72 (pp. A10-A11). doi:10.1136/thoraxjnl-2017-210983.18
EU Policy on Lung Cancer CT Screening 2017.
Field, J. K., Zulueta, J., Veronesi, G., Oudkerk, M., Baldwin, D. R., Holst Pedersen, J., . . . de Koning, H. J. (2017). EU Policy on Lung Cancer CT Screening 2017.. Biomedicine hub, 2(Suppl 1), 154-161. doi:10.1159/000479810
P2.13-025 Selecting the Risk Cut off for the LLP Model
Haaf, K. T., De Koning, H., & Field, J. (2017). P2.13-025 Selecting the Risk Cut off for the LLP Model. Journal of Thoracic Oncology, 12(11), S2174. doi:10.1016/j.jtho.2017.09.1371
Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review)
McCarthy, C. E., Field, J. K., & Marcus, M. W. (2017). Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review). ONCOLOGY REPORTS, 38(4), 1915-1922. doi:10.3892/or.2017.5867
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium
Wang, T., Moon, J. -Y., Wu, Y., Amos, C. I., Hung, R. J., Tardon, A., . . . Ho, G. Y. F. (2017). Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium. PLOS ONE, 12(9). doi:10.1371/journal.pone.0185660
Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial
Brain, K., Carter, B., Lifford, K. J., Burke, O., Devaraj, A., Baldwin, D. R., . . . Field, J. K. (2017). Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. THORAX, 72(10), 912-918. doi:10.1136/thoraxjnl-2016-209690
Management of proliferative verrucous leukoplakia: Justification for a conservative approach.
Borgna, S. C., Clarke, P. T., Schache, A. G., Lowe, D., Ho, M. W., McCarthy, C. E., . . . Shaw, R. J. (2017). Management of proliferative verrucous leukoplakia: Justification for a conservative approach.. Head & neck, 39(10), 1997-2003. doi:10.1002/hed.24845
Association between smoking and health outcomes in an economically deprived population: the Liverpool Lung Project
Sherratt, F. C., Field, J. K., & Marcus, M. W. (2017). Association between smoking and health outcomes in an economically deprived population: the Liverpool Lung Project. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 71(8), 806-810. doi:10.1136/jech-2016-208730
Scientific Advances in Thoracic Oncology 2016
Soo, R. A., Stone, E. C. A., Cummings, K. M., Jett, J. R., Field, J. K., Groen, H. J. M., . . . Spigel, D. R. (2017). Scientific Advances in Thoracic Oncology 2016. JOURNAL OF THORACIC ONCOLOGY, 12(8), 1183-1209. doi:10.1016/j.jtho.2017.05.019
The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals
Dunn, C. E., Edwards, A., Carter, B., Field, J. K., Brain, K., & Lifford, K. J. (2017). The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals. PATIENT EDUCATION AND COUNSELING, 100(8), 1572-1579. doi:10.1016/j.pec.2017.02.024
COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.
Oleksiewicz, U., Liloglou, T., Tasopoulou, K. -M., Daskoulidou, N., Gosney, J. R., Field, J. K., & Xinarianos, G. (2017). COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer.. Journal of Cancer Research and Clinical Oncology, 143(7), 1133-1141. doi:10.1007/s00432-017-2381-y
Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium
Lohavanichbutr, P., Sakoda, L. C., Amos, C. I., Arnold, S. M., Christiani, D. C., Davies, M. P., . . . Chen, C. (2017). Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium. In CANCER RESEARCH Vol. 77. doi:10.1158/1538-7445.AM2017-2248
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study
Schroeck, A., Leisse, A., de Vos, L., Gevensleben, H., Droege, F., Franzen, A., . . . Dietrich, D. (2017). Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study. CLINICAL CHEMISTRY, 63(7), 1288-1296. doi:10.1373/clinchem.2016.270207
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.
McKay, J. D., Hung, R. J., Han, Y., Zong, X., Carreras-Torres, R., Christiani, D. C., . . . Field, J. K. (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.. Nature Genetics, 49(7), 1126-1132. doi:10.1038/ng.3892
Liverpool healthy lung project: a primary care initiative to identify hard to reach individuals with a high risk of developing lung cancer
Field, J. K., Gaynor, E. S., Duffy, S. W., Gardner, K., Hubbert, C., Tsintzos, D., . . . Ledson, M. (2017). Liverpool healthy lung project: a primary care initiative to identify hard to reach individuals with a high risk of developing lung cancer. In CANCER RESEARCH Vol. 77. doi:10.1158/1538-7445.AM2017-4220
Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium
Kachuri, L., Johansson, M., Brennan, P., Haycock, P., Liu, G., Landi, M. T., . . . Hung, R. J. (2017). Lung function and lung cancer risk: a Mendelian randomization study of UK Biobank cohort and the International Lung Cancer Consortium. In CANCER RESEARCH Vol. 77. doi:10.1158/1538-7445.AM2017-2292
AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer
Al-Khafaji, A. S. K., Marcus, M. W., Davies, M. P. A., Risk, J. M., Shaw, R. J., Field, J. K., & Liloglou, T. (2017). AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncology letters, 13(6), 4463-4468. doi:10.3892/ol.2017.6012
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
Carreras-Torres, R., Johansson, M., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., . . . Brennan, P. (2017). Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLOS ONE, 12(6). doi:10.1371/journal.pone.0177875
Risk prediction modeling in lung cancer: How can we improve?
Field, J. K., & Marcus, M. W. (2017). Risk prediction modeling in lung cancer: How can we improve?. In CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Vol. 26. doi:10.1158/1538-7755.CARISK16-IA17
Is Bootstrapping Sufficient for Validating a Risk Model for Selection of Participants for a Lung Cancer Screening Program?
Marcus, M. W., & Field, J. K. (2017). Is Bootstrapping Sufficient for Validating a Risk Modelfor Selection of Participants for a Lung CancerScreening Program?. Journal of Clinical Oncology, 35(8), 818-819. doi:10.1200/JCO.2016.71.3214
Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies
Olsson, A. C., Vermeulen, R., Schuz, J., Kromhout, H., Pesch, B., Peters, S., . . . Straif, K. (2017). Exposure-Response Analyses of Asbestos and Lung Cancer Subtypes in a Pooled Analysis of Case-Control Studies. EPIDEMIOLOGY, 28(2), 288-299. doi:10.1097/EDE.0000000000000604
Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
Al-Khafaji, A. S., Davies, M. P., Risk, J. M., Marcus, M. W., Koffa, M., Gosney, J. R., . . . Liloglou, T. (2017). Aurora B expression modulates paclitaxel response in non-small cell lung cancer.. British journal of cancer, 116(05), 592-599. doi:10.1038/bjc.2016.453
Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer
Carvalho, A. S., Cuco, C. M., Lavareda, C., Miguel, F., Ventura, M., Almeida, S., . . . Matthiesen, R. (2017). Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer. SCIENTIFIC REPORTS, 7. doi:10.1038/srep42190
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.
Amos, C. I., Dennis, J., Wang, Z., Byun, J., Schumacher, F. R., Gayther, S. A., . . . Easton, D. F. (2017). The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.. Cancer Epidemiology, Biomarkers and Prevention, 26(1), 126-135. doi:10.1158/1055-9965.epi-16-0106
Genome-Wide Interaction Study of Smoking Behavior and Non-Small Cell Lung Cancer Risk in Caucasian Population
Li, Y., Xiao, X., Han, Y., Gorlova, O. Y., Christiani, D., Johansson, M., . . . Amos, C. I. (2017). Genome-Wide Interaction Study of Smoking Behavior and Non-Small Cell Lung Cancer Risk in Caucasian Population. In GENETIC EPIDEMIOLOGY Vol. 41 (pp. 662). Retrieved from https://www.webofscience.com/
Optimum low dose CT screening interval for lung cancer: the answer from NELSON?
Baldwin, D. R., Duffy, S. W., Devaraj, A., & Field, J. K. (2017). Optimum low dose CT screening interval for lung cancer: the answer from NELSON?. THORAX, 72(1), 6-7. doi:10.1136/thoraxjnl-2016-209011
Risk assessment in relation to the detection of small pulmonary nodules
Field, J. K., Marcus, M. W., & Oudkerk, M. (2017). Risk assessment in relation to the detection of small pulmonary nodules. TRANSLATIONAL LUNG CANCER RESEARCH, 6(1), 35-41. doi:10.21037/tlcr.2017.02.05
Selecting the Risk Cut off for the LLP Model
Ten Haaf, K., De Koning, H., & Field, J. (2017). Selecting the Risk Cut off for the LLP Model. In JOURNAL OF THORACIC ONCOLOGY Vol. 12 (pp. S2173). Retrieved from https://www.webofscience.com/
The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer
Meyer, M., Bell, T., Sussman, D., Wilbur, D., Presley, C., Hayenga, J., . . . Nelson, A. (2017). The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer. In JOURNAL OF THORACIC ONCOLOGY Vol. 12 (pp. S343-S344). doi:10.1016/j.jtho.2016.11.375
UK Lung Screening Trial Cost Effectiveness and Current Planning Status of International Lung Cancer Screening Programs
Field, J. (2017). UK Lung Screening Trial Cost Effectiveness and Current Planning Status of International Lung Cancer Screening Programs. In JOURNAL OF THORACIC ONCOLOGY Vol. 12 (pp. S119). doi:10.1016/j.jtho.2016.11.105
2016
THE LIVERPOOL HEALTHY LUNG PROJECT - SEEKING OUT EARLY STAGE LUNG CANCER
Ledson, M. J., Grundy, S., Gaynor, E., Arvanitis, R., Timoney, M., & Field, J. (2016). THE LIVERPOOL HEALTHY LUNG PROJECT - SEEKING OUT EARLY STAGE LUNG CANCER. In THORAX Vol. 71 (pp. A138-A139). doi:10.1136/thoraxjnl-2016-209333.245
Lung Cancer Among Firefighters: Smoking-Adjusted Risk Estimates in a Pooled Analysis of Case-Control Studies
Bigert, C., Gustavsson, P., Straif, K., Taeger, D., Pesch, B., Kendzia, B., . . . Olsson, A. C. (2016). Lung Cancer Among Firefighters: Smoking-Adjusted Risk Estimates in a Pooled Analysis of Case-Control Studies. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 58(11), 1137-1143. doi:10.1097/JOM.0000000000000878
Defining the Genetic Architecture of Lung Cancer Etiology
Amos, C. I., Hung, R., Bosse, Y., Christiani, D. C., Fields, J. K., Landi, M. T., . . . McKay, J. P. (2016). Defining the Genetic Architecture of Lung Cancer Etiology. In JOURNAL OF THORACIC ONCOLOGY Vol. 11 (pp. S182). doi:10.1016/j.jtho.2016.08.026
P1.04: Defining the Genetic Architecture of Lung Cancer Etiology: Track: Prevention, Early Detection, Epidemiology and Tobacco Control.
Amos, C. I., Hung, R., Bosse, Y., Christiani, D. C., Field, J. K., Landi, M. T., . . . Mckay, J. P. (2016). P1.04: Defining the Genetic Architecture of Lung Cancer Etiology: Track: Prevention, Early Detection, Epidemiology and Tobacco Control.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 11(10S), S182. doi:10.1016/j.jtho.2016.08.026
Implementation planning for lung cancer screening: five major challenges
Field, J. K., Duffy, S. W., Devaraj, A., & Baldwin, D. R. (2016). Implementation planning for lung cancer screening: five major challenges. LANCET RESPIRATORY MEDICINE, 4(9), 685-687. doi:10.1016/S2213-2600(16)30233-8
P025 Lung cancer risk among firefighters when accounting for tobacco smoking – preliminary results from a pooled analysis of case-control studies from europe, canada, new zealand and china
Bigert, C., Gustavsson, P., Straif, K., Taeger, D., Pesch, B., Kendzia, B., . . . Olsson, A. C. (2016). P025 Lung cancer risk among firefighters when accounting for tobacco smoking – preliminary results from a pooled analysis of case-control studies from europe, canada, new zealand and china. In Cancer. BMJ Publishing Group Ltd. doi:10.1136/oemed-2016-103951.350
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study
Carreras-Torres, R., Haycock, P. C., Relton, C. L., Martin, R. M., Smith, G. D., Kraft, P., . . . Brennan, P. (2016). The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31121
Long-term psychosocial outcomes of low-dose CT screening: Results of the UK Lung Cancer Screening randomised controlled trial
Brain, K., Lifford, K. J., Carter, B., Burke, O., McRonald, F., Devaraj, A., . . . Field, J. K. (2016). Long-term psychosocial outcomes of low-dose CT screening: Results of the UK Lung Cancer Screening randomised controlled trial. Thorax, 71(11), 996-1005. doi:10.1136/thoraxjnl-2016-208283
A genome wide association study of lung cancer identifies 11 novel susceptibility loci
Mckay, J. D., Li, Y., Han, Y., Xioa, X., Field, J., Zong, X., . . . Amos, C. I. (2016). A genome wide association study of lung cancer identifies 11 novel susceptibility loci. In CANCER RESEARCH Vol. 76. doi:10.1158/1538-7445.AM2016-2569
Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk
Kachuri, L., Smith, G. D., Liu, G., Landi, M. T., Christiani, D. C., Caporaso, N. E., . . . Hung, R. J. (2016). Mendelian randomization and mediation analysis of 5p15.33, telomere length and lung cancer risk. In CANCER RESEARCH Vol. 76. doi:10.1158/1538-7445.AM2016-817
UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles
Whynes, D., Duffy, S. W., Baldwin, D. R., Devaraj, A., & Field, J. K. (2016). UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles. In CANCER RESEARCH Vol. 76. doi:10.1158/1538-7445.AM2016-3458
Occupational prestige, social mobility and the association with lung cancer in men
Behrens, T., Gross, I., Siemiatycki, J., Conway, D. I., Olsson, A., Stuecker, I., . . . Bruening, T. (2016). Occupational prestige, social mobility and the association with lung cancer in men. BMC CANCER, 16. doi:10.1186/s12885-016-2432-9
Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage.
Zheng, D., Sato, S., Arima, H., Heeley, E., Delcourt, C., Cao, Y., . . . INTERACT2 Investigators. (2016). Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage.. American journal of kidney diseases : the official journal of the National Kidney Foundation, 68(1), 94-102. doi:10.1053/j.ajkd.2016.01.020
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model
Marcus, M. W., Raji, O. Y., Duffy, S. W., Young, R. P., Hopkins, R. J., & Field, J. K. (2016). Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model. INTERNATIONAL JOURNAL OF ONCOLOGY, 49(1), 361-370. doi:10.3892/ijo.2016.3499
Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology group
Sherratt, F. C., Newson, L., & Field, J. K. (2016). Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology group. RESPIRATORY RESEARCH, 17. doi:10.1186/s12931-016-0367-y
Lung cancer CT screening: is annual screening necessary?
Field, J. K., & Duffy, S. W. (2016). Lung cancer CT screening: is annual screening necessary?. LANCET ONCOLOGY, 17(5), 543-544. doi:10.1016/S1470-2045(16)00079-6
Perceptions towards electronic cigarettes for smoking cessation among Stop Smoking Service users
Sherratt, F. C., Newson, L., Marcus, M. W., Field, J. K., & Robinson, J. (2016). Perceptions towards electronic cigarettes for smoking cessation among Stop Smoking Service users. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 21(2), 421-433. doi:10.1111/bjhp.12177
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
Field, J. K., Duffy, S. W., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., . . . Hansell, D. M. (2016). The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.. Health Technology Assessment, 20(40), 1-146. doi:10.3310/hta20400
Response to Oral epithelial dysplasia in oral submucous fibrosis: A challenge
Field, E. A., McCarthy, C. E., Ho, M. W., Rajlawat, B. P., Holt, D., Rogers, S. N., . . . Shaw, R. J. (2016). Response to Oral epithelial dysplasia in oral submucous fibrosis: A challenge. ORAL ONCOLOGY, 54, E20. doi:10.1016/j.oraloncology.2015.11.006
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
Field, J. K., Duffy, S. W., Baldwin, D. R., Whynes, D. K., Devaraj, A., Brain, K. E., . . . Hansell, D. M. (2016). UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax, 71(2), 161-170. doi:10.1136/thoraxjnl-2015-207140
CT screening for lung cancer: Is the evidence strong enough?
Field, J. K., Devaraj, A., Duffy, S. W., & Baldwin, D. R. (2016). CT screening for lung cancer: Is the evidence strong enough?. LUNG CANCER, 91, 29-35. doi:10.1016/j.lungcan.2015.11.003
Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer
Escriu, C., & Field, J. K. (2016). Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer. JOURNAL OF THORACIC DISEASE, 8(9), 2357-2359. doi:10.21037/jtd.2016.07.96
Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial
Nair, A., Gartland, N., Barton, B., Jones, D., Clements, L., Screaton, N. J., . . . Devaraj, A. (2016). Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial. BRITISH JOURNAL OF RADIOLOGY, 89(1066). doi:10.1259/bjr.20160301
Computed Tomography Characterisation of Lung Nodules and Management of Incidentally Detected Nodules
Devaraj, A., Sayer, C., & Field, J. (2016). Computed Tomography Characterisation of Lung Nodules and Management of Incidentally Detected Nodules. In MULTIDETECTOR-ROW CT OF THE THORAX, 2ND EDITION (pp. 183-193). doi:10.1007/978-3-319-30355-0_10
Electronic cigarettes: a survey of observed patient use and attitudes among members of the British Thoracic Oncology Group
Sherratt, F. C., Newson, L., & Field, J. K. (2016). Electronic cigarettes: a survey of observed patient use and attitudes among members of the British Thoracic Oncology Group. In LUNG CANCER Vol. 91 (pp. S42). doi:10.1016/S0169-5002(16)30134-9
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci
Kachuri, L., Amos, C. I., Mckay, J. D., Johansson, M., Vineis, P., Bueno-de-Mesquita, H. B., . . . Hung, R. J. (2016). Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci. CARCINOGENESIS, 37(1), 96-105. doi:10.1093/carcin/bgv165
2015
Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions
Qian, D. C., Byun, J., Han, Y., Greene, C. S., Field, J. K., Hung, R. J., . . . Amos, C. I. (2015). Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions. HUMAN MOLECULAR GENETICS, 24(25), 7406-7420. doi:10.1093/hmg/ddv440
Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Huang, R., Wei, Y., Hung, R. J., Liu, G., Su, L., Zhang, R., . . . Christiani, D. C. (2015). Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBIOMEDICINE, 2(11), 1677-1685. doi:10.1016/j.ebiom.2015.09.031
Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer
Hung, R. J., Ulrich, C. M., Goode, E. L., Brhane, Y., Muir, K., Chan, A. T., . . . Henderson, B. (2015). Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 107(11). doi:10.1093/jnci/djv246
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia
Brenner, D. R., Amos, C. I., Brhane, Y., Timofeeva, M. N., Caporaso, N., Wang, Y., . . . Hung, R. J. (2015). Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis, 36(11), 1314-1326. doi:10.1093/carcin/bgv128
The management of oral epithelial dysplasia: The Liverpool algorithm
Field, E. A., McCarthy, C. E., Ho, M. W., Rajlawat, B. P., Holt, D., Rogers, S. N., . . . Shaw, R. J. (2015). The management of oral epithelial dysplasia: The Liverpool algorithm. ORAL ONCOLOGY, 51(10), 883-887. doi:10.1016/j.oraloncology.2015.06.015
Lung cancer among coal miners, ore miners and quarrymen: smoking-adjusted risk estimates from the synergy pooled analysis of case-control studies
Taeger, D., Pesch, B., Kendzia, B., Behrens, T., Joeckel, K. -H., Dahmann, D., . . . Bruening, T. (2015). Lung cancer among coal miners, ore miners and quarrymen: smoking-adjusted risk estimates from the synergy pooled analysis of case-control studies. SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 41(5), 467-477. doi:10.5271/sjweh.3513
Comprehensive genomic profiles of small cell lung cancer.
Field, J. (2015). Comprehensive genomic profiles of small cell lung cancer.. Nature, 524, 47-53. doi:10.1038/nature14664
Exome sequencing of UKLS lung cancer CT screened early stage cancers
Hyde, R., Davies, M., Ledson, M., Holemans, J. A., Page, R. D., Gosney, J., . . . FieId, J. K. (2015). Exome sequencing of UKLS lung cancer CT screened early stage cancers. In CANCER RESEARCH Vol. 75. doi:10.1158/1538-7445.AM2015-4602
Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020
Olajide, O. O., Field, J. K., Davies, M. M. P. A., & Marcus, M. W. (2015). Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020. INTERNATIONAL JOURNAL OF ONCOLOGY, 47(2), 739-746. doi:10.3892/ijo.2015.3049
Electronic cigarette use and risk perception in a Stop Smoking Service in England
Sherratt, F. C., Marcus, M. W., Robinson, J., Newson, L., & Field, J. K. (2015). Electronic cigarette use and risk perception in a Stop Smoking Service in England. ADDICTION RESEARCH & THEORY, 23(4), 336-342. doi:10.3109/16066359.2015.1006629
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial
Ali, N., Lifford, K. J., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D. R., . . . Brain, K. (2015). Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ OPEN, 5(7). doi:10.1136/bmjopen-2015-008254
Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011
McCarthy, C. E., Field, J. K., Rajlawat, B. P., Field, A. E., & Marcus, M. W. (2015). Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011. INTERNATIONAL JOURNAL OF ONCOLOGY, 47(1), 204-210. doi:10.3892/ijo.2015.2990
Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020
OLAJIDE, O. O., FIELD, J. K., DAVIES, M. M. P. A., & MARCUS, M. W. (2015). Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020. International Journal of Oncology, 47(2), 739-746. doi:10.3892/ijo.2015.3049
Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020.
Olajide, O. O., Field, J., Davies, M. M. P. A., & Marcus, M. W. (2015). Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020.. International Journal of Oncology.
LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence
Marcus, M. W., Chen, Y., Raji, O. Y., Duffy, S. W., & Field, J. K. (2015). LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence. CANCER PREVENTION RESEARCH, 8(6), 570-575. doi:10.1158/1940-6207.CAPR-14-0438
Risk prediction models in lung cancer: The methodology for identifying high risk individuals for future lung cancer computed tomography (CT) screening programs
Field, J. K., & Marcus, M. W. (2015). Risk prediction models in lung cancer: The methodology for identifying high risk individuals for future lung cancer computed tomography (CT) screening programs. AACR Education book, 2015(1), 125-132. doi:10.1158/aacr.edb-15-8767
Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.
Marcus, M. W., Chen, Y., Duffy, S. W., & Field, J. (2015). Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.. Oncology Letters, 9(4), 1902-1906.
Lung cancer screening: identifying the high risk cohort.
Marcus, M. W., Raji, O. Y., & Field, J. K. (2015). Lung cancer screening: identifying the high risk cohort.. Journal of thoracic disease, 7(Suppl 2), S156-S162. doi:10.3978/j.issn.2072-1439.2015.04.19
Lung Cancer Risk Among Cooks When Accounting for Tobacco Smoking <i>A Pooled Analysis of Case</i>-<i>Control Studies From Europe, Canada, New Zealand, and China</i>
Bigert, C., Gustavsson, P., Straif, K., Pesch, B., Bruening, T., Kendzia, B., . . . Olsson, A. C. (2015). Lung Cancer Risk Among Cooks When Accounting for Tobacco Smoking <i>A Pooled Analysis of Case</i>-<i>Control Studies From Europe, Canada, New Zealand, and China</i>. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 57(2), 202-209. doi:10.1097/JOM.0000000000000337
A concordance index for matched case-control studies with applications in cancer risk
Brentnall, A. R., Cuzick, J., Field, J., & Duffy, S. W. (2015). A concordance index for matched case-control studies with applications in cancer risk. STATISTICS IN MEDICINE, 34(3), 396-405. doi:10.1002/sim.6335
Lung cancer risk among bricklayers in a pooled analysis of case-control studies
Consonni, D., De Matteis, S., Pesatori, A. C., Bertazzi, P. A., Olsson, A. C., Kromhout, H., . . . Straif, K. (2015). Lung cancer risk among bricklayers in a pooled analysis of case-control studies. INTERNATIONAL JOURNAL OF CANCER, 136(2), 360-371. doi:10.1002/ijc.28986
124: Electronic cigarette use and risk perception in a Stop Smoking Service in England
Sherratt, F., Marcus, M., Robinson, J., Newson, L., & Field, J. (2015). 124: Electronic cigarette use and risk perception in a Stop Smoking Service in England. In Lung Cancer Vol. 87 (pp. S45). Elsevier BV. doi:10.1016/s0169-5002(15)50118-9
Application of SureSeq solid tumour panel sequencing to a panel of FFPE samples of non small cell lung cancer from the Liverpool lung project
Hyde, R., Davies, M. P. A., Gosney, J., & Field, J. (2015). Application of SureSeq solid tumour panel sequencing to a panel of FFPE samples of non small cell lung cancer from the Liverpool lung project. In LUNG CANCER Vol. 87 (pp. S5). doi:10.1016/S0169-5002(15)50011-1
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial
Ali, N., Lifford, K. J., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D. R., . . . Brain, K. (2015). Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ open, 5(7), e008254.
Electronic cigarette use and risk perception in a Stop Smoking Service in England
Sherratt, F., Marcus, M., Robinson, J., Newson, L., & Field, J. (2015). Electronic cigarette use and risk perception in a Stop Smoking Service in England. In LUNG CANCER Vol. 87 (pp. S45). doi:10.1016/S0169-5002(15)50118-9
Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project
Marcus, M. W., Chen, Y., Duffy, S. W., & Field, J. K. (2015). Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project. ONCOLOGY LETTERS, 9(4), 1902-1906. doi:10.3892/ol.2015.2916
Lung Cancer Screening
Field, J. K. (2015). Lung Cancer Screening. In New Therapeutic Strategies in Lung Cancers (pp. 1-11). Springer International Publishing. doi:10.1007/978-3-319-06062-0_1
Lung cancer screening: identifying the high risk cohort
Marcus, M. W., Raji, O. Y., & Field, J. K. (2015). Lung cancer screening: identifying the high risk cohort. JOURNAL OF THORACIC DISEASE, 7, S156-S162. doi:10.3978/j.issn.2072-1439.2015.04.19
Screening
Field, J. K., Devaraj, A., Duffy, S. W., & Baldwin, D. R. (n.d.). Screening. Unknown Journal, 12-23. doi:10.1183/2312508x.10009214
Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011
McCARTHY, C. E., FIELD, J. K., RAJLAWAT, B. P., FIELD, A. E., & MARCUS, M. W. (2015). Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011. International Journal of Oncology, 47(1), 204-210. doi:10.3892/ijo.2015.2990
UKLS Impact of Utilization of Risk Assessment in Trial Selection
Field, J. K., Devaraj, A., Baldwin, D. R., & Duffy, S. (2015). UKLS Impact of Utilization of Risk Assessment in Trial Selection. JOURNAL OF THORACIC ONCOLOGY, 10(9), S114-S115. Retrieved from https://www.webofscience.com/
Volatile biomarkers for discrimination of lung cancer risk and mutation
Davies, M. P. A., Barash, O., Jeries, R., Peled, N., Ilouze, M., Hyde, R., . . . Field, J. (2015). Volatile biomarkers for discrimination of lung cancer risk and mutation. In LUNG CANCER Vol. 87 (pp. S4-S5). doi:10.1016/S0169-5002(15)50010-X
2014
Education and Lung Cancer Among Never Smokers
Menvielle, G., Truong, T., Jellouli, F., Stücker, I., Brenner, H., Field, J. K., . . . Luce, D. (2014). Education and Lung Cancer Among Never Smokers. Epidemiology, 25(6), 934-935. doi:10.1097/ede.0000000000000183
Education and lung cancer among never smokers
Menvielle, G., Truong, T., Jellouli, F., Stücker, I., Brenner, H., Field, J., . . . Luce, D. (2014). Education and lung cancer among never smokers. Epidemiology (Cambridge, Mass.), 25(6), 934-935.
Cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets
Fernandez-Cuesta, L., Peifer, M., Lu, X., Seidel, D., Zander, T., Leenders, F., . . . Thomas, R. K. (2014). Cross-entity mutation analysis of lung neuroendocrine tumors sheds light into their molecular origin and identifies new therapeutic targets. In CANCER RESEARCH Vol. 74. doi:10.1158/1538-7445.AM2014-1531
Perspective: The screening imperative
Field, J. K. (2014). Perspective: The screening imperative. NATURE, 513(7517), S7. doi:10.1038/513S7a
Perspective: The screening imperative.
Field, J. (2014). Perspective: The screening imperative.. Nature, 513(7517), S7.
Unique volatolomic signatures of TP53 and KRAS in lung cells
Davies, M. P. A., Barash, O., Jeries, R., Peled, N., Ilouze, M., Hyde, R., . . . Haick, H. (2014). Unique volatolomic signatures of TP53 and KRAS in lung cells. BRITISH JOURNAL OF CANCER, 111(6), 1213-1221. doi:10.1038/bjc.2014.411
Unique volatolomic signatures of TP53 and KRAS in lung cells.
Davies, M. P. A., Barash, O., Jeries, R., Peled, N., Ilouze, M., Hyde, R., . . . Haick, H. (2014). Unique volatolomic signatures of TP53 and KRAS in lung cells.. British Journal of Cancer, 111(6), 1213-1221.
Is Previous Respiratory Disease a Risk Factor for Lung Cancer?
Denholm, R., Schuez, J., Straif, K., Stuecker, I., Joecke, K. -H. I., Brenner, D. R., . . . Olsson, A. C. (2014). Is Previous Respiratory Disease a Risk Factor for Lung Cancer?. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 190(5), 549-559. doi:10.1164/rccm.201402-0338OC
Is previous respiratory disease a risk factor for lung cancer?
Denholm, R., Schüz, J., Straif, K., Stücker, I., Jöckel, K. -H., Brenner, D. R., . . . C Olsson, A. (2014). Is previous respiratory disease a risk factor for lung cancer?. American Journal of Respiratory and Critical Care Medicine, 190(5), 549-559.
Is previous respiratory disease a risk factor for lung cancer?
Denholm, R., Schüz, J., Straif, K., Stücker, I., Jöckel, K. -H., Brenner, D. R., . . . C Olsson, A. (2014). Is previous respiratory disease a risk factor for lung cancer?. American Journal of Respiratory and Critical Care Medicine, 190(5), 549-559.
Market survey of aromatic amines in textiles and leathers to support health Canada's Chemicals Management Plan
Field, J., Ritchot, N., Chantal, P., Aikawa, B., Barrett, G., Pelletier, P., . . . Sutton, C. (2014). Market survey of aromatic amines in textiles and leathers to support health Canada's Chemicals Management Plan. In TOXICOLOGY LETTERS Vol. 229 (pp. S221). doi:10.1016/j.toxlet.2014.06.743
Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).
Kim, C. H., Lee, Y. -C. A., Hung, R. J., McNallan, S. R., Cote, M. L., Lim, W. -Y., . . . Zhang, Z. -F. (2014). Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).. International Journal of Cancer. Journal international du cancer, 135(8), 1918-1930. doi:10.1002/ijc.28835
MyLungRisk: a user-friendly, web-based calculator for risk assessment of lung cancer based on the validated Liverpool Lung Project risk prediction model
Chen, Y., Marcus, M. W., Niaz, A., Duffy, S. W., & Field, J. K. (2014). MyLungRisk: a user-friendly, web-based calculator for risk assessment of lung cancer based on the validated Liverpool Lung Project risk prediction model. International Journal of Health Promotion and Education, 52(3), 144-152. doi:10.1080/14635240.2014.888814
Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom
Duffy, S. W., Field, J. K., Allgood, P. C., & Seigneurin, A. (2014). Translation of research results to simple estimates of the likely effect of a lung cancer screening programme in the United Kingdom. BRITISH JOURNAL OF CANCER, 110(7), 1834-1840. doi:10.1038/bjc.2014.63
E-Cigarettes and Cancer Patients
Cummings, K. M., Dresler, C. M., Field, J. K., Fox, J., Gritz, E. R., Hanna, N. H., . . . Zhou, C. (2014). E-Cigarettes and Cancer Patients. JOURNAL OF THORACIC ONCOLOGY, 9(4), 438-441. doi:10.1097/JTO.0000000000000129
Pleiotropic Associations of Risk Variants Identified for Other Cancers With Lung Cancer Risk: The PAGE and TRICL Consortia
Park, S. L., Fesinmeyer, M. D., Timofeeva, M., Caberto, C. P., Kocarnik, J. M., Han, Y., . . . Cheng, I. (2014). Pleiotropic Associations of Risk Variants Identified for Other Cancers With Lung Cancer Risk: The PAGE and TRICL Consortia. Journal of the National Cancer Institute, 106(4). doi:10.1093/jnci/dju061
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Fernandez-Cuesta, L., Peifer, M., Lu, X., Sun, R., Ozretic, L., Seidel, D., . . . Thomas, R. K. (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. NATURE COMMUNICATIONS, 5. doi:10.1038/ncomms4518
Lung cancer screening with low dose computed tomography
Baldwin, D. R., Hansell, D. M., Duffy, S. W., & Field, J. K. (2014). Lung cancer screening with low dose computed tomography. BMJ-BRITISH MEDICAL JOURNAL, 348. doi:10.1136/bmj.g1970
Lung cancer screening with low dose computed tomography.
Baldwin, D. R., Hansell, D. M., Duffy, S. W., & Field, J. K. (2014). Lung cancer screening with low dose computed tomography.. BMJ (Clinical research ed.), 348, g1970. doi:10.1136/bmj.g1970
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Fernandez-Cuesta, L., Peifer, M., Lu, X., Sun, R., Ozretić, L., Seidel, D., . . . Thomas, R. K. (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nature Communications, 5, 3518.
The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening
McRonald, F. E., Yadegarfar, G., Baldwin, D. R., Devaraj, A., Brain, K. E., Eisen, T., . . . Field, J. K. (2014). The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening. CANCER PREVENTION RESEARCH, 7(3), 362-371. doi:10.1158/1940-6207.CAPR-13-0206
Effect Modification of the Association of Cumulative Exposure and Cancer Risk by Intensity of Exposure and Time Since Exposure Cessation: A Flexible Method Applied to Cigarette Smoking and Lung Cancer in the SYNERGY Study
Vlaanderen, J., Portengen, L., Schuez, J., Olsson, A., Pesch, B., Kendzia, B., . . . Vermeulen, R. (2014). Effect Modification of the Association of Cumulative Exposure and Cancer Risk by Intensity of Exposure and Time Since Exposure Cessation: A Flexible Method Applied to Cigarette Smoking and Lung Cancer in the SYNERGY Study. AMERICAN JOURNAL OF EPIDEMIOLOGY, 179(3), 290-298. doi:10.1093/aje/kwt273
Epigenetic biomarkers in lung cancer
Liloglou, T., Bediaga, N. G., Brown, B. R. B., Field, J. K., & Davies, M. P. A. (2014). Epigenetic biomarkers in lung cancer. CANCER LETTERS, 342(2), 200-212. doi:10.1016/j.canlet.2012.04.018
A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer
Seigneurin, A., Field, J. K., Gachet, A., & Duffy, S. W. (2014). A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer. ANNALS OF ONCOLOGY, 25(4), 781-791. doi:10.1093/annonc/mdt491
Education and Lung Cancer Among Never Smokers
Menvielle, G., Truong, T., Jellouli, F., Stuecker, I., Brenner, H., Field, J. K., . . . Luce, D. (2014). Education and Lung Cancer Among Never Smokers. EPIDEMIOLOGY, 25(6), 934-+. doi:10.1097/EDE.0000000000000183
Factors associated with dropout in a lung cancer high-risk cohort - the Liverpool lung project
Marcus, M. W., Raji, O. Y., Chen, Y., Duffy, S. W., & Field, J. K. (2014). Factors associated with dropout in a lung cancer high-risk cohort - the Liverpool lung project. INTERNATIONAL JOURNAL OF ONCOLOGY, 44(6), 2146-2152. doi:10.3892/ijo.2014.2371
IMPACT OF LUNG CANCER SCREENING IN A HIGH-RISK POPULATION: THE UK LUNG SCREENING (UKLS) TRIAL
Brains, K. E., Lifford, K., Carter, B., McRonald, F., Yadegarfar, G., Baldwin, D., . . . Field, J. K. (2014). IMPACT OF LUNG CANCER SCREENING IN A HIGH-RISK POPULATION: THE UK LUNG SCREENING (UKLS) TRIAL. In INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE Vol. 21 (pp. S81). Retrieved from https://www.webofscience.com/
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) Response to the USPSTF Recommendations
Field, J. K., Aberle, D. R., Altorki, N., Baldwin, D. R., Dresler, C., Duffy, S. W., . . . Travis, W. D. (2014). The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) Response to the USPSTF Recommendations. JOURNAL OF THORACIC ONCOLOGY, 9(2), 141-143. doi:10.1097/JTO.0000000000000060
UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline
Field, J. K., Devaraj, A., Baldwin, D. R., Holemans, J., Screaton, N., Ledson, M., . . . Hansell, D. M. (2014). UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline. LUNG CANCER, 83, S24-S25. doi:10.1016/S0169-5002(14)70066-2
2013
Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer
Udyavar, A. R., Hoeksema, M. D., Clark, J. E., Zou, Y., Tang, Z., Li, Z., . . . Quaranta, V. (2013). Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer. In BMC SYSTEMS BIOLOGY Vol. 7. doi:10.1186/1752-0509-7-S5-S1
CT screening for lung cancer: countdown to implementation
Field, J. K., Hansell, D. M., Duffy, S. W., & Baldwin, D. R. (2013). CT screening for lung cancer: countdown to implementation. LANCET ONCOLOGY, 14(13), E591-E600. doi:10.1016/S1470-2045(13)70293-6
EXPERIENCE WITH SUSPECTED CANCER REFERRALS FROM THE UK LUNG SCREEN TRIAL
Jones, G., Komrower, D., Murthy, M., Hunt, N., Holemans, J., Field, J., . . . Walshaw, M. (2013). EXPERIENCE WITH SUSPECTED CANCER REFERRALS FROM THE UK LUNG SCREEN TRIAL. In THORAX Vol. 68 (pp. A57-A58). doi:10.1136/thoraxjnl-2013-204457.117
Improving care for patients with lung cancer in the UK
Sethi, T., Lim, E., Peake, M., Field, J., White, J., Nicolson, M., . . . Pinnock, H. (2013). Improving care for patients with lung cancer in the UK. THORAX, 68(12), 1181-1185. doi:10.1136/thoraxjnl-2013-204588
Modélisation du risque et dépistage du cancer bronchique par scanner
Saelens, T. (2013). Modélisation du risque et dépistage du cancer bronchique par scanner. Revue des Maladies Respiratoires Actualités, 5(7), 657-658. doi:10.1016/s1877-1203(13)70474-9
A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., . . . Esteller, M. (2013). A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer. JOURNAL OF CLINICAL ONCOLOGY, 31(32), 4140-+. doi:10.1200/JCO.2012.48.5516
Lung cancer risk among bakers, pastry cooks and confectionary makers: the SYNERGY study
Behrens, T., Kendzia, B., Treppmann, T., Olsson, A., Joeckel, K. -H., Gustavsson, P., . . . Bruening, T. (2013). Lung cancer risk among bakers, pastry cooks and confectionary makers: the SYNERGY study. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 70(11), 810-814. doi:10.1136/oemed-2013-101469
A Genomics-Based Classification of Human Lung Tumors
Seidel, D., Zander, T., Heukamp, L. C., Peifer, M., Bos, M., Fernandez-Cuesta, L., . . . Thomas, R. K. (2013). A Genomics-Based Classification of Human Lung Tumors. SCIENCE TRANSLATIONAL MEDICINE, 5(209). doi:10.1126/scitranslmed.3006802
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
Bediaga, N. G., Davies, M. P. A., Acha-Sagredo, A., Hyde, R., Raji, O. Y., Page, R., . . . Liloglou, T. (2013). A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. BRITISH JOURNAL OF CANCER, 109(9), 2404-2411. doi:10.1038/bjc.2013.623
European Randomized Lung Cancer Screening Trials: Post NLST
Field, J. K., van Klaveren, R., Pedersen, J. H., Pastorino, U., Paci, E., Becker, N., . . . de Koning, H. J. (2013). European Randomized Lung Cancer Screening Trials: Post NLST. JOURNAL OF SURGICAL ONCOLOGY, 108(5), 280-286. doi:10.1002/jso.23383
European randomized lung cancer screening trials: Post NLST.
Field, J. K., van, K. R., Pedersen, J. H., Pastorino, U., Paci, E., Becker, N., . . . de, K. H. J. O. B. O. T. E. R. S. T. (2013). European randomized lung cancer screening trials: Post NLST.. J Surg Oncol.. doi:10.1002/jso.23383
Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic
Ho, M. W., Field, E. A., Field, J. K., Risk, J. M., Rajlawat, B. P., Rogers, S. N., . . . Shaw, R. J. (2013). Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 51(7), 594-599. doi:10.1016/j.bjoms.2013.03.014
The Contribution of Risk Prediction Models to Early Detection of Lung Cancer
Field, J. K., Chen, Y., Marcus, M. W., Mcronald, F. E., Raji, O. Y., & Duffy, S. W. (2013). The Contribution of Risk Prediction Models to Early Detection of Lung Cancer. JOURNAL OF SURGICAL ONCOLOGY, 108(5), 304-311. doi:10.1002/jso.23384
Prospects for population screening and diagnosis of lung cancer
Field, J. K., Oudkerk, M., Pedersen, J. H., & Duffy, S. W. (2013). Prospects for population screening and diagnosis of lung cancer. LANCET, 382(9893), 732-741. doi:10.1016/S0140-6736(13)61614-1
Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines
Oleksiewicz, U., Liloglou, T., Tasopoulou, K. -M., Daskoulidou, N., Bryan, J., Gosney, J. R., . . . Xinarianos, G. (2013). Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines. HUMAN MOLECULAR GENETICS, 22(16), 3207-3217. doi:10.1093/hmg/ddt174
The role of DNA methylation as biomarkers in the clinical management of lung cancer.
Fleischhacker, M., Dietrich, D., Liebenberg, V., Field, J. K., & Schmidt, B. (2013). The role of DNA methylation as biomarkers in the clinical management of lung cancer.. Expert Rev Respir Med., 7, 363-383. doi:10.1586/17476348.2013.814397
TPL2 kinase is a suppressor of lung carcinogenesis
Gkirtzimanaki, K., Gkouskou, K. K., Oleksiewicz, U., Nikolaidis, G., Vyrla, D., Liontos, M., . . . Eliopoulos, A. G. (2013). TPL2 kinase is a suppressor of lung carcinogenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(16), E1470-E1479. doi:10.1073/pnas.1215938110
Abstract 5216: Gene co-expression network analysis of small cell lung cancer (SCLC) identifies new subclasses and novel therapeutic targets including Src family kinase Fyn and Spleen Tyrosine Kinase Syk.
Udyavar, A. R., Hoeksema, M. D., Clark, J., Zou, Y., Li, M., Chen, C. -L. H., . . . Massion, P. P. (2013). Abstract 5216: Gene co-expression network analysis of small cell lung cancer (SCLC) identifies new subclasses and novel therapeutic targets including Src family kinase Fyn and Spleen Tyrosine Kinase Syk.. Cancer Research, 73(8_Supplement), 5216. doi:10.1158/1538-7445.am2013-5216
United Kingdom lung cancer screening trial (UKLS): First 88897 approaches.
Field, J. K., Baldwin, D., Devaraj, A., Brain, K., Eisen, T., Holemans, J., . . . Duffy, S. W. (2013). United Kingdom lung cancer screening trial (UKLS): First 88897 approaches.. In CANCER RESEARCH Vol. 73. doi:10.1158/1538-7445.AM2013-3631
Predictive Accuracy of the Liverpool Lung Project Risk Model RESPONSE
Field, J. K., Raji, O. Y., & Duffy, S. W. (2013). Predictive Accuracy of the Liverpool Lung Project Risk Model RESPONSE. ANNALS OF INTERNAL MEDICINE, 158(7), 568-569. doi:10.7326/0003-4819-158-7-201304020-00015
11th Annual British Thoracic Oncology Group Conference 2013
Field, J. K., Darlison, L., Horne, N., Hatton, M. Q., Lim, E., & McKinley, D. (2013). 11th Annual British Thoracic Oncology Group Conference 2013. Lung Cancer Management, 2(2), 103-105. doi:10.2217/lmt.13.7
New perspectives to respiratory tract cancers
Marcus, M. W., Chen, Y., Liloglou, T., & Field, J. K. (2013). New perspectives to respiratory tract cancers. Head and Neck Oncology, 5(3).
A novel <i>in silico</i> reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer
Barh, D., Jain, N., Tiwari, S., Field, J. K., Padin-Iruegas, E., Ruibal, A., . . . Liloglou, T. (2013). A novel <i>in silico</i> reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer. BMC GENOMICS, 14. doi:10.1186/1471-2164-14-S6-S5
Authors' response
Field, J. K., Baldwin, D., Brain, K., Devaraj, A., Eisen, T., Duffy, S. W., . . . Williamson, P. (2013). Authors' response. THORAX, 68(1), 105. doi:10.1136/thoraxjnl-2012-202442
MyLungRisk calculator: a user-friendly, web-based questionnaire for risk prediction of lung cancer based on the validated Liverpool Lung Project model
Field, J. K., Niaz, A., Farley, J., Hodge, N., Raji, O. Y., Duffy, S. W., . . . Chen, Y. (2013). MyLungRisk calculator: a user-friendly, web-based questionnaire for risk prediction of lung cancer based on the validated Liverpool Lung Project model. LUNG CANCER, 79, S18. doi:10.1016/S0169-5002(13)70054-0
Prospects for population screening and diagnosis of lung cancer.
Field, J. K., Oudkerk, M., Pedersen, J. H., & Duffy, S. W. (2013). Prospects for population screening and diagnosis of lung cancer.. Lancet., 382, 732-741. doi:10.1016/S0140-6736
The role of DNA methylation as biomarkers in the clinical management of lung cancer
Fleischhacker, M., Dietrich, D., Liebenberg, V., Field, J. K., & Schmidt, B. (2013). The role of DNA methylation as biomarkers in the clinical management of lung cancer. EXPERT REVIEW OF RESPIRATORY MEDICINE, 7(4), 363-383. doi:10.1586/17476348.2013.814397
The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) - a population screening study
McRonald, F., Baldwin, D. R., Devaraj, A., Brain, K., Eisen, T., Holeman, J., . . . Field, J. K. (2013). The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) - a population screening study. LUNG CANCER, 79, S28-S29. doi:10.1016/S0169-5002(13)70081-3
UK LUNG CANCER SCREENING TRIAL (UKLS): BASE LINE DATA
Field, J. K., Devaraj, A., Baldwin, D. R., Holemans, J., Screaton, N., Ledson, M., . . . Hansell, D. H. (2013). UK LUNG CANCER SCREENING TRIAL (UKLS): BASE LINE DATA. JOURNAL OF THORACIC ONCOLOGY, 8, S685. Retrieved from https://www.webofscience.com/
2012
DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
Nikolaidis, G., Raji, O. Y., Markopoulou, S., Gosney, J. R., Bryan, J., Warburton, C., . . . Liloglou, T. (2012). DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer. CANCER RESEARCH, 72(22), 5692-5701. doi:10.1158/0008-5472.CAN-12-2309
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls
Timofeeva, M. N., Hung, R. J., Rafnar, T., Christiani, D. C., Field, J. K., Bickeboeller, H., . . . Landi, M. T. (2012). Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. HUMAN MOLECULAR GENETICS, 21(22), 4980-4995. doi:10.1093/hmg/dds334
Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies
Zaitlen, N., Lindstroem, S., Pasaniuc, B., Cornelis, M., Genovese, G., Pollack, S., . . . Price, A. L. (2012). Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies. PLOS GENETICS, 8(11). doi:10.1371/journal.pgen.1003032
Early Detection of Lung Cancer with Low-Dose Computed Tomography: An Update on Recently Presented Data
Devaraj, A., & Field, J. K. (2012). Early Detection of Lung Cancer with Low-Dose Computed Tomography: An Update on Recently Presented Data. Lung Cancer Management, 1(3), 189-194. doi:10.2217/lmt.12.31
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Peifer, M., Fernandez-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., . . . Thomas, R. K. (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. NATURE GENETICS, 44(10), 1104-+. doi:10.1038/ng.2396
Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium
Brenner, D. R., Boffetta, P., Duell, E. J., Bickeboeller, H., Rosenberger, A., McCormack, V., . . . Hung, R. J. (2012). Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium. AMERICAN JOURNAL OF EPIDEMIOLOGY, 176(7), 573-585. doi:10.1093/aje/kws151
The clinical determinants of malignant transformation in oral epithelial dysplasia
Ho, M. W., Risk, J. M., Woolgar, J. A., Field, E. A., Field, J. K., Steele, J. C., . . . Shaw, R. J. (2012). The clinical determinants of malignant transformation in oral epithelial dysplasia. ORAL ONCOLOGY, 48(10), 969-976. doi:10.1016/j.oraloncology.2012.04.002
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
Cote, M. L., Liu, M., Bonassi, S., Neri, M., Schwartz, A. G., Christiani, D. C., . . . Hung, R. J. (2012). Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium. EUROPEAN JOURNAL OF CANCER, 48(13), 1957-1968. doi:10.1016/j.ejca.2012.01.038
Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study
Raji, O. Y., Duffy, S. W., Agbaje, O. F., Baker, S. G., Christiani, D. C., Cassidy, A., & Field, J. K. (2012). Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer A Case-Control and Cohort Validation Study. ANNALS OF INTERNAL MEDICINE, 157(4), 242-+. doi:10.7326/0003-4819-157-4-201208210-00004
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: Recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance
Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., MacMahon, H., . . . Jaklitsch, M. T. (2012). Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: Recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144(1), 25-32. doi:10.1016/j.jtcvs.2012.05.059
Measurement Methods and Algorithms for the Management of Solid Nodules
Nair, A., Baldwin, D. R., Field, J. K., Hansell, D. M., & Devaraj, A. (2012). Measurement Methods and Algorithms for the Management of Solid Nodules. JOURNAL OF THORACIC IMAGING, 27(4), 230-239. doi:10.1097/RTI.0b013e31824f83e1
Prognostic value of <i>TP53</i>, <i>KRAS</i> and <i>EGFR</i> mutations in nonsmall cell lung cancer: the EUELC cohort
Scoccianti, C., Vesin, A., Martel, G., Olivier, M., Brambilla, E., Timsit, J. -F., . . . Hainaut, P. (2012). Prognostic value of <i>TP53</i>, <i>KRAS</i> and <i>EGFR</i> mutations in nonsmall cell lung cancer: the EUELC cohort. EUROPEAN RESPIRATORY JOURNAL, 40(1), 177-184. doi:10.1183/09031936.00097311
Progressive lung cancer determined by expression profiling and transcriptional regulation
Han, N., Dol, Z., Vasieva, O., Hyde, R., Liloglou, T., Raji, O., . . . Field, J. K. (2012). Progressive lung cancer determined by expression profiling and transcriptional regulation. INTERNATIONAL JOURNAL OF ONCOLOGY, 41(1), 242-252. doi:10.3892/ijo.2012.1421
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
Jaklitsch, M. T., Jacobson, F. L., Austin, J. H. M., Field, J. K., Jett, J. R., Keshavjee, S., . . . Sugarbaker, D. J. (2012). The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144(1), 33-38. doi:10.1016/j.jtcvs.2012.05.060
DNA Methylation of the Homeobox Genes <i>PITX2</i> and <i>SHOX2</i> Predicts Outcome in Non-small-cell Lung Cancer Patients
Dietrich, D., Hasinger, O., Liebenberg, V., Field, J. K., Kristiansen, G., & Soltermann, A. (2012). DNA Methylation of the Homeobox Genes <i>PITX2</i> and <i>SHOX2</i> Predicts Outcome in Non-small-cell Lung Cancer Patients. DIAGNOSTIC MOLECULAR PATHOLOGY, 21(2), 93-104. doi:10.1097/PDM.0b013e318240503b
Development and performance evaluation of a CE-IVD for measuring <i>SHOX2</i> DNA methylation in bronchial aspirates for the diagnosis of lung cancer
Dietrich, D., Liebenberg, V., Schmidt, B., Fleischhacker, M., Kneip, C., Kristiansen, G., & Field, J. K. (2012). Development and performance evaluation of a CE-IVD for measuring <i>SHOX2</i> DNA methylation in bronchial aspirates for the diagnosis of lung cancer. LUNG CANCER, 77, S22. doi:10.1016/j.lungcan.2012.05.036
Selected Papers from the Eleventh International Conference on Coordination Models and Languages
Field, J., & Vasconcelos, V. T. (2012). Selected Papers from the Eleventh International Conference on Coordination Models and Languages. SCIENCE OF COMPUTER PROGRAMMING, 77(6), 661-662. doi:10.1016/j.scico.2011.10.013
Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium
Kazma, R., Babron, M. -C., Gaborieau, V., Genin, E., Brennan, P., Hung, R. J., . . . Benhamou, S. (2012). Lung cancer and DNA repair genes: multilevel association analysis from the International Lung Cancer Consortium. CARCINOGENESIS, 33(5), 1059-1064. doi:10.1093/carcin/bgs116
MicroRNAs for early detection of lung cancer
Bediaga, N., Davies, M. P. A., Raji, O. Y., Alfirevic, A., Liloglou, T., & Field, J. K. (2012). MicroRNAs for early detection of lung cancer. CANCER RESEARCH, 72. doi:10.1158/1538-7445.AM2012-4133
UKLS - United Kingdom Lung Cancer Screening Trial
Field, J. K., Baldwin, D., Stephen, D. W., Devaraj, A., & Hansell, D. M. (2012). UKLS - United Kingdom Lung Cancer Screening Trial. CANCER RESEARCH, 72. doi:10.1158/1538-7445.AM2012-3571
Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung
Pajares, M. J., Agorreta, J., Larrayoz, M., Vesin, A., Ezponda, T., Zudaire, I., . . . Montuenga, L. M. (2012). Expression of Tumor-Derived Vascular Endothelial Growth Factor and Its Receptors Is Associated With Outcome in Early Squamous Cell Carcinoma of the Lung. JOURNAL OF CLINICAL ONCOLOGY, 30(10), 1129-1136. doi:10.1200/JCO.2011.37.4231
Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium
Rosenberger, A., Bickeboeller, H., McCormack, V., Brenner, D. R., Duell, E. J., Tjonneland, A., . . . Hung, R. J. (2012). Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. CARCINOGENESIS, 33(3), 587-597. doi:10.1093/carcin/bgr307
Performance evaluation of the DNA methylation biomarker <i>SHOX2</i> for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates
Dietrich, D., Kneip, C., Raji, O., Lloglou, T., Seegebarth, A., Schlegel, T., . . . Field, J. K. (2012). Performance evaluation of the DNA methylation biomarker <i>SHOX2</i> for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. INTERNATIONAL JOURNAL OF ONCOLOGY, 40(3), 825-832. doi:10.3892/ijo.2011.1264
SHOX2 DNA Methylierung in Plasma – ein vielversprechender Biomarker für die Detektion von Lungenkrebs
Schmidt, B., Kneip, C., Fleischhacker, M., Dietrich, D., Liebenberg, V., & Field, J. (2012). SHOX2 DNA Methylierung in Plasma – ein vielversprechender Biomarker für die Detektion von Lungenkrebs. Pneumologie, 66(S 01). doi:10.1055/s-0032-1302885
SHOX2 DNA Methylierung – ein validierter Biomarker für Lungenkrebs in Bronchialaspiraten
Schmidt, B., Liloglou, L., Dietrich, D., Liebenberg, V., & Field, J. (2012). SHOX2 DNA Methylierung – ein validierter Biomarker für Lungenkrebs in Bronchialaspiraten. Pneumologie, 66(S 01). doi:10.1055/s-0032-1302806
<i>RHBDF2</i> Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome
Blaydon, D. C., Etheridge, S. L., Risk, J. M., Hennies, H. -C., Gay, L. J., Carroll, R., . . . Kelsell, D. P. (2012). <i>RHBDF2</i> Mutations Are Associated with Tylosis, a Familial Esophageal Cancer Syndrome. AMERICAN JOURNAL OF HUMAN GENETICS, 90(2), 340-346. doi:10.1016/j.ajhg.2011.12.008
Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development
Thunnissen, F. B., Prinsen, C., Hol, B., Van der Drift, M., Vesin, A., Brambilla, C., . . . Field, J. K. (2012). Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development. LUNG CANCER, 75(2), 156-160. doi:10.1016/j.lungcan.2011.07.013
BIOMARKERS AND RISK MODELS FOR LUNG CANCER SCREENING
Field, J. K., Raji, O. Y., Davies, M. P., & Liloglou, T. (2012). BIOMARKERS AND RISK MODELS FOR LUNG CANCER SCREENING. In JOURNAL OF THORACIC ONCOLOGY Vol. 7 (pp. S21). Retrieved from https://www.webofscience.com/
GENOME-WIDE ASSOCIATION STUDY OF LUNG CANCER IN NEVER SMOKERS
Gorlova, O., Broderick, P., Field, J., Schwartz, A., Houlston, R., Ying, J., . . . Spitz, M. (2012). GENOME-WIDE ASSOCIATION STUDY OF LUNG CANCER IN NEVER SMOKERS. In JOURNAL OF THORACIC ONCOLOGY Vol. 7 (pp. S169). Retrieved from https://www.webofscience.com/
Informed Conditioning on Clinical Covariates Increases Power in Case-control Association Studies
Zaitlen, N., Lindstrom, S., Pasaniuc, B., Cornelis, M., Genovese, G., Pollack, S., . . . Price, A. L. (2012). Informed Conditioning on Clinical Covariates Increases Power in Case-control Association Studies. GENETIC EPIDEMIOLOGY, 36(7), 745. Retrieved from https://www.webofscience.com/
Integrative genomic analyses of somatic mutations identifies key drivers of small cell lung cancer
Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., . . . Thomas, R. K. (2012). Integrative genomic analyses of somatic mutations identifies key drivers of small cell lung cancer. Nature Genetics.
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report
Field, J. K., Smith, R. A., Aberle, D. R., Oudkerk, M., Baldwin, D. R., Yankelevitz, D., . . . Mulshine, J. L. (2012). International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report. JOURNAL OF THORACIC ONCOLOGY, 7(1), 10-19. doi:10.1097/JTO.0b013e31823c58ab
Tuberculosis through the rose tinted spectacles of the EBUS endoscopist: be aware of the bias response
Field, J., Baldwin, D., Brain, K., Devaraj, A., Eisen, T., Duffy, S. W., . . . Williamson, P. (2012). Tuberculosis through the rose tinted spectacles of the EBUS endoscopist: be aware of the bias response. THORAX, 67(7), 650. doi:10.1136/thoraxjnl-2011-200822
2011
Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family
Oleksiewicz, U., Liloglou, T., Field, J. K., & Xinarianos, G. (2011). Cytoglobin: biochemical, functional and clinical perspective of the newest member of the globin family. CELLULAR AND MOLECULAR LIFE SCIENCES, 68(23), 3869-3883. doi:10.1007/s00018-011-0764-9
Neuroglobin and myoglobin in non-small cell lung cancer: Expression, regulation and prognosis
Oleksiewicz, U., Daskoulidou, N., Liloglou, T., Tasopoulou, K., Bryan, J., Gosney, J. R., . . . Xinarianos, G. (2011). Neuroglobin and myoglobin in non-small cell lung cancer: Expression, regulation and prognosis. LUNG CANCER, 74(3), 411-418. doi:10.1016/j.lungcan.2011.05.001
Lung Cancer Risk Prediction to Select Smokers for Screening CT-a Model Based on the Italian COSMOS Trial
Maisonneuve, P., Bagnardi, V., Bellomi, M., Spaggiari, L., Pelosi, G., Rampinelli, C., . . . Veronesi, G. (2011). Lung Cancer Risk Prediction to Select Smokers for Screening CT-a Model Based on the Italian COSMOS Trial. CANCER PREVENTION RESEARCH, 4(11), 1778-1789. doi:10.1158/1940-6207.CAPR-11-0026
Abstract SS03-01: Follow-up on the National Lung Screening Trial: The next steps
Field, J. K. (2011). Abstract SS03-01: Follow-up on the National Lung Screening Trial: The next steps. Cancer Prevention Research, 4(10_Supplement). doi:10.1158/1940-6207.prev-11-ss03-01
CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report
Field, J. K., Baldwin, D., Brain, K., Devaraj, A., Eisen, T., Duffy, S. W., . . . Whynes, D. (2011). CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report. THORAX, 66(8), 736-737. doi:10.1136/thoraxjnl-2011-200351
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma (vol 85, pg 679, 2009)
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., . . . Caporaso, N. E. (2011). A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma (vol 85, pg 679, 2009). AMERICAN JOURNAL OF HUMAN GENETICS, 88(6), 861. doi:10.1016/j.ajhg.2011.05.003
Abstract 4158: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma
Field, J. K., Raji, O., & Liloglou, T. (2011). Abstract 4158: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. Cancer Research, 71(8_Supplement), 4158. doi:10.1158/1538-7445.am2011-4158
DNA methylation biomarkers for lung cancer diagnostics: Validation in bronchial washings
Liloglou, T., Nikolaidis, G., Raji, O., & Field, J. K. (2011). DNA methylation biomarkers for lung cancer diagnostics: Validation in bronchial washings. CANCER RESEARCH, 71. doi:10.1158/1538-7445.AM2011-3015
High VEGFA pathway expression predicts good prognosis in stage I squamous cell carcinoma of the lung
Agorreta, J., Pajares, M. J., Larrayoz, M., Vesin, A., Exponda, T., Zudaire, I., . . . Montuenga, L. M. (2011). High VEGFA pathway expression predicts good prognosis in stage I squamous cell carcinoma of the lung. In CANCER RESEARCH Vol. 71. doi:10.1158/1538-7445.AM2011-2251
The Liverpool Lung Project risk model: An independent validation and clinical utility in primary care
Field, J. K., Raji, O. Y., Cassidy, A., Duffy, S. W., Baker, S. G., & Christiani, D. C. (2011). The Liverpool Lung Project risk model: An independent validation and clinical utility in primary care. In CANCER RESEARCH Vol. 71. doi:10.1158/1538-7445.AM2011-1898
Correction: A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium
Correction: A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium (2011). PLoS genetics, 7(4).
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer
Baldwin, D. R., Duffy, S. W., Wald, N. J., Page, R., Hansell, D. M., & Field, J. K. (2011). UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. THORAX, 66(4), 308-313. doi:10.1136/thx.2010.152066
UHRF1-Mediated Tumor Suppressor Gene Inactivation in Nonsmall Cell Lung Cancer
Daskalos, A., Oleksiewicz, U., Filia, A., Nikolaidis, G., Xinarianos, G., Gosney, J. R., . . . Liloglou, T. (2011). UHRF1-Mediated Tumor Suppressor Gene Inactivation in Nonsmall Cell Lung Cancer. CANCER, 117(5), 1027-1037. doi:10.1002/cncr.25531
<i>SHOX2</i> DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
Kneip, C., Schmidt, B., Seegebarth, A., Weickmann, S., Fleischhacker, M., Liebenberg, V., . . . Dietrich, D. (2011). <i>SHOX2</i> DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma. JOURNAL OF THORACIC ONCOLOGY, 6(10), 1632-1638. doi:10.1097/JTO.0b013e318220ef9a
A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium
McKay, J. D., Therese, T., Gaborieau, V., Chabrier, A., Chuang, S. -C., Byrnes, G., . . . Brennan, P. (2011). A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium. PLOS GENETICS, 7(3). doi:10.1371/journal.pgen.1001333
A PILOT LUNG CANCER EARLY DETECTION STUDY IN A PRIMARY CARE PRACTICE IN KNOWSLEY, MERSEYSIDE: THE LIVERPOOL LUNG PROJECT PRIMARY CARE IMPLEMENTATION PROGRAMME (LLP-PCIP)
Field, J. K., Raji, O. Y., Cassidy, A., Mimnagh, C., Hughes, J., Warburton, C., . . . Ashton, M. (2011). A PILOT LUNG CANCER EARLY DETECTION STUDY IN A PRIMARY CARE PRACTICE IN KNOWSLEY, MERSEYSIDE: THE LIVERPOOL LUNG PROJECT PRIMARY CARE IMPLEMENTATION PROGRAMME (LLP-PCIP). JOURNAL OF THORACIC ONCOLOGY, 6(6), S1393. Retrieved from https://www.webofscience.com/
ADDED PREDICTIVE VALUE OF SNPS EPISTASIS IN THE LLP LUNG CANCER RISK PREDICTION MODEL
Raji, O. Y., Duffy, S. W., Liloglou, T., Young, R. P., & Field, J. K. (2011). ADDED PREDICTIVE VALUE OF SNPS EPISTASIS IN THE LLP LUNG CANCER RISK PREDICTION MODEL. JOURNAL OF THORACIC ONCOLOGY, 6(6), S624. Retrieved from https://www.webofscience.com/
COMORBIDITY AND FUTURE LUNG CANCER RISK IN A UK HIGH RISK PRIMARY CARE PRACTICE
De Souza, N. B., Raji, O. Y., Mimnagh, C., Hughes, J., Duffy, S. W., Ashton, M., & Field, J. K. (2011). COMORBIDITY AND FUTURE LUNG CANCER RISK IN A UK HIGH RISK PRIMARY CARE PRACTICE. JOURNAL OF THORACIC ONCOLOGY, 6(6), S1424-S1425. Retrieved from https://www.webofscience.com/
EVALUATION OF NSCLC DIAGNOSTIC EFFICIENCY OF DNA METHYLATION BIOMARKERS IN BRONCHIAL WASHINGS
Nikolaidis, G., Raji, O. Y., Bryan, J., Goggin, J., Unsworth, S., Giles, T., . . . Liloglou, T. (2011). EVALUATION OF NSCLC DIAGNOSTIC EFFICIENCY OF DNA METHYLATION BIOMARKERS IN BRONCHIAL WASHINGS. JOURNAL OF THORACIC ONCOLOGY, 6(6), S613-S614. Retrieved from https://www.webofscience.com/
Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer
Daskalos, A., Logotheti, S., Markopoulou, S., Xinarianos, G., Gosney, J. R., Kastania, A. N., . . . Liloglou, T. (2011). Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer. CANCER LETTERS, 300(1), 79-86. doi:10.1016/j.canlet.2010.09.009
RHBDF2 mutations in Tylosis with Oesophageal Cancer cause dysregulation of downstream EGF and EphrinB3 signalling
Etheridge, S., Blaydon, D., Risk, J., Hennies, H. -C., Stevens, H., Field, J., . . . Kelsell, D. (2011). RHBDF2 mutations in Tylosis with Oesophageal Cancer cause dysregulation of downstream EGF and EphrinB3 signalling. In JOURNAL OF INVESTIGATIVE DERMATOLOGY Vol. 131 (pp. S63). Retrieved from https://www.webofscience.com/
SECOND-GENERATION SEQUENCING OF NON-SMALL CELL LUNG CANCER: IDENTIFICATION OF MUTATIONS ASSOCIATED WITH PROGRESSIVE DISEASE
Hyde, R., Raji, O. Y., Olohan, L., Vasieva, O., Ashelford, K., Brass, A., . . . Field, J. K. (2011). SECOND-GENERATION SEQUENCING OF NON-SMALL CELL LUNG CANCER: IDENTIFICATION OF MUTATIONS ASSOCIATED WITH PROGRESSIVE DISEASE. JOURNAL OF THORACIC ONCOLOGY, 6(6), S589. Retrieved from https://www.webofscience.com/
UNITED KINGDOM LUNG CANCER SCREENING (UKLS) TRIAL
Field, J. K., Duffy, S., Baldwin, D., Brain, K., Eisen, T., Hands, C. J. D., . . . Hansell, D. (2011). UNITED KINGDOM LUNG CANCER SCREENING (UKLS) TRIAL. JOURNAL OF THORACIC ONCOLOGY, 6(6), S1382-S1383. Retrieved from https://www.webofscience.com/
2010
Abstract B31: Gene-based lung cancer risk test (Respiragene), identifies high-risk smokers for early detection of lung cancer
Young, R. P., Hopkins, R. J., Field, J., Zulueta, J., & Hay, B. A. (2010). Abstract B31: Gene-based lung cancer risk test (Respiragene), identifies high-risk smokers for early detection of lung cancer. Cancer Prevention Research, 3(12_Supplement), B31. doi:10.1158/1940-6207.prev-10-b31
SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
Schmidt, B., Liebenberg, V., Dietrich, D., Schlegel, T., Kneip, C., Seegebarth, A., . . . Field, J. K. (2010). SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer, 10(1). doi:10.1186/1471-2407-10-600
SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates
Schmidt, B., Liebenberg, V., Dietrich, D., Schlegel, T., Kneip, C., Seegebarth, A., . . . Field, J. K. (2010). SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates. BMC CANCER, 10. doi:10.1186/1471-2407-10-600
A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14.
Solouki, A. M., Verhoeven, V. J. M., van Duijn, C. M., Verkerk, A. J. M. H., Ikram, M. K., Hysi, P. G., . . . Klaver, C. C. W. (2010). A genome-wide association study identifies a susceptibility locus for refractive errors and myopia at 15q14.. Nature genetics, 42(10), 897-901. doi:10.1038/ng.663
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors
Al Omar, S., Middleton, D., Marshall, E., Porter, D., Xinarianos, G., Raji, O., . . . Christmas, S. E. (2010). Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors. HUMAN IMMUNOLOGY, 71(10), 976-981. doi:10.1016/j.humimm.2010.06.019
DNA methylation epigenotypes in breast cancer molecular subtypes
Bediaga, N. G., Acha-Sagredo, A., Guerra, I., Viguri, A., Albaina, C., Ruiz Diaz, I., . . . de Pancorbo, M. M. (2010). DNA methylation epigenotypes in breast cancer molecular subtypes. BREAST CANCER RESEARCH, 12(5). doi:10.1186/bcr2721
Comparison of discriminatory power and accuracy of three lung cancer risk models
D'Amelio, A. M. J., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., . . . Etzel, C. J. (2010). Comparison of discriminatory power and accuracy of three lung cancer risk models. BRITISH JOURNAL OF CANCER, 103(3), 423-429. doi:10.1038/sj.bjc.6605759
Comparison of discriminatory power and accuracy of three lung cancer risk models
D'Amelio, A. M., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., . . . Etzel, C. J. (2010). Comparison of discriminatory power and accuracy of three lung cancer risk models. British Journal of Cancer, 103(3), 423-429. doi:10.1038/sj.bjc.6605759
Sp1 binds to the external promoter of the <i>p73</i> gene and induces the expression of TAp73γ in lung cancer
Logotheti, S., Michalopoulos, I., Sideridou, M., Daskalos, A., Kossida, S., Spandidos, D. A., . . . Zoumpourlis, V. (2010). Sp1 binds to the external promoter of the <i>p73</i> gene and induces the expression of TAp73γ in lung cancer. FEBS JOURNAL, 277(14), 3014-3027. doi:10.1111/j.1742-4658.2010.07710.x
Sp1 binds to the external promoter of the <i>p73</i> gene and induces the expression of TAp73γ in lung cancer
Logotheti, S., Michalopoulos, I., Sideridou, M., Daskalos, A., Kossida, S., Spandidos, D. A., . . . Zoumpourlis, V. (2010). Sp1 binds to the external promoter of the <i>p73</i> gene and induces the expression of TAp73γ in lung cancer. The FEBS Journal, 277(14), 3014-3027. doi:10.1111/j.1742-4658.2010.07710.x
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project
Van den Berg, R. M., Brokx, H., Vesin, A., Field, J. K., Brambilla, C., Meijer, C. J. L. M., . . . Snijders, P. J. F. (2010). Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project. INTERNATIONAL JOURNAL OF ONCOLOGY, 37(2), 455-461. doi:10.3892/ijo_00000694
The potential for using risk models in future lung cancer screening trials.
Field, J. K., & Raji, O. Y. (2010). The potential for using risk models in future lung cancer screening trials.. F1000 medicine reports, 2, 38. doi:10.3410/m2-38
Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project
Raji, O. Y., Agbaje, O. F., Duffy, S. W., Cassidy, A., & Field, J. K. (2010). Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project. Cancer Prevention Research, 3(5), 664-669. doi:10.1158/1940-6207.capr-09-0141
Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project
Raji, O. Y., Agbaje, O. F., Duffy, S. W., Cassidy, A., & Field, J. K. (2010). Incorporation of a Genetic Factor into an Epidemiologic Model for Prediction of Individual Risk of Lung Cancer: The Liverpool Lung Project. CANCER PREVENTION RESEARCH, 3(5), 664-669. doi:10.1158/1940-6207.CAPR-09-0141
Abstract 2893: Incorporation of the SEZ6L SNP into The Liverpool Lung Project Risk Prediction Model
Field, J. K., Raji, O., Abgaje, O. F., Cassidy, A., & Duffy, S. W. (2010). Abstract 2893: Incorporation of the SEZ6L SNP into The Liverpool Lung Project Risk Prediction Model. Cancer Research, 70(8_Supplement), 2893. doi:10.1158/1538-7445.am10-2893
DTMETH: A novel method for increased length quantitative CpG methylation analysis
Liloglou, T., Filia, A., Daskalos, A., Nikolaidis, G., Bottomley, H., Ma, P. N., . . . Field, J. K. (2010). DTMETH: A novel method for increased length quantitative CpG methylation analysis. In CANCER RESEARCH Vol. 70. doi:10.1158/1538-7445.AM10-163
International Lung Cancer Consortium: Pooled analysis of previous lung diseases and lung cancer risk
Brenner, D. R., Boffetta, P., Duel, E. J., Bickeboller, H., Rosenberger, A., Muscat, J. E., . . . Hung, R. J. (2010). International Lung Cancer Consortium: Pooled analysis of previous lung diseases and lung cancer risk. In CANCER RESEARCH Vol. 70. doi:10.1158/1538-7445.AM10-4826
Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals
Lips, E. H., Gaborieau, V., McKay, J. D., Chabrier, A., Hung, R. J., Boffetta, P., . . . Brennan, P. (2010). Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 39(2), 563-577. doi:10.1093/ije/dyp288
Methylierung von SHOX2 in Bronchiallavage: ein hochspezifischer molekularer Tumormarker für das Lungenkarzinom
Schmidt, B., Liebenberg, V., Dietrich, D., Schlegel, T., Kneip, C., Seegebarth, A., . . . Field, J. (2010). Methylierung von SHOX2 in Bronchiallavage: ein hochspezifischer molekularer Tumormarker für das Lungenkarzinom. Pneumologie, 64(S 03). doi:10.1055/s-0030-1251121
Abstract A127: Comparison of discriminatory power and accuracy of three lung cancer risk models
D'Amelio, A. M., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., . . . Etzel, C. J. (2010). Abstract A127: Comparison of discriminatory power and accuracy of three lung cancer risk models. Cancer Prevention Research, 3(1_Supplement), A127. doi:10.1158/1940-6207.prev-09-a127
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumours
Al Omar, S., Middleton, D., Marshall, E., Porter, D., Xinarianos, G., Raji, O., . . . Christmas, S. E. (2010). Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumours. Human Immunology, 71(10), 976-981. doi:10.1016/j.humimm.2010.06.019
Detection of DNA Methylation Changes in Body Fluids
Liloglou, T., & Field, J. K. (2010). Detection of DNA Methylation Changes in Body Fluids. EPIGENETICS AND CANCER, PT B, 71, 177-207. doi:10.1016/S0065-2660(10)71006-3
Detection of DNA methylation changes in body fluids.
Liloglou, T., & Field, J. K. (2010). Detection of DNA methylation changes in body fluids.. Advances in genetics, 71, 177-207. doi:10.1016/b978-0-12-380864-6.00006-7
European Early Lung Cancer (EUELC) Project: A multi-centre, multipurpose study to investigate early stage non-small cell lung cancer, and to establish a biobank for ongoing collaboration
K. Field, J., Liloglou, T., Niaz, A., Bryan, J., R. Gosney, J., Giles, T., . . . Collaborators+, E. U. E. L. C. (2010). European Early Lung Cancer (EUELC) Project: A multi-centre, multipurpose study to investigate early stage non-small cell lung cancer, and to establish a biobank for ongoing collaboration. Eur Respir J, 34, 1-10.
Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.
Raji, O. Y., Agbaje, O. F., Duffy, S. W., Cassidy, A., & Field, J. K. (2010). Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.. Cancer Prev Res (Phila Pa)., 5, 644-649.
Integrating seismic & potential field data in hydrocarbon prospectivity assessment-pantelleria region offshore sicily
Coomber, S. J., Field, J., & Harrison, D. (2010). Integrating seismic & potential field data in hydrocarbon prospectivity assessment-pantelleria region offshore sicily. In 72nd European Association of Geoscientists and Engineers Conference and Exhibition 2010: A New Spring for Geoscience. Incorporating SPE EUROPEC 2010 Vol. 4 (pp. 2861-2865).
METHYLATED SHOX2 DNA IN BRONCHIAL LAVAGE - A HIGHLY SPECIFIC MOLECULAR TUMOR MARKER FOR LUNG CARCINOMA
Schmidt, B., Liebenberg, V., Dietrich, D., Walshaw, M. J., Schlegel, T., Kneip, C., . . . Field, J. K. (2010). METHYLATED SHOX2 DNA IN BRONCHIAL LAVAGE - A HIGHLY SPECIFIC MOLECULAR TUMOR MARKER FOR LUNG CARCINOMA. JOURNAL OF THORACIC ONCOLOGY, 5(5), S40. Retrieved from https://www.webofscience.com/
Methylation of SHOX2 in Bronchial lavage - a highly specific molecular Tumor markers for Lung cancer.
Schmidt, B., Liebenberg, V., Dietrich, D., Kneip, C., Schlegel, T., Seegebarth, A., . . . Field, J. K. (2010). Methylation of SHOX2 in Bronchial lavage - a highly specific molecular Tumor markers for Lung cancer.. ONKOLOGIE, 33, 11. Retrieved from https://www.webofscience.com/
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
Van den Berg, R. M., Brokx, H., Vesin, A., Field, J. K., Brambilla, C., Meijer, C. J. L. M., . . . Snijders, P. J. F. (2010). Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.. International journal of oncology, 37(2), 455-461. doi:10.3892/ijo_00000694
Representing Epistasis Effects of Susceptibility SNPs in a Risk Prediction Model for Lung Cancer
Raji, O. Y., Duffy, S. W., Xinarianos, G., Liloglou, T., Young, R. P., & Field, J. K. (2010). Representing Epistasis Effects of Susceptibility SNPs in a Risk Prediction Model for Lung Cancer. In GENETIC EPIDEMIOLOGY Vol. 34 (pp. 979-980). Retrieved from https://www.webofscience.com/
SHOX2 DNA METHYLATION-A VALIDATED BIOMARKER FOR DETECTING LUNG CANCER IN BRONCHIAL ASPIRATES
Field, J. K., Dietrich, D., Kneip, C., Raji, O., Liloglou, T., Seegebarth, A., . . . Schmidt, B. (2010). SHOX2 DNA METHYLATION-A VALIDATED BIOMARKER FOR DETECTING LUNG CANCER IN BRONCHIAL ASPIRATES. In TUMOR BIOLOGY Vol. 31 (pp. S47). Retrieved from https://www.webofscience.com/
UHRF1-mediated tumor suppressor gene inactivation in non-small cell lung cancer
Daskalos, A., Oleksiewicz, U., Filia, A., Nikolaidis, G., Xinarianos, G., Gosney, J. R., . . . Liloglou, T. (2010). UHRF1-mediated tumor suppressor gene inactivation in non-small cell lung cancer. Cancer, 117(5), 1027-1037.
2009
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
Field, J. K., Liloglou, T., Niaz, A., Bryan, J., Gosney, J. R., Giles, T., . . . Cassidy, A. (2009). EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration. EUROPEAN RESPIRATORY JOURNAL, 34(6), 1477-1486. doi:10.1183/09031936.00077809
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., . . . Caporaso, N. E. (2009). A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma. AMERICAN JOURNAL OF HUMAN GENETICS, 85(5), 679-691. doi:10.1016/j.ajhg.2009.09.012
Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case-control study in Europe
Cassidy, A., Balsan, J., Vesin, A., Wu, X., Liloglou, T., Brambilla, C., . . . Field, J. K. (2009). Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case-control study in Europe. EUROPEAN JOURNAL OF CANCER, 45(17), 3047-3053. doi:10.1016/j.ejca.2009.05.006
Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer
Duffy, S. W., Raji, O. Y., Agbaje, O. F., Allgood, P. C., Cassidy, A., & Field, J. K. (2009). Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer. EXPERT REVIEW OF ANTICANCER THERAPY, 9(10), 1467-1472. doi:10.1586/ERA.09.87
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
Shaw, R. J., Omar, M. M., Rokadiya, S., Kogera, F. A., Lowe, D., Hall, G. L., . . . Risk, J. M. (2009). Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. BRITISH JOURNAL OF CANCER, 101(1), 139-144. doi:10.1038/sj.bjc.6605121
A Novel Type of p53 Pathway Dysfunction in Chronic Lymphocytic Leukemia Resulting from Two Interacting Single Nucleotide Polymorphisms within the <i>p21</i> Gene
Johnson, G. G., Sherrington, P. D., Carter, A., Lin, K., Liloglou, T., Field, J. K., & Pettitt, A. R. (2009). A Novel Type of p53 Pathway Dysfunction in Chronic Lymphocytic Leukemia Resulting from Two Interacting Single Nucleotide Polymorphisms within the <i>p21</i> Gene. CANCER RESEARCH, 69(12), 5210-5217. doi:10.1158/0008-5472.CAN-09-0627
Fragile Histidine Triad Gene Inactivation in Lung Cancer The European Early Lung Cancer Project
Verri, C., Roz, L., Conte, D., Liloglou, T., Livio, A., Vesin, A., . . . Sozzi, G. (2009). Fragile Histidine Triad Gene Inactivation in Lung Cancer The European Early Lung Cancer Project. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 179(5), 396-401. doi:10.1164/rccm.200807-1153OC
Reactors: A data-oriented synchronous/asynchronous programming model for distributed applications
Field, J., Marinescu, M. -C., & Stefansen, C. (2009). Reactors: A data-oriented synchronous/asynchronous programming model for distributed applications. In THEORETICAL COMPUTER SCIENCE Vol. 410 (pp. 168-201). doi:10.1016/j.tcs.2008.09.052
A comprehensive genome-wide association study of lung cancer
Landi, M., Chatterjee, N., Yu, K., Jacobs, K., Bergen, A., Goldin, L., . . . Caporaso, N. (2009). A comprehensive genome-wide association study of lung cancer. In CANCER RESEARCH Vol. 69. Retrieved from https://www.webofscience.com/
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma
Landi, M. T., Chatterjee, N., Yu, K., Goldin, L. R., Goldstein, A. M., Rotunno, M., . . . Caporaso, N. E. (2009). A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. The American Journal of Human Genetics, 85, 1-13.
Cancer diagnosis in a first-degree relative and lung cancer risk: results from a multicenter case-control study of early lung cancer in Europe (EUELC).
Cassidy, A., Balsan, J., Vesin, A., Wu, X., Liloglou, T., Brambilla, C., . . . Early Lung Cancer EUELC Study Group, E. (2009). Cancer diagnosis in a first-degree relative and lung cancer risk: results from a multicenter case-control study of early lung cancer in Europe (EUELC).. European Journal of Cancer.
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.
Field, J. K., Liloglou, T., Niaz, A., Bryan, J., Gosney, J. R., Giles, T., . . . EUELC Collaborators. (2009). EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.. Eur Respir J, 34(6), 1477-1486.
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.
Field, J. K., Liloglou, T., Niaz, A., Bryan, J., Gosney, J. R., Giles, T., . . . EUELC Collaborators. (2009). EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration.. Eur Respir J, 34(6), 1477-1486.
Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer
Daskalos, A., Nikolaidis, G., Xinarianos, G., Savvari, P., Cassidy, A., Zakopoulou, R., . . . Liloglou, T. (2009). Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. INTERNATIONAL JOURNAL OF CANCER, 124(1), 81-87. doi:10.1002/ijc.23849
SHOX2, a novel biomarker for the detection of lung cancer in bronchial fluid
Field, J., Liebenberg, V., Dietrich, D., Liloglou, T., Raji, O., Walshaw, M., . . . Schmidt, B. (2009). SHOX2, a novel biomarker for the detection of lung cancer in bronchial fluid. In CANCER RESEARCH Vol. 69. Retrieved from https://www.webofscience.com/
Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison
Cairns, D. A., Barrett, J. H., Billingham, L. J., Stanley, A. J., Xinarianos, G., Field, J. K., . . . Banks, R. E. (2009). Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison. PROTEOMICS, 9(1), 74-86. doi:10.1002/pmic.200800417
The predictive ability of LLP lung cancer risk model with and without seizure 6-Like (SEZ6L) gene
Raji, O. Y., Agbaje, O. F., Duffy, S. W., & Field, J. K. (2009). The predictive ability of LLP lung cancer risk model with and without seizure 6-Like (SEZ6L) gene. JOURNAL OF THORACIC ONCOLOGY, 4(9), S408-S409. Retrieved from https://www.webofscience.com/
2008
International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle Pathways
Hung, R. J., Christiani, D. C., Risch, A., Popanda, O., Haugen, A., Zienolddiny, S., . . . Brennan, P. (2008). International Lung Cancer Consortium: Pooled Analysis of Sequence Variants in DNA Repair and Cell Cycle Pathways. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 17(11), 3081-3089. doi:10.1158/1055-9965.EPI-08-0411
A global approach to cancer-screening trials
Smith, R. A., Field, J. K., & Duffy, S. W. (2008). A global approach to cancer-screening trials. LANCET ONCOLOGY, 9(10), 908-909. doi:10.1016/S1470-2045(08)70211-0
Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene
Shivapurkar, N., Stastny, V., Okumura, N., Girard, L., Xie, Y., Prinsen, C., . . . Gazdar, A. F. (2008). Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. CANCER RESEARCH, 68(18), 7448-7456. doi:10.1158/0008-5472.CAN-08-0565
Lung Cancer Risk Models Come of Age
Field, J. K. (2008). Lung Cancer Risk Models Come of Age. CANCER PREVENTION RESEARCH, 1(4), 226-228. doi:10.1158/1940-6207.CAPR-08-0144
Lung cancer screening: the way forward
Field, J. K., & Duffy, S. W. (2008). Lung cancer screening: the way forward. BRITISH JOURNAL OF CANCER, 99(4), 557-562. doi:10.1038/sj.bjc.6604509
<i>p16</i> promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia
Hall, G. L., Shaw, R. J., Field, E. A., Rogers, S. N., Sutton, D. N., Woolgar, J. A., . . . Risk, J. M. (2008). <i>p16</i> promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 17(8), 2174-2179. doi:10.1158/1055-9965.EPI-07-2867
Detecting new genes for tobacco-related cancers - genomewide association study of lung cancer
Huno, R. J., Mckay, J., Gaborieau, V., Boffetta, P., Chu, C., Field, J. K., . . . Brennan, P. (2008). Detecting new genes for tobacco-related cancers - genomewide association study of lung cancer. In EJC SUPPLEMENTS Vol. 6 (pp. 64-65). Retrieved from https://www.webofscience.com/
Generation of a non-small cell lung cancer transcriptome microarray
Tanney, A., Oliver, G. R., Farztdinov, V., Kennedy, R. D., Mulligan, J. M., Fulton, C. E., . . . Mulligan, K. A. (2008). Generation of a non-small cell lung cancer transcriptome microarray. BMC MEDICAL GENOMICS, 1. doi:10.1186/1755-8794-1-20
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
Hung, R. J., Mckay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., . . . Brennan, P. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. NATURE, 452(7187), 633-637. doi:10.1038/nature06885
The role of pyrosequencing in head and neck cancer epigenetics - Correlation of quantitative methylation data with gene expression
Shaw, R. J., Hall, G. L., Lowe, D., Liloglou, T., Field, J. K., Sloan, P., & Risk, J. M. (2008). The role of pyrosequencing in head and neck cancer epigenetics - Correlation of quantitative methylation data with gene expression. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 134(3), 251-256. doi:10.1001/archoto.2007.50
The LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008). The LLP risk model: an individual risk prediction model for lung cancer. BRITISH JOURNAL OF CANCER, 98(2), 270-276. doi:10.1038/sj.bjc.6604158
A pilot study to explore lung cancer early detection and clinical intervention in a primary care setting in Knowsley Merseyside
Ashton, M. J., Mimnagh, C., Forrest, D., & Field, J. K. (2008). A pilot study to explore lung cancer early detection and clinical intervention in a primary care setting in Knowsley Merseyside. In 1st International Lung Cancer Conference Vol. 7 (pp. 257). Liverpool: Journal of Thoracic Oncology.
Biomarker selection in non small cell lung cancer data: early experiences from the EUELC Lung Cancer Collaboration Datasets
Dol, Z., Brown, G., Field, J., Brass, A., & Consortium, O. B. O. T. E. (2008). Biomarker selection in non small cell lung cancer data: early experiences from the EUELC Lung Cancer Collaboration Datasets. In 1st International Lung Cancer Conference (pp. S246). Liverpool: Journal of Thoracic Oncology.
Cancer diagnosis in a first degree relative and lung cancer risk: results from a multicentre case control study of early lung cancer in Europe (EUELC)
Cassidy, A., Balsan, J., Vesin, A., Timsit, J. F., Brambilla, C., Field, J. K., & on behalf of the EUELC consortium. (2008). Cancer diagnosis in a first degree relative and lung cancer risk: results from a multicentre case control study of early lung cancer in Europe (EUELC). In 1st International Lung Cancer Conference (pp. S249). Liverpool: Journal of Thoracic Oncology.
Cancer diagnosis in a first-degree relative and lung cancer risk, the European Union Early Lung Cancer study
Balsan, J., Vesin, A., Cassidy, A., Field, J. K., Timsit, J. F., & Brambilla, C. (2008). Cancer diagnosis in a first-degree relative and lung cancer risk, the European Union Early Lung Cancer study. BULLETIN DU CANCER, 95, S45-S46. Retrieved from https://www.webofscience.com/
DIRAS3 is hypermethylated in NSCLC
Markopoulou, S., Daskalos, A., Nikolaidis, N., Xinarianos, G., Vaggeli, D., Gourgoulianis, K., . . . Liloglou, T. (2008). DIRAS3 is hypermethylated in NSCLC. In 1st International Lung Cancer Conference (pp. S251). Liverpool: Journal of Thoracic Oncology.
Expression and methylation of globin family genes in lung cancer
Babiskiewicz, U., Liloglou, T., Field, J. K., & Xinarianos, G. (2008). Expression and methylation of globin family genes in lung cancer. In 1st International Lung Cancer Conference (pp. S254). Liverpool: Journal of Thoracic Oncology.
FHIT gene inactivation in lung cancer patients: results of a prospective European study (EUELC).
Verri, V. C., Roz, L., Conte, D., Liloglou, T., Livio, A., Vesin, A., . . . Bossi, P. (2008). FHIT gene inactivation in lung cancer patients: results of a prospective European study (EUELC).. Am J Respir Crit Care Med.
Hypomethylation of retrotransposable elements in NSCLC
Xinarianos, G., Daskalos, A., Nikolaidis, G., Savvari, P., Cassidy, A., Zakopoulou, R., . . . Liloglou, T. (2008). Hypomethylation of retrotransposable elements in NSCLC. In 1st International Lung Cancer Conference (pp. S248). Liverpool: Journal of Thoracic Oncology.
Lung cancer screening with spiral CT- Scientific and policy issues
Duffy, S. W., Field, J. K., Smith, R. A., & Whynes, D. (2008). Lung cancer screening with spiral CT- Scientific and policy issues. In 1st International Lung Cancer Conference (pp. S250). Liverpool: Journal of Thoracic Oncology.
Lung cancer susceptibility locus at 5p15.33
McKay, J. D., Hung, R. J., Gaborieau, V., Boffetta, P., Chabrier, A., Byrnes, G., . . . Brennan, P. (2008). Lung cancer susceptibility locus at 5p15.33. NATURE GENETICS, 40(12), 1404-1406. doi:10.1038/ng.254
Sp1 regulates expression of TAp73 isoform in lung cancer cell lines
Stella, L., Ioannis, M., Gerry, M., Sofia, K., Mikas, D., & Field, J. K. (2008). Sp1 regulates expression of TAp73 isoform in lung cancer cell lines. In 1st International Conference on Lung Cancer (pp. S252). Liverpool: Journal of Thoracic Oncology.
TP73 promoter methylation in NSCLC
Daskalos, A., Nikolaidis, G., Xinarianos, G., Cassidy, A., Field, J. K., & Liloglou, T. (2008). TP73 promoter methylation in NSCLC. In 1st International Lung Cancer Conference (pp. 256). Liverpool: Journal of Thoracic Oncology.
The LLP Risk Model : Predicting lung cancer's risk in the presence of missing factors
Raji, O., Duffy, S., & Field, J. K. (2008). The LLP Risk Model : Predicting lung cancer's risk in the presence of missing factors. In 1st International Conference on Lung Cancer (pp. S254). Liverpool: Journal of Thoracic Oncology.
qMSP assay development for early lung cancer detection
Nikolaidis, G., Markopoulou, S., Daskalos, A., Xinarianos, G., Field, J., & Liloglou, T. (2008). qMSP assay development for early lung cancer detection. In NCRI Annual Meeting 2008 (pp. A146). Birmingham: NCRI.
2007
Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma
Shaw, R. J., Hall, G. L., Woolgar, J. A., Lowe, D., Rogers, S. N., Field, J. K., . . . Risk, J. M. (2007). Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 45(8), 617-622. doi:10.1016/j.bjoms.2007.04.015
CpG island methylation phenotype (CIMP) in oral cancer: Associated with a marked inflammatory response and less aggressive tumour biology
Shaw, R. J., Hall, G. L., Lowe, D., Bowers, N. L., Liloglou, T., Field, J. K., . . . Risk, J. M. (2007). CpG island methylation phenotype (CIMP) in oral cancer: Associated with a marked inflammatory response and less aggressive tumour biology. ORAL ONCOLOGY, 43(9), 878-886. doi:10.1016/j.oraloncology.2006.10.006
“CIMP” in head and neck cancer
Shaw, R., Hall, G. L., Lowe, D., Bowers, N. L., Liloglou, T., Field, J. K., . . . Risk, J. M. (2007). “CIMP” in head and neck cancer. In British Journal of Oral and Maxillofacial Surgery Vol. 45 (pp. e42-e43). Elsevier BV. doi:10.1016/j.bjoms.2007.07.041
<i>Seizure 6-like</i> (<i>SEZ6L</i>) gene and risk for lung cancer
Gorlov, I. P., Meyer, P., Lilogiou, T., Myles, J., Boettger, M. B., Cassidy, A., . . . Amos, C. I. (2007). <i>Seizure 6-like</i> (<i>SEZ6L</i>) gene and risk for lung cancer. CANCER RESEARCH, 67(17), 8406-8411. doi:10.1158/0008-5472.CAN-06-4784
Biomarkers and risk models for stratification of high risk individuals
Field, J. K., Cassidy, A., Miles, J., Liloglou, T., Xinarianos, G., Smith, D., . . . Duffy, S. (2007). Biomarkers and risk models for stratification of high risk individuals. JOURNAL OF THORACIC ONCOLOGY, 2(8), S176. doi:10.1097/01.JTO.0000282955.20898.72
P1-201: The peninsula lung cancer project (P-LLP)
Yiannakis, D., Lansdell, K., Cassidy, A., & Field, J. (2007). P1-201: The peninsula lung cancer project (P-LLP). Journal of Thoracic Oncology, 2(8), S817. doi:10.1097/01.jto.0000284299.87101.03
'Analysis of GSTM4 in non-small cell lung cancer'
Xinarianos, G., Nikolaidis, G., Wu, H., Cassidy, A., Myles, J. P., Duffy, S. W., . . . Liloglou, T. (2007). 'Analysis of GSTM4 in non-small cell lung cancer'. In American Association for Cancer Research Annual Meeting Vol. 48 (pp. 311). Los Angeles: American Association of Cancer Research.
'GAST gene expression is upregulated in non-small cell lung cancer
Liloglou, T., Daskalos, A., Xinarianos, G., Nikolaidis, G., Varro, A., & Field, J. K. (2007). 'GAST gene expression is upregulated in non-small cell lung cancer. In National Cancer Research Institute Conference (pp. 86). Birmingham: National Cancer Research Institute.
'Hypermethylation of endothelin receptor type B (EDRNB) in non-small cell lung cancer'
Knight, L., Burrage, J., Bujac, S., Gibson, N., Ellison, G., Growcott, J., . . . Liloglou, T. (2007). 'Hypermethylation of endothelin receptor type B (EDRNB) in non-small cell lung cancer'. In National Cancer Research Institute (pp. 88). Birmingham: National Cancer Research Institute.
'Hypermethylation of endothelin receptor type B (EDRNB) is a frequent event in non-small cell lung cancer
Knight, L. J., Gibson, N., Ellison, G., Growcott, J., Brooks, N., Hughes, A. M., . . . Field, J. K. (2007). 'Hypermethylation of endothelin receptor type B (EDRNB) is a frequent event in non-small cell lung cancer. In American Association for Cancer Research Annual Meeting Vol. 48 (pp. 429). Los Angeles: American Association of Cancer Research.
'Liverpool lung project:lung cancer risk prediction model
Field, J. K., Cassidy, A., Myles, J., Liloglou, T., Xinarianos, G., Smith, D., . . . Duffy, S. (2007). 'Liverpool lung project:lung cancer risk prediction model. In American Association for Cancer Research Annual Meeting Vol. 48 (pp. 402). Los Angeles: American Association of Cancer Research.
'Molecular analysis of the GSTM4 gene in lung cancer'
Xinarianos, G., Nikolaidis, G., Wu, H., Myles, J. P., Duffy, S. W., Field, J. K., & Liloglou, T. (2007). 'Molecular analysis of the GSTM4 gene in lung cancer'. In National Cancer Research Institute Conference (pp. 92). Birmingham: National Cancer Research Institute.
Chapter 4 Environmental and Genetic Risk Factors of Lung Cancer
Cassidy, A., & Field, J. K. (2007). Chapter 4 Environmental and Genetic Risk Factors of Lung Cancer. In Outcome Prediction in Cancer (pp. 67-100). Elsevier. doi:10.1016/b978-044452855-1/50006-4
Environmental and Genetic Risk Factors of Lung Cancer
Cassidy, A., & Field, J. K. (2007). Environmental and Genetic Risk Factors of Lung Cancer. In OUTCOME PREDICTION IN CANCER (pp. 67-100). doi:10.1016/B978-044452855-1/50006-4
Lung cancer risk prediction: A tool for early detection
Cassidy, A., Duffy, S. W., Myles, J. P., Liloglou, T., & Field, J. K. (2007). Lung cancer risk prediction: A tool for early detection. INTERNATIONAL JOURNAL OF CANCER, 120(1), 1-6. doi:10.1002/ijc.22331
Occupational exposure to crystalline silica and risk of lung cancer - A multicenter case-control study in Europe
Cassidy, A., 't Mannetje, A., van Tongeren, M., Field, J. K., Zaridze, D., Szeszenia-Dabrowska, N., . . . Boffetta, P. (2007). Occupational exposure to crystalline silica and risk of lung cancer - A multicenter case-control study in Europe. EPIDEMIOLOGY, 18(1), 36-43. doi:10.1097/01.ede.0000248515.28903.3c
The LLP Risk Model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2007). The LLP Risk Model: an individual risk prediction model for lung cancer. British J Cancer, 98(2), 270-276.
2006
Downregulation of the KIP family members p27<SUP>KIP1</SUP> and p57<SUP>KIP2</SUP> by SKP2 and the role of methylation in p57<SUP>KIP2</SUP> inactivation in nonsmall cell lung cancer
Pateras, I. S., Apostolopoulou, K., Koutsami, M., Evangelou, K., Tsantoulis, P., Liloglou, T., . . . Gorgoulis, V. G. (2006). Downregulation of the KIP family members p27<SUP>KIP1</SUP> and p57<SUP>KIP2</SUP> by SKP2 and the role of methylation in p57<SUP>KIP2</SUP> inactivation in nonsmall cell lung cancer. INTERNATIONAL JOURNAL OF CANCER, 119(11), 2546-2556. doi:10.1002/ijc.22214
Cytosine methylation profiles as a molecular marker in non-small cell lung cancer
Ehrich, M., Field, J. K., Liloglou, T., Xinarianos, G., Oeth, P., Nelson, M. R., . . . van den Boom, D. (2006). Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. CANCER RESEARCH, 66(22), 10911-10918. doi:10.1158/0008-5472.CAN-06-0400
Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives
Cassidy, A., Myles, J. P., Duffy, S. W., Liloglou, T., & Field, J. K. (2006). Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. BRITISH JOURNAL OF CANCER, 95(9), 1288-1290. doi:10.1038/sj.bjc.6603386
P096 Cytoglobin: A Candidate Tumor Suppressor Gene Epigenetically Silenced in Head and Neck Cancer
Shaw, R. J., Liloglou, T., Field, J. K., & Risk, J. M. (2006). P096 Cytoglobin: A Candidate Tumor Suppressor Gene Epigenetically Silenced in Head and Neck Cancer. In Archives of Otolaryngology–Head & Neck Surgery Vol. 132 (pp. 884). American Medical Association (AMA). doi:10.1001/archotol.132.8.884-b
P182 Clinical Application of Epigenetic Biomarkers in Head and Neck Cancer
Shaw, R. J., Hall, G., Liloglou, T., Rogers, S., Brown, J., Field, J. K., & Risk, J. M. (2006). P182 Clinical Application of Epigenetic Biomarkers in Head and Neck Cancer. In Archives of Otolaryngology–Head & Neck Surgery Vol. 132 (pp. 900). American Medical Association (AMA). doi:10.1001/archotol.132.8.900-c
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer
Xinarianos, G., McRonald, F. E., Risk, J. M., Bowers, N. L., Nikolaidis, G., Field, J. K., & Liloglou, T. (2006). Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer. HUMAN MOLECULAR GENETICS, 15(13), 2038-2044. doi:10.1093/hmg/ddl128
Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing
Shaw, R. J., Akufo-Tetteh, E. K., Risk, J. M., Field, J. K., & Liloglou, T. (2006). Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. NUCLEIC ACIDS RESEARCH, 34(11). doi:10.1093/nar/gkl424
The Liverpool Statement 2005: Priorities for the European Union/United States Spiral Computed Tomography Collaborative Group
Field, J. K., Smith, R. A., Duffy, S. W., Berg, C. D., van Klaveren, R., Henschke, C. I., . . . Mulshine, J. L. (2006). The Liverpool Statement 2005: Priorities for the European Union/United States Spiral Computed Tomography Collaborative Group. Journal of Thoracic Oncology, 1(5), 497-498. doi:10.1016/s1556-0864(15)31618-x
The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group.
Field, J. K., Smith, R. A., Duffy, S. W., Berg, C. D., van Klaveren, R., Henschke, C. I., . . . Mulshine, J. L. (2006). The Liverpool Statement 2005: priorities for the European Union/United States spiral computed tomography collaborative group.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 1(5), 497-498. doi:10.1016/s1556-0864(15)31618-x
Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC):: evidence for <i>trans</i>-allele repression
McRonald, F. E., Liloglou, T., Xinarianos, G., Hill, L., Rowbottom, L., Langan, J. E., . . . Risk, J. M. (2006). Down-regulation of the cytoglobin gene, located on 17q25, in tylosis with oesophageal cancer (TOC):: evidence for <i>trans</i>-allele repression. HUMAN MOLECULAR GENETICS, 15(8), 1271-1277. doi:10.1093/hmg/ddl042
Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer:: quantitative evaluation using pyrosequencing
Shaw, R. J., Liloglou, T., Rogers, S. N., Brown, J. S., Vaughan, E. D., Lowe, D., . . . Risk, J. M. (2006). Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer:: quantitative evaluation using pyrosequencing. BRITISH JOURNAL OF CANCER, 94(4), 561-568. doi:10.1038/sj.bjc.6602972
A multi-centre case-control study of occupational exposure to crystalline silica and lung cancer risk.
Cassidy, A., Mannetje, A., van Tongeren, M., Field, J. K., Zaridze, D., Szeszenia-Dabrowska, N., . . . Boffetta, P. (2006). A multi-centre case-control study of occupational exposure to crystalline silica and lung cancer risk.. Epidemiology (in press).
Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer
Cassidy, A., Myles, J. P., Liloglou, T., Duffy, S. W., & Field, J. K. (2006). Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer. INTERNATIONAL JOURNAL OF ONCOLOGY, 28(5), 1295-1301. Retrieved from https://www.webofscience.com/
Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.
Cassidy, A., Myles, J., Liloglou, T., Duffy, S., & Field, J. K. (2006). Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer.. Int J Oncol., 5(5), 1295-1301.
Down-regulation of the KIP family members p27 KIP1 and p57 KIP2 by SKP2 and the role of methylation in p57KIP2
Pateras, I. S., Kotsinas, A., Liloglou, T., Nikolaidis, G., Foukas, P., Koutsami, M., . . . Gorgoulis, V. G. (2006). Down-regulation of the KIP family members p27 KIP1 and p57 KIP2 by SKP2 and the role of methylation in p57KIP2. Int J Cancer.
Loss of CACNA2D2 expression in non-small cell lung cancer
Xinarianos, G., Panutsopulos, D., Fielding, P., Gosney, J. R., Spandidos, D. A., Liloglou, T., & Field, J. K. (2006). Loss of CACNA2D2 expression in non-small cell lung cancer. In CANCER RESEARCH Vol. 66. Retrieved from https://www.webofscience.com/
Methylation profiling in Bronchial Alveolar Lavage Samples from heavy smokers using MALDI TOF Mass Spectrometry
Ehrich, M., Liloglou, T., Xinarianos, G., Field, J., & Van Den Boom, D. (2006). Methylation profiling in Bronchial Alveolar Lavage Samples from heavy smokers using MALDI TOF Mass Spectrometry. In CANCER RESEARCH Vol. 66. Retrieved from https://www.webofscience.com/
Pyrosequencing-based DNA methylation profiling in lung cancer
Liloglou, T., Xinarianos, G., Nikolaidis, G., Kotsinas, A., Pateras, I., Gorgoulis, V., & Field, J. K. (2006). Pyrosequencing-based DNA methylation profiling in lung cancer. In CANCER RESEARCH Vol. 66. Retrieved from https://www.webofscience.com/
Using logical data models for understanding and transforming legacy business applications
Chandra, S., de Vries, J., Field, J., Hess, H., Kalidasan, M., Raghavan, K. V., . . . Xue, J. (2006). Using logical data models for understanding and transforming legacy business applications. IBM SYSTEMS JOURNAL, 45(3), 647-655. doi:10.1147/sj.453.0647
2005
The Liverpool Lung Project research protocol
Field, J. K., Smith, D. L., Duffy, S., & Cassidy, A. (2005). The Liverpool Lung Project research protocol. INTERNATIONAL JOURNAL OF ONCOLOGY, 27(6), 1633-1645. Retrieved from https://www.webofscience.com/
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry
Ehrich, M., Nelson, M. R., Stanssens, P., Zabeau, M., Liloglou, T., Xinarianos, G., . . . van den Boom, D. (2005). Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 102(44), 15785-15790. doi:10.1073/pnas.0507816102
Abnormal CYGB expression and hypermethylation in non-small cell lung cancer
Liloglou, T., McRonald, F., Xinarianos, G., Bowers, N., Risk, J., & Field, J. (2005). Abnormal CYGB expression and hypermethylation in non-small cell lung cancer. In LUNG CANCER Vol. 49 (pp. S134). doi:10.1016/S0169-5002(05)80572-0
PD-053 Lung cancer susceptibility: A CDKN1A promoter polymorphismenhances the risk for lung cancer
Field, J., Xinarianos, G., Myles, J., Nikolaidis, G., Cassidy, A., Duffy, S., & Liloglou, L. (2005). PD-053 Lung cancer susceptibility: A CDKN1A promoter polymorphismenhances the risk for lung cancer. Lung Cancer, 49, S81-S82. doi:10.1016/s0169-5002(05)80386-1
Promotor-methylation profiling in lung cancer using MALDI TOF mass spectrometry
Ehrich, M., Liloglou, T., Field, J., Nelson, M., & van den Boom, D. (2005). Promotor-methylation profiling in lung cancer using MALDI TOF mass spectrometry. In LUNG CANCER Vol. 49 (pp. S18). doi:10.1016/S0169-5002(05)80177-1
Analysis of familial tylosis oesophageal cancer genes on 17Q25
Rowbottom, L., McRonald, F. E., Langan, J. E., Ellis, A., Field, J. K., & Risk, J. M. (2005). Analysis of familial tylosis oesophageal cancer genes on 17Q25. In CLINICA CHIMICA ACTA Vol. 355 (pp. S167-S168). Retrieved from https://www.webofscience.com/
Lung cancer susceptibility: A CDKN1A promoter polymorphism enhances the risk for lung cancer
Field, J., Xinarianos, G., Myles, J., Nikolaidis, G., Cassidy, A., Duffy, S., & Liloglou, T. (2005). Lung cancer susceptibility: A CDKN1A promoter polymorphism enhances the risk for lung cancer. In LUNG CANCER Vol. 49 (pp. S82). Retrieved from https://www.webofscience.com/
Methylation discriminators in NSCLC identified by a microarray based approach
Field, J. K., Liloglou, T., Warrak, S., Burger, M., Becker, E., Berlin, K., . . . Maier, S. (2005). Methylation discriminators in NSCLC identified by a microarray based approach. INTERNATIONAL JOURNAL OF ONCOLOGY, 27(1), 105-111. Retrieved from https://www.webofscience.com/
2004
S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas
Smith, S. L., Gugger, M., Hoban, P., Ratschiller, D., Watson, S. G., Field, J. K., . . . Heighway, J. (2004). S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas. BRITISH JOURNAL OF CANCER, 91(8), 1515-1524. doi:10.1038/sj.bjc.6602188
METH-2 silencing and promoter hypermethylation in NSCLC
Dunn, J. R., Panutsopulos, D., Shaw, M. W., Heighway, J., Dormer, R., Salmo, E. N., . . . Liloglou, T. (2004). METH-2 silencing and promoter hypermethylation in NSCLC. BRITISH JOURNAL OF CANCER, 91(6), 1149-1154. doi:10.1038/sj.bjc.6602107
Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (<i>TOC</i>) minimal region on 17q25 to 42.5 kb:: sequencing does not identify the causative gene
Langan, J. E., Cole, C. G., Huckle, E. J., Byrne, S., McRonald, F. E., Rowbottom, L., . . . Risk, J. M. (2004). Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (<i>TOC</i>) minimal region on 17q25 to 42.5 kb:: sequencing does not identify the causative gene. HUMAN GENETICS, 114(6), 534-540. doi:10.1007/s00439-004-1100-3
Session 7
Field, J. K., Heighway, J., Smith, S., Liloglou, T., Payne, T., Duffy, S., . . . Maier, S. (2004). Session 7. European Journal of Cancer Supplements, 2(1), 21. doi:10.1016/s1359-6349(04)90108-5
An investigation of the tylosis with oesophageal cancer (<i>TOC</i>) locus in Iranian patients with oesophageal squamous cell carcinoma
Shahabi, M., Daloii, M. R. N., Langan, J. E., Rowbottom, L., Jahanzad, E., Khoshbin, E., . . . Risk, J. M. (2004). An investigation of the tylosis with oesophageal cancer (<i>TOC</i>) locus in Iranian patients with oesophageal squamous cell carcinoma. INTERNATIONAL JOURNAL OF ONCOLOGY, 25(2), 389-395. Retrieved from https://www.webofscience.com/
Fine mapping of genetic alterations on chromosome 6 in uveal melanoma
Risk, J. M., Nunn, J., Damoto, B., Burrows, K. E., Hagan, S., Scholes, A. G. M., . . . Field, J. K. (2004). Fine mapping of genetic alterations on chromosome 6 in uveal melanoma. BRITISH JOURNAL OF CANCER, 91, S54. Retrieved from https://www.webofscience.com/
Genetic analysis of the tylosis with oesophageal cancer (<i>TOC</i>) gene region on 17q25
McRonald, F. E., Rowbottom, L., Langan, J. E., Ellis, A., Shaw, J. M., Field, J. K., & Risk, J. M. (2004). Genetic analysis of the tylosis with oesophageal cancer (<i>TOC</i>) gene region on 17q25. In BRITISH JOURNAL OF CANCER Vol. 91 (pp. S12). Retrieved from https://www.webofscience.com/
Glycine-extended gastrin promotes the growth of lung cancer
Koh, T. J., Field, J. K., Varro, A., Liloglou, T., Fielding, P., Cui, G. L., . . . Wang, T. C. (2004). Glycine-extended gastrin promotes the growth of lung cancer. Cancer Research, 64(1), 196-201. Retrieved from http://cancerres.aacrjournals.org/cgi/reprint/64/1/196
Glycine-extended gastrin promotes the growth of lung cancer
Koh, T. J., Field, J. K., Varro, A., Liloglou, L., Fielding, P., Cui, G., . . . Wang, T. C. (2004). Glycine-extended gastrin promotes the growth of lung cancer. Cancer Research, 64(1), 196-201. doi:10.1158/0008-5472.CAN-03-2112
Glycine-extended gastrin promotes the growth of lung cancer
Koh, T. J., Field, J. K., Varro, A., Liloglou, T., Fielding, P., Cui, G. L., . . . Wang, T. C. (2004). Glycine-extended gastrin promotes the growth of lung cancer. CANCER RESEARCH, 64(1), 196-201. doi:10.1158/0008-5472.CAN-03-2112
Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?
Dolan, K., Morris, A. I., Gosney, J. R., Field, J. K., & Sutton, R. (2004). Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 19(1), 24-30. doi:10.1111/j.1440-1746.2004.03280.x
2003
E-26. Molecular markers in early detection
Field, J. K., Heighway, J., Smith, S. L., Liloglou, T., Payne, T. H., Duffy, S., . . . Maier, S. (2003). E-26. Molecular markers in early detection. Lung Cancer, 41, S33-S34. doi:10.1016/s0169-5002(03)90433-8
Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays
Leversha, M. A., Fielding, P., Watson, S., Gosney, J. R., & Field, J. K. (2003). Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. JOURNAL OF PATHOLOGY, 200(5), 610-619. doi:10.1002/path.1374
Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma
Dunn, J. R., Risk, J. M., Langan, J. E., Marlee, D., Ellis, A., Campbell, F., . . . Field, J. K. (2003). Physical and transcript map of the minimally deleted region III on 17p implicated in the early development of Barrett's oesophageal adenocarcinoma. ONCOGENE, 22(26), 4134-4142. doi:10.1038/sj.onc.1206466
Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus
Dolan, K., Morris, A. I., Gosney, J. R., Field, J. K., & Sutton, R. (2003). Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 18(6), 683-689. doi:10.1046/j.1440-1746.2003.03048.x
TP53 mutations in malignant and premalignant Barrett's esophagus
Dolan, K., Walker, S. J., Gosney, J., Field, J. K., & Sutton, R. (2003). TP53 mutations in malignant and premalignant Barrett's esophagus. DISEASES OF THE ESOPHAGUS, 16(2), 83-89. doi:10.1046/j.1442-2050.2003.00302.x
Major conceptual change required to improve lung cancer: see a respiratory physician
Field, J. K., & Brambilla, C. (2003). Major conceptual change required to improve lung cancer: see a respiratory physician. EUROPEAN RESPIRATORY JOURNAL, 21(4), 565-566. doi:10.1183/09031936.03.00116202
Absence of mutations in the <i>VHL</i> gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas
Miyakis, S., Liloglou, T., Kearney, S., Xinarianos, G., Spandidos, D. A., & Field, J. K. (2003). Absence of mutations in the <i>VHL</i> gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas. LUNG CANCER, 39(3), 273-277. doi:10.1016/S0169-5002(02)00506-8
Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival
Scholes, A. G. M., Damato, B. E., Nunn, J., Hiscott, P., Grierson, I., & Field, J. K. (2003). Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 44(3), 1008-1011. doi:10.1167/iovs.02-0159
Allelic imbalance at the DNA mismatch repair loci, <i>hMSH2</i>, <i>hMLH1</i>, <i>hPMS1</i>, <i>hPMS2</i> and <i>hMSH3</i>, in squamous cell carcinoma of the head and neck
Nunn, J., Nagini, S., Risk, J. M., Prime, W., Maloney, P., Liloglou, T., . . . Field, J. K. (2003). Allelic imbalance at the DNA mismatch repair loci, <i>hMSH2</i>, <i>hMLH1</i>, <i>hPMS1</i>, <i>hPMS2</i> and <i>hMSH3</i>, in squamous cell carcinoma of the head and neck. ORAL ONCOLOGY, 39(2), 115-129. doi:10.1016/S1368-8375(02)00028-3
Chapter 9 Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma
Scully, C., Field, J. K., & Tanzawa, H. (2003). Chapter 9 Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma. In Head and Neck Cancer (pp. 117-135). Elsevier. doi:10.1016/b978-012239990-9/50010-2
Early genetic diagnosis of oral dysplastic lesions using oral scrapings.
Risk, J. M., Struttman, D. C. H., Rogers, S., Sutton, D. N., Woolgar, J., Field, A. E., & Field, J. K. (2003). Early genetic diagnosis of oral dysplastic lesions using oral scrapings.. In JOURNAL OF DENTAL RESEARCH Vol. 82 (pp. 485). Retrieved from https://www.webofscience.com/
Fluorescent microsatellite analysis in bronchial lavage as a potential diagnostic tool for lung cancer.
Field, J. K., & Liloglou, T. (2003). Fluorescent microsatellite analysis in bronchial lavage as a potential diagnostic tool for lung cancer.. Methods in molecular medicine, 75, 251-262. doi:10.1385/1-59259-324-0:251
In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree
Sikkink, S. K., Liloglou, T., Maloney, P., Gosney, J. R., & Field, J. K. (2003). In-depth analysis of molecular alterations within normal and tumour tissue from an entire bronchial tree. INTERNATIONAL JOURNAL OF ONCOLOGY, 22(3), 589-595. Retrieved from https://www.webofscience.com/
Microsatellite analysis in bronchial lavage and sputum as a diagnostic tool of lung cancer
Field, J. K., & Liloglou, T. (2003). Microsatellite analysis in bronchial lavage and sputum as a diagnostic tool of lung cancer (Vol. 2). B. Driscol (Ed.), NY: Humana Press.
Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma
Scully, C., Field, J. K., & Tanzawa, H. (2003). Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma. In Head and Neck Cancer (pp. 117-135). Elsevier. doi:10.1016/b978-012239990-9/50010-2
The use of oral scrapings in the assessment of genetic damage in oral lesions.
Risk, J. M., Sutton, D. N., Rogers, S. N., Field, E. A., & Field, J. K. (2003). The use of oral scrapings in the assessment of genetic damage in oral lesions.. JOURNAL OF DENTAL RESEARCH, 82, B111. Retrieved from https://www.webofscience.com/
2002
Tobacco money: up in smoke?
Mulshine, J. L., Smith, R. A., Field, J. K., & Hirsch, F. R. (2002). Tobacco money: up in smoke?. LANCET, 360(9349), 1979-1980. doi:10.1016/S0140-6736(02)11880-0
Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival
Smith, S. L., Damato, B. E., Scholes, A. G. M., Nunn, J., Field, J. K., & Heighway, J. (2002). Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival. BRITISH JOURNAL OF CANCER, 87(11), 1308-1313. doi:10.1038/sj.bjc.6600620
Expression profiling of primary non-small cell lung cancer for target identification
Heighway, J., Knapp, T., Boyce, L., Brennand, S., Field, J. K., Betticher, D. C., . . . Rickert, P. (2002). Expression profiling of primary non-small cell lung cancer for target identification. ONCOGENE, 21(50), 7749-7763. doi:10.1038/sj.onc.1205979
<i>p53</i> status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma
Xinarianos, G., Liloglou, T., Prime, W., Sourvinos, G., Karachristos, A., Gosney, J. R., . . . Field, J. K. (2002). <i>p53</i> status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma. INTERNATIONAL JOURNAL OF CANCER, 101(3), 248-252. doi:10.1002/ijc.10598
Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (<i>TOC</i>) locus
Risk, J. M., Evans, K. E., Jones, J., Langan, J. E., Rowbottom, L., McRonald, F. E., . . . Field, J. K. (2002). Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (<i>TOC</i>) locus. ONCOGENE, 21(41), 6395-6402. doi:10.1038/sj.onc.1205768
IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.
Hirsch, F. R., Bunn, P. A., Dmitrovsky, E., Field, J. K., Franklin, W. A., Greenberg, R. E., . . . Mulshine, J. L. (2002). IV international conference on prevention and early detection of lung cancer, Reykjavik, Iceland, August 9-12, 2001.. In Lung cancer (Amsterdam, Netherlands) Vol. 37 (pp. 325-344). doi:10.1016/s0169-5002(02)00141-1
A T2517C polymorphism in the <i>GSTM4</i> gene is associated with risk of developing lung cancer
Liloglou, T., Walters, M., Maloney, P., Youngson, J., & Field, J. K. (2002). A T2517C polymorphism in the <i>GSTM4</i> gene is associated with risk of developing lung cancer. LUNG CANCER, 37(2), 143-146. doi:10.1016/S0169-5002(02)00078-8
Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark
Skuladottir, H., Hirsch, F. R., Hansen, H. H., & Olsen, J. H. (2002). Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark. LUNG CANCER, 37(2), 127-135. doi:10.1016/S0169-5002(02)00080-6
A comparative guide to gene prediction tools for the bioinformatics amateur
Jones, J., Field, J. K., & Risk, J. M. (2002). A comparative guide to gene prediction tools for the bioinformatics amateur. INTERNATIONAL JOURNAL OF ONCOLOGY, 20(4), 697-705. Retrieved from https://www.webofscience.com/
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Works
Field, J. K., Brambilla, C., Caporaso, N., Flahault, A., Henschke, C., Herman, J., . . . Youngson, J. (2002). Consensus statements from the Second International Lung Cancer Molecular Biomarkers Works. Int J Oncol, 21(2), 369-373. Retrieved from http://www.ncbi.nlm.nih.gov/
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: A European strategy for developing lung cancer molecular diagnostics in high risk populations
Field, J. K., Brambilla, C., Caporaso, N., Flahault, A., Henschke, C., Herman, J., . . . Youngson, J. (2002). Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: A European strategy for developing lung cancer molecular diagnostics in high risk populations. INTERNATIONAL JOURNAL OF ONCOLOGY, 21(2), 369-373. Retrieved from https://www.webofscience.com/
Identification of novel candidate genes within the 250KB tylosis with oesophageal cancer (TOC) minimal region on chromosome 17q25
McRonald, F., Risk, J., Ellis, T., Rowbottom, L., Langan, J., & Field, J. (2002). Identification of novel candidate genes within the 250KB tylosis with oesophageal cancer (TOC) minimal region on chromosome 17q25. Retrieved from https://www.webofscience.com/
Oral scrapes used in molecular diagnosis of oral cancer and dysplastic lesions.
Field, J. K., Struttman, D. C., Trierveiler, M. A., Rogers, S., Sutton, D., Woolgar, J., & Field, E. A. (2002). Oral scrapes used in molecular diagnosis of oral cancer and dysplastic lesions.. In JOURNAL OF DENTAL RESEARCH Vol. 81 (pp. A149). Retrieved from https://www.webofscience.com/
Refinement of the tylosis oesophageal cancer (<i>TOC</i>) minimal region to 65KB by haplotype analysis using novel microsatelite markers and SNPS
Langan, J. E., Risk, J. M., & Field, J. K. (2002). Refinement of the tylosis oesophageal cancer (<i>TOC</i>) minimal region to 65KB by haplotype analysis using novel microsatelite markers and SNPS. BRITISH JOURNAL OF CANCER, 86, S119-S120. Retrieved from https://www.webofscience.com/
Sequencing of difficult templates containing poly(A/T) tracts: Closure of sequence gaps
Langan, J. E., Rowbottom, L., Liloglou, T., Field, J. K., & Risk, J. M. (2002). Sequencing of difficult templates containing poly(A/T) tracts: Closure of sequence gaps. BIOTECHNIQUES, 33(2), 276-+. doi:10.2144/02332bm04
The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection
Field, J. K., & Youngson, J. H. (2002). The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection. EUROPEAN RESPIRATORY JOURNAL, 20(2), 464-479. doi:10.1183/09031936.02.00290202
2001
Loss of heterozygosity on chromosomes 3, 9, 13 and 17, including the retinoblastoma locus, in uveal melanoma
Scholes, A. G. M., Liloglou, T., Maloney, P., Hagan, S., Nunn, J., Hiscott, P., . . . Field, J. K. (2001). Loss of heterozygosity on chromosomes 3, 9, 13 and 17, including the retinoblastoma locus, in uveal melanoma. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 42(11), 2472-2477. Retrieved from https://www.webofscience.com/
Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-<i>ras</i> gene:: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas
Kotsinas, A., Gorgoulis, V. G., Zacharatos, P., Mariatos, G., Kokotas, S., Liloglou, T., . . . Kittas, C. (2001). Additional characterization of a hexanucleotide polymorphic site in the first intron of human H-<i>ras</i> gene:: comparative study of its alterations in non-small cell lung carcinomas and sporadic invasive breast carcinomas. CANCER GENETICS AND CYTOGENETICS, 126(2), 147-154. doi:10.1016/S0165-4608(00)00407-6
Assessing cyclin D1 & p53 as markers of malignant potential using tissue microarray technology in Barrett's oesophageal adenocarcinoma.
Oates, B. C., Dunn, J. R., Campbell, F., Fielding, P., Morris, A. I., Ellis, A., . . . Watson, A. J. M. (2001). Assessing cyclin D1 & p53 as markers of malignant potential using tissue microarray technology in Barrett's oesophageal adenocarcinoma.. GASTROENTEROLOGY, 120(5), A444-A445. Retrieved from https://www.webofscience.com/
Evidence for a molecular biomarker of malignant potential specific to Barrett's adenocarcinoma on the p arm of chromosome 17
Dunn, J. R., Oates, B. C., Garde, J., Gosney, J. R., Watson, A. J. M., & Field, J. K. (2001). Evidence for a molecular biomarker of malignant potential specific to Barrett's adenocarcinoma on the p arm of chromosome 17. GASTROENTEROLOGY, 120(5), A291-A292. Retrieved from https://www.webofscience.com/
Evidence for a molecular biomarker of malignant potential specific to Barrett's adenocarcinoma on the p arm of chromosome 17
Dunn, J. R., Oates, B. C., Garde, J., Gosney, J. R., Watson, A. J., & Field, J. K. (2001). Evidence for a molecular biomarker of malignant potential specific to Barrett's adenocarcinoma on the p arm of chromosome 17. Gastroenterology, 120(5), A291-A292. doi:10.1016/s0016-5085(08)81446-1
Prevention of lung cancer in the new millennium
Field, J. K., & Youngson, J. H. (2001). Prevention of lung cancer in the new millennium. European Journal of Cancer, 37, S367. doi:10.1016/s0959-8049(01)81857-8
Association of allelic loss at the <i>FHIT</i> locus and <i>p53</i> alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs)
Garinis, G. A., Gorgoulis, V. G., Mariatos, G., Zacharatos, P., Kotsinas, A., Liloglou, T., . . . Kittas, C. (2001). Association of allelic loss at the <i>FHIT</i> locus and <i>p53</i> alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). JOURNAL OF PATHOLOGY, 193(1), 55-65. doi:3.0.CO;2-#">10.1002/1096-9896(2000)9999:9999<::AID-PATH731>3.0.CO;2-#
Cancer-specific genomic instability in bronchial lavage: A molecular tool for lung cancer detection
Liloglou, T., Maloney, P., Xinarianos, G., Hulbert, M., Walshaw, M. J., Gosney, J. R., . . . Field, J. K. (2001). Cancer-specific genomic instability in bronchial lavage: A molecular tool for lung cancer detection. CANCER RESEARCH, 61(4), 1624-1628. Retrieved from https://www.webofscience.com/
Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations
Field, J. K., Brambilla, C., Hirsch, F. R., Hittelman, W., Hogan, M., Marshall, D., . . . Weiss, S. (2001). Molecular Biomarkers Workshop: a European Strategy for Developing Lung Cancer Molecular Diagnostics in High Risk Populations. In Lung Cancer Vol. 31 (pp. 339-345). Elsevier BV. doi:10.1016/s0169-5002(00)00236-1
Deregulated expression of c-<i>mos</i> in non-small cell lung carcinomas:: Relationship with <i>p53</i> status, genomic instability, and tumor kinetics
Gorgoulis, V. G., Zacharatos, P., Mariatos, G., Liloglou, T., Kokotas, S., Kastrinakis, N., . . . Field, J. K. (2001). Deregulated expression of c-<i>mos</i> in non-small cell lung carcinomas:: Relationship with <i>p53</i> status, genomic instability, and tumor kinetics. CANCER RESEARCH, 61(2), 538-549. Retrieved from https://www.webofscience.com/
A new rare allele at the CGG repeat polymorphism in the first intron of human c-H-ras gene
Kotsinas, A., Gorgoulis, V. G., Zacharatos, P., Liloglou, T., Leonardou, P., Brami, J., . . . Kittas, C. (2001). A new rare allele at the CGG repeat polymorphism in the first intron of human c-H-ras gene. IN VIVO, 15(1), 105-108. Retrieved from https://www.webofscience.com/
Assessing cyclin D1 & p53 as markers of malignant potential in Barrett's oesophageal adenocarcinoma using tissue microarrays
Oates, B. C., Dunn, J. R., Campbell, F., Fielding, P., Morris, A. I., Ellis, A., . . . Watson, A. J. M. (2001). Assessing cyclin D1 & p53 as markers of malignant potential in Barrett's oesophageal adenocarcinoma using tissue microarrays. GUT, 48, A15-A16. Retrieved from https://www.webofscience.com/
Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
Garinis, G. A., Gorgoulis, V. G., Mariatos, G., Zacharatos, P., Kotsinas, A., Liloglou, T., . . . Kittas, C. (2001). Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).. The Journal of pathology, 193(1), 55-65. doi:3.0.co;2-#">10.1002/1096-9896(2000)9999:9999<::aid-path731>3.0.co;2-#
Cancer specific genomic instability in bronchial lavage as a method of lung cancer detection
Liloglou, T., Maloney, P., Xinarianos, G., Hulbert, M., & Field, J. K. (2001). Cancer specific genomic instability in bronchial lavage as a method of lung cancer detection. BRITISH JOURNAL OF CANCER, 85, 58. Retrieved from https://www.webofscience.com/
Comparison of the clinico-epidemiological, pathological and molecular features of adenocarcinomas around the GOJ
Dolan, K., Field, J. K., Walker, S. J., & Sutton, R. (2001). Comparison of the clinico-epidemiological, pathological and molecular features of adenocarcinomas around the GOJ. BRITISH JOURNAL OF CANCER, 85, 71. Retrieved from https://www.webofscience.com/
High-throughput molecular profiling using tissue microarrays - Assessing accuracy & practicality
Oates, B. C., Dunn, J. R., Campbell, F., Fielding, P., Morris, A. I., Ellis, A., . . . Watson, A. J. M. (2001). High-throughput molecular profiling using tissue microarrays - Assessing accuracy & practicality. GUT, 48, A61. Retrieved from https://www.webofscience.com/
Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma
Scholes, A. G., Liloglou, T., Maloney, P., Hagan, S., Nunn, J., Hiscott, P., . . . Field, J. K. (2001). Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma. Invest Ophthalmol Vis Sci, 42(11), 2472-2477.
Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer
Sourvinos, G., Miyakis, S., Liloglou, T. L., Field, J. K., & Spandidos, D. A. (2001). Von Hippel-Lindau tumour suppressor gene is not involved in sporadic human breast cancer. TUMOR BIOLOGY, 22(3), 131-136. doi:10.1159/000050607
2000
K-<i>ras</i> point mutation detection in lung cancer:: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification
Clayton, S. J., Scott, F. M., Walker, J., Callaghan, K., Haque, K., Liloglou, T., . . . Fox, J. C. (2000). K-<i>ras</i> point mutation detection in lung cancer:: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. CLINICAL CHEMISTRY, 46(12), 1929-1938. Retrieved from https://www.webofscience.com/
The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens
Dunn, J. R., Garde, J., Dolan, K., Gosney, J. R., Oates, B. C., Watson, A. J. M., . . . Field, J. K. (2000). The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens. CLINICAL CANCER RESEARCH, 6(10), 4033-4042. Retrieved from https://www.webofscience.com/
Association of allelic imbalance at locus <i>D13S171</i> <i>(BRCA2)</i> and <i>p53</i> alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma
Gorgoulis, V. G., Kotsinas, A., Zacharatos, P., Mariatos, G., Liloglou, T., Tsoli, E., . . . Kittas, C. (2000). Association of allelic imbalance at locus <i>D13S171</i> <i>(BRCA2)</i> and <i>p53</i> alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma. CANCER, 89(9), 1933-1945. doi:3.3.CO;2-4">10.1002/1097-0142(20001101)89:9<1933::AID-CNCR9>3.3.CO;2-4
Association of allelic imbalance at locus <i>D13S171</i> (<i>BRCA2</i>) and <i>p53</i> alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma
Gorgoulis, V. G., Kotsinas, A., Zacharatos, P., Mariatos, G., Liloglou, T., Tsoli, E., . . . Kittas, C. (2000). Association of allelic imbalance at locus <i>D13S171</i> (<i>BRCA2</i>) and <i>p53</i> alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma. Cancer, 89(9), 1933-1945. doi:3.0.co;2-d">10.1002/1097-0142(20001101)89:9<1933::aid-cncr9>3.0.co;2-d
The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas
Miyakis, S., Sourvinos, G., Liloglou, T. L., Stathopoulos, G. P., Field, J. K., & Spandidos, D. A. (2000). The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. INTERNATIONAL JOURNAL OF CANCER, 88(3), 503-505. doi:3.0.CO;2-9">10.1002/1097-0215(20001101)88:3<503::AID-IJC28>3.0.CO;2-9
The Von HippelLindau VHL tumor‐suppressor gene is not mutated in sporadic human colon adenocarcinomas
Miyakis, S., Sourvinos, G., Liloglou, T. L., Stathopoulos, G. P., Field, J. K., & Spandidos, D. A. (2000). The Von HippelLindau VHL tumor‐suppressor gene is not mutated in sporadic human colon adenocarcinomas. International Journal of Cancer, 88(3), 503-505. doi:3.3.co;2-0">10.1002/1097-0215(20001101)88:3<503::aid-ijc28>3.3.co;2-0
The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas
Miyakis, S., Sourvinos, G., Liloglou, T. L., Stathopoulos, G. P., Field, J. K., & Spandidos, D. A. (2000). The Von Hippel-Lindau (VHL) tumor-suppressor gene is not mutated in sporadic human colon adenocarcinomas. International Journal of Cancer, 88(3), 503-505. doi:3.0.CO;2-9">10.1002/1097-0215(20001101)88:3<503::AID-IJC28>3.0.CO;2-9
Cancer specific genomic instability: For early detection of lung cancer
Field, J. K., Liloglou, T., Maloney, P., Fear, S., Fielding, P., & Walshaw, M. J. (2000). Cancer specific genomic instability: For early detection of lung cancer. Lung Cancer, 29(1), 228. doi:10.1016/s0169-5002(00)80782-5
c-mos immunoreactivity is an indicator of good prognosis in lung cancer
Athanasiou, A., Gorgoulis, V. G., Zacharatos, P., Mariatos, G., Kotsinas, A., Liloglou, T., . . . Kittas, C. (2000). c-mos immunoreactivity is an indicator of good prognosis in lung cancer. HISTOPATHOLOGY, 37(1), 45-54. doi:10.1046/j.1365-2559.2000.00898.x
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas
Xinarianos, G., Liloglou, T., Prime, W., Maloney, P., Callaghan, J., Fielding, P., . . . Field, J. K. (2000). hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. CANCER RESEARCH, 60(15), 4216-4221. Retrieved from https://www.webofscience.com/
Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations
Scully, C., Field, J. K., & Tanzawa, H. (2000). Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. ORAL ONCOLOGY, 36(4), 311-327. doi:10.1016/S1368-8375(00)00021-X
Allelic imbalance at the <i>5q14</i> locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs).: Possible synergistic effect with <i>p53</i> gene alterations on apoptosis
Gorgoulis, V. G., Mariatos, G., Manolis, E. N., Zacharatos, P., Kotsinas, A., Liloglou, T., . . . Kittas, C. (2000). Allelic imbalance at the <i>5q14</i> locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs).: Possible synergistic effect with <i>p53</i> gene alterations on apoptosis. LUNG CANCER, 28(3), 211-224. doi:10.1016/S0169-5002(99)00137-3
Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control
Scully, C., Field, J. K., & Tanzawa, H. (2000). Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. ORAL ONCOLOGY, 36(3), 256-263. doi:10.1016/S1368-8375(00)00007-5
Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease
Xinarianos, G., Scott, F. M., Liloglou, T., Prime, W., Turnbull, L., Walshaw, M., & Field, J. K. (2000). Evaluation of telomerase activity in bronchial lavage as a potential diagnostic marker for malignant lung disease. LUNG CANCER, 28(1), 37-42. doi:10.1016/S0169-5002(99)00111-7
Expression of <i>p16<SUP>INK4A</SUP></i> and alterations of the 9<i>p</i>21-23 chromosome region in non-small-cell lung carcinomas:: Relationship with tumor growth parameters and ploidy status
Mariatos, G., Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Vogiatzi, T., Rassidakis, G., . . . Kittas, C. (2000). Expression of <i>p16<SUP>INK4A</SUP></i> and alterations of the 9<i>p</i>21-23 chromosome region in non-small-cell lung carcinomas:: Relationship with tumor growth parameters and ploidy status. INTERNATIONAL JOURNAL OF CANCER, 89(2), 133-141. doi:3.0.CO;2-C">10.1002/(SICI)1097-0215(20000320)89:2<133::AID-IJC6>3.0.CO;2-C
Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs)
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Mariatos, G., Liloglou, T., Vogiatzi, T., . . . Kittas, C. (2000). Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). MOLECULAR MEDICINE, 6(3), 208-237. doi:10.1007/BF03402115
A physical map of the tylosis oesophageal cancer gene (TOC).
Mills, H., Risk, J., Kuhlenbaumer, G., Langen, J., & Field, J. K. (2000). A physical map of the tylosis oesophageal cancer gene (TOC).. JOURNAL OF DENTAL RESEARCH, 79(5), 1196. Retrieved from https://www.webofscience.com/
A unifying concept of carcinogenesis in acro-digestive tract cancers.
Field, J. K., Liloglou, T., Maloney, P., Sikkink, S., & Dunn, J. (2000). A unifying concept of carcinogenesis in acro-digestive tract cancers.. JOURNAL OF DENTAL RESEARCH, 79(5), 1173. Retrieved from https://www.webofscience.com/
Cancer specific genomic instability (CSGI) as an early detection biomarker for cancer of the aerorespiratory tract.
Liloglou, T., Maloney, P., Banks, J., & Field, J. K. (2000). Cancer specific genomic instability (CSGI) as an early detection biomarker for cancer of the aerorespiratory tract.. JOURNAL OF DENTAL RESEARCH, 79(5), 1174. Retrieved from https://www.webofscience.com/
Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: Relationship with tumor growth parameters and ploidy status
Mariatos, G., Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Vogiatzi, T., Rassidakis, G., . . . Kittas, C. (2000). Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: Relationship with tumor growth parameters and ploidy status. International Journal of Cancer, 86(3), 133-141. doi:3.0.co;2-c">10.1002/(sici)1097-0215(20000320)89:2<133::aid-ijc6>3.0.co;2-c
Genetic aberrations in oral or head and neck squamous cell carcinoma 3. clinico-pathological applications
Scully, C., Field, J. K., & Tanzawa, H. (2000). Genetic aberrations in oral or head and neck squamous cell carcinoma 3. clinico-pathological applications. ORAL ONCOLOGY, 36(5), 404-413. doi:10.1016/S1368-8375(00)00023-3
Genetic diagnosis in familial oesophageal cancer.
Jones, J., Risk, J. M., Ellis, A., & Field, J. K. (2000). Genetic diagnosis in familial oesophageal cancer.. JOURNAL OF DENTAL RESEARCH, 79(5), 1195. Retrieved from https://www.webofscience.com/
Genetic instability analysis of aero-respiratory tissues using laser microscopy
Sikkink, S., Maloney, P., Callaghan, J., Gosney, J. R., & Field, J. K. (2000). Genetic instability analysis of aero-respiratory tissues using laser microscopy. JOURNAL OF DENTAL RESEARCH, 79(5), 1171. Retrieved from https://www.webofscience.com/
High throughput molecular screening for aerorespiratory tumours.
Maloney, P., Liloglou, T., Banks, J., & Field, J. K. (2000). High throughput molecular screening for aerorespiratory tumours.. JOURNAL OF DENTAL RESEARCH, 79(5), 1195. Retrieved from https://www.webofscience.com/
Histological and molecular mapping of adenocarcinoma of the oesophagus and gastroesophageal junction: Loss of heterozygosity occurs in histologically normal epithelium in the oesophagus and stomach
Dolan, K., Garde, J., Walker, S. J., Sutton, R., Gosney, J., & Field, J. K. (2000). Histological and molecular mapping of adenocarcinoma of the oesophagus and gastroesophageal junction: Loss of heterozygosity occurs in histologically normal epithelium in the oesophagus and stomach. ONCOLOGY REPORTS, 7(3), 521-528. Retrieved from https://www.webofscience.com/
Peptide amidating activity in human bronchoalveolar lavage fluid: Relationship to lung cancer, inflammation and infection
Scott, F. M., Prime, W., Walshaw, M., Turnbull, L., & Field, J. K. (2000). Peptide amidating activity in human bronchoalveolar lavage fluid: Relationship to lung cancer, inflammation and infection. INTERNATIONAL JOURNAL OF ONCOLOGY, 16(2), 327-332. Retrieved from https://www.webofscience.com/
Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: Application in lung tumors
Liloglou, T., Maloney, P., Xinarianos, G., Fear, S., & Field, J. K. (2000). Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: Application in lung tumors. INTERNATIONAL JOURNAL OF ONCOLOGY, 16(1), 5-14. Retrieved from https://www.webofscience.com/
Site of a putative TSG at 17p13.1 in Barrett's oesophageal adenocarcinoma.
Dunn, J. R., Garde, J., Gosney, J. R., Oates, B. C., Watson, A. J. M., & Field, J. K. (2000). Site of a putative TSG at 17p13.1 in Barrett's oesophageal adenocarcinoma.. AMERICAN JOURNAL OF HUMAN GENETICS, 67(4), 96. Retrieved from https://www.webofscience.com/
Site of putative TSG at 17p13.1 in Barrett's oesophageal adenocarcinoma.
Dunn, J., Garde, J., Gosney, J. R., Watson, A. J. M., Oates, B. C., & Field, J. K. (2000). Site of putative TSG at 17p13.1 in Barrett's oesophageal adenocarcinoma.. JOURNAL OF DENTAL RESEARCH, 79(5), 1173. Retrieved from https://www.webofscience.com/
The Tylosis Oesophageal Cancer (TOC) gene in sporadic oesophageal cancer
Risk, J. M., Jones, J., Mills, H. S., Garde, J., & Field, J. K. (2000). The Tylosis Oesophageal Cancer (TOC) gene in sporadic oesophageal cancer. JOURNAL OF DENTAL RESEARCH, 79(5), 1174. Retrieved from https://www.webofscience.com/
1999
Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection
Fielding, P., Turnbull, L., Prime, W., Walshaw, M., & Field, J. K. (1999). Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: A clinical marker of early lung cancer detection. CLINICAL CANCER RESEARCH, 5(12), 4048-4052. Retrieved from https://www.webofscience.com/
The tylosis esophageal cancer (<i>TOC</i>) locus:: more than just a familial cancer gene
Risk, J. M., Mills, H. S., Garde, J., Dunn, J. R., Evans, K. E., Hollstein, M., & Field, J. K. (1999). The tylosis esophageal cancer (<i>TOC</i>) locus:: more than just a familial cancer gene. DISEASES OF THE ESOPHAGUS, 12(3), 173-176. doi:10.1046/j.1442-2050.1999.00042.x
Genomic instability in bronchial lavage specimens from Individuals with no evidence of lung cancer: An early detection marker?
Field, J. K., Liloglou, T., Xinarianos, G., Turnbull, L., & Walshaw, M. (1999). Genomic instability in bronchial lavage specimens from Individuals with no evidence of lung cancer: An early detection marker?. EUROPEAN JOURNAL OF CANCER, 35, S104. doi:10.1016/S0959-8049(99)80795-3
Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (<i>TOC</i>):: The integration of genetic and physical maps of the <i>TOC</i> region on 17q25
Risk, J. M., Ruhrberg, C., Hennies, H. C., Mills, H. S., Di Colandrea, T., Evans, K. E., . . . Field, J. K. (1999). Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (<i>TOC</i>):: The integration of genetic and physical maps of the <i>TOC</i> region on 17q25. GENOMICS, 59(2), 234-242. doi:10.1006/geno.1999.5857
Genetic alterations is bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer
Field, J. K., Liloglou, T., Xinarianos, G., Prime, W., Fielding, P., Walshaw, M. J., & Turnbull, L. (1999). Genetic alterations is bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. CANCER RESEARCH, 59(11), 2690-2695. Retrieved from https://www.webofscience.com/
Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer
Dunn, J., Garde, J., Dolan, K., Gosney, J. R., Sutton, R., Meltzer, S. J., & Field, J. K. (1999). Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer. ONCOGENE, 18(4), 987-993. doi:10.1038/sj.onc.1202371
Candidate genes causing familial oesophageal cancer associated with the skin condition tylosis (focal NEPPK).
Evans, K. E., Risk, J. M., Kuhlenbaeumer, G., Mills, H. S., Ellis, A., Bishop, D. T., . . . Field, J. K. (1999). Candidate genes causing familial oesophageal cancer associated with the skin condition tylosis (focal NEPPK).. AMERICAN JOURNAL OF HUMAN GENETICS, 65(4), A125. Retrieved from https://www.webofscience.com/
Cover legend: Roy Castle International Centre for Lung Cancer Research, Liverpool, UK
Field, J. K. (1999). Cover legend: Roy Castle International Centre for Lung Cancer Research, Liverpool, UK. ONCOLOGY REPORTS, 6(5), 947-948. Retrieved from https://www.webofscience.com/
Expression of hMHL1 and hMSH2 and allelic imbalance on chromosomes 3P21 and 2P16 in non small cell lung carcinomas.
Xinarianos, G., Liloglou, T., Prime, W., Maloney, P., Fielding, P., Callaghan, J., & Field, J. K. (1999). Expression of hMHL1 and hMSH2 and allelic imbalance on chromosomes 3P21 and 2P16 in non small cell lung carcinomas.. BRITISH JOURNAL OF CANCER, 80, 79. Retrieved from https://www.webofscience.com/
Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN)
Nunn, J., Scholes, A. G. M., Liloglou, T., Nagini, S., Jones, A. S., Vaughan, E. D., . . . Field, J. K. (1999). Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN). CARCINOGENESIS, 20(12), 2219-2228. doi:10.1093/carcin/20.12.2219
Investigation into the role of telomerase in the molecular pathogenesis of non-small cell lung carcinomas
Xinarianos, G., Liloglou, T., Maloney, P., Callaghan, J., Gosney, J. R., Turnbull, L., . . . Field, J. K. (1999). Investigation into the role of telomerase in the molecular pathogenesis of non-small cell lung carcinomas. JOURNAL OF MEDICAL GENETICS, 36, S41. Retrieved from https://www.webofscience.com/
LOH at the sites of the <i>DCC</i>, <i>APC</i>, and <i>TP53</i> tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus
Dolan, K., Garde, J., Walker, S. J., Sutton, R., Gosney, J., & Field, J. K. (1999). LOH at the sites of the <i>DCC</i>, <i>APC</i>, and <i>TP53</i> tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. HUMAN PATHOLOGY, 30(12), 1508-1514. doi:10.1016/S0046-8177(99)90175-2
Microsatellite assays on chromosomes 3, 9, 13 and 17 in uveal melanoma
Scholes, A. G. M., Liloglou, T., Maloney, P., Hiscott, P., Damato, B. E., Grierson, I., & Field, J. K. (1999). Microsatellite assays on chromosomes 3, 9, 13 and 17 in uveal melanoma. BRITISH JOURNAL OF CANCER, 80, 31. Retrieved from https://www.webofscience.com/
Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Karachristos, A., Liloglou, T., Field, J. K., Deligiorgi, E., Kouskouni, E., & Spandidos, D. A. (1999). Microsatellite instability and p53 mutations in hepatocellular carcinoma.. Molecular cell biology research communications : MCBRC, 2(3), 155-161. doi:10.1006/mcbr.1999.0170
Telomerase activity in non-small cell lung carcinomas correlates with smoking status
Xinarianos, G., Scott, F. M., Liloglou, T., Prime, W., Callaghan, J., Gosney, J. R., & Field, J. K. (1999). Telomerase activity in non-small cell lung carcinomas correlates with smoking status. INTERNATIONAL JOURNAL OF ONCOLOGY, 15(5), 961-965. Retrieved from https://www.webofscience.com/
The evolution of LOH on chromosome 17 during the progression to Barrett's adenocarcinoma
Garde, J., Dunn, J., Dolan, K., Gosney, J., Sutton, R., & Field, J. K. (1999). The evolution of LOH on chromosome 17 during the progression to Barrett's adenocarcinoma. BRITISH JOURNAL OF CANCER, 81(4), 581-582. Retrieved from https://www.webofscience.com/
1998
Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q
von Brevern, M., Hollstein, M. C., Risk, J. M., Garde, J., Bennett, W. P., Harris, C. C., . . . Field, J. K. (1998). Loss of heterozygosity in sporadic oesophageal tumors in the tylosis oesophageal cancer (TOC) gene region of chromosome 17q. ONCOGENE, 17(16), 2101-2105. doi:10.1038/sj.onc.1202139
Synchronous oral carcinomas: Independent or common clonal origin?
Scholes, A. G. M., Woolgar, J. A., Boyle, M. A., Brown, J. S., Vaughan, E. D., Hart, C. A., . . . Field, J. K. (1998). Synchronous oral carcinomas: Independent or common clonal origin?. CANCER RESEARCH, 58(9), 2003-2006. Retrieved from https://www.webofscience.com/
ARMSTM with real time fluorescence detection to identify k-ras mutations in bronchoalveolar lavage specimens for early lung cancer detection
Clayton, S. J., Scott, F. M., Callaghan, K., Prime, W., Walshaw, M., Turnbull, L., . . . Field, J. K. (1998). ARMSTM with real time fluorescence detection to identify k-ras mutations in bronchoalveolar lavage specimens for early lung cancer detection. EUROPEAN JOURNAL OF HUMAN GENETICS, 6, 122. Retrieved from https://www.webofscience.com/
Adenocarcinomas of the lower oesophagus and cardia are similar both epidemiologically and clinically: a population-based study from 1974 to 1993
Dolan, K., Walker, S. J., Sutton, R., & Williams, E. M. I. (1998). Adenocarcinomas of the lower oesophagus and cardia are similar both epidemiologically and clinically: a population-based study from 1974 to 1993. In BRITISH JOURNAL OF SURGERY Vol. 85 (pp. 417). Retrieved from https://www.webofscience.com/
Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites
Dolan, K., Garde, J., Gosney, J., Sissons, M., Wright, T., Kingsnorth, A. N., . . . Field, J. K. (1998). Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites. BRITISH JOURNAL OF CANCER, 78(7), 950-957. doi:10.1038/bjc.1998.607
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas - Relationship with p53 and MDM2 protein expression
Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., . . . Kittas, C. (1998). Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas - Relationship with p53 and MDM2 protein expression. AMERICAN JOURNAL OF PATHOLOGY, 153(6), 1749-1765. doi:10.1016/S0002-9440(10)65690-8
Application of the amplification refractory mutation system (ARMS™) with real-time fluorescence detection to assess K-<i>ras</i> mutations in bronchoalveolar lavage (BL) specimens for early lung cancer detection
Scott, F. M., Clayton, S. J., Callaghan, K., Prime, W., Walshaw, M., Turnbull, L., . . . Field, J. K. (1998). Application of the amplification refractory mutation system (ARMS™) with real-time fluorescence detection to assess K-<i>ras</i> mutations in bronchoalveolar lavage (BL) specimens for early lung cancer detection. BRITISH JOURNAL OF CANCER, 78(2), 147. Retrieved from https://www.webofscience.com/
Detection of telomerase activity in lung tumours and bronchoalveolar lavage
Xinarianos, G., Scott, F. M., Prime, W., Walshaw, M., Turnbull, L., & Field, J. K. (1998). Detection of telomerase activity in lung tumours and bronchoalveolar lavage. BRITISH JOURNAL OF CANCER, 78, 60. Retrieved from https://www.webofscience.com/
Loss of heterozygosity occurs on chromosome 17p and 18q in Barrett's metaplastic and dysplastic mucosa adjacent to adenocarcinoma of the oesophagus
Dolan, K., Gosney, J., Walker, S. J., Sutton, R., & Field, J. K. (1998). Loss of heterozygosity occurs on chromosome 17p and 18q in Barrett's metaplastic and dysplastic mucosa adjacent to adenocarcinoma of the oesophagus. BRITISH JOURNAL OF SURGERY, 85(3), 417. Retrieved from https://www.webofscience.com/
Loss of heterozygosity on chromosome 17p predicts carcinogenesis progression in patients with Barrett's oesophagus
Dolan, K., Gosney, J., Walker, S. J., Sutton, R., & Field, J. K. (1998). Loss of heterozygosity on chromosome 17p predicts carcinogenesis progression in patients with Barrett's oesophagus. BRITISH JOURNAL OF SURGERY, 85(5), 697. Retrieved from https://www.webofscience.com/
Microsatellite instability and loss of heterozygosity in bronchial lavage specimens
Liloglou, T., Xinarianos, G., Prime, W., Walshaw, M., Turnbull, L., & Field, J. K. (1998). Microsatellite instability and loss of heterozygosity in bronchial lavage specimens. BRITISH JOURNAL OF CANCER, 78(2), 147-148. Retrieved from https://www.webofscience.com/
Molecular pathological mechanisms in NSCLC and the assessment of individuals with a high risk of developing lung cancer
Field, J. K., Ross, H., Liloglou, T., Scott, F., Prime, W., Gosney, J. R., . . . Donnelly, R. J. (1998). Molecular pathological mechanisms in NSCLC and the assessment of individuals with a high risk of developing lung cancer. Retrieved from https://www.webofscience.com/
Smoking correlates with the presence of p53 mutations in squamous cell carcinomas of the head and neck (SCCHN)
Liloglou., Scholes., Spandidos., Jones., Vaughan., & Field. (1998). Smoking correlates with the presence of p53 mutations in squamous cell carcinomas of the head and neck (SCCHN). In Clinical Otolaryngology and Allied Sciences Vol. 23 (pp. 268-269). Wiley. doi:10.1046/j.1365-2273.1998.0135m.x
Telomerase activity in lung cancer and human bronchoalveolar lavage fluid
Xinarianos, G., Scott, F. M., Prime, W., Walshaw, M., Turnbull, L., & Field, J. K. (1998). Telomerase activity in lung cancer and human bronchoalveolar lavage fluid. BRITISH JOURNAL OF CANCER, 78(2), 148. Retrieved from https://www.webofscience.com/
The Knights of the Round Table hypothesis of tumour suppressor gene function - noble sacrifice or sexual dalliance: Genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis
Gosden, C. M., Liloglou, T., Nunn, J., Gardener, D., Nickson, P., Crampton, J. M., & Field, J. K. (1998). The Knights of the Round Table hypothesis of tumour suppressor gene function - noble sacrifice or sexual dalliance: Genes, including p53, BRCA1/2 and RB have evolved by horizontal and vertical transmission of mating factor genes and are involved in gametogenesis, implantation, development and tumourigenesis. INTERNATIONAL JOURNAL OF ONCOLOGY, 12(1), 5-35. Retrieved from https://www.webofscience.com/
1997
p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability
Liloglou, T., Scholes, A. G. M., Spandidos, D. A., Vaughan, E. D., Jones, A. S., & Field, J. K. (1997). p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability. CANCER RESEARCH, 57(18), 4070-4074. Retrieved from https://www.webofscience.com/
Allelotype of Barrett’s adenocarcinoma: A search for novel tumour suppressor genes
Dolan, K., Garde, J., Walker, S. J., Sutton, R., & Field, J. K. (1997). Allelotype of Barrett’s adenocarcinoma: A search for novel tumour suppressor genes. European Journal of Cancer, 33, S12. doi:10.1016/s0959-8049(97)84424-3
Molecular-pathological assessment of individuals with a high risk of developing lung cancer
Field, J. K., Youngson, J., Ross, H. L., Liloglou, L., Scott, F., Xinarianos, G., . . . Donnelly, R. J. (1997). Molecular-pathological assessment of individuals with a high risk of developing lung cancer. Lung Cancer, 18, 39. doi:10.1016/s0169-5002(97)83881-0
p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck
Scholes, A. G. M., Liloglou, T., Snijders, P. J. F., Hart, C. A., Jones, A. S., Woolgar, J. A., . . . Field, J. K. (1997). p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. International Journal of Cancer, 71(5), 796-799. doi:3.0.CO;2-6">10.1002/(SICI)1097-0215(19970529)71:5<796::AID-IJC17>3.0.CO;2-6
p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck
Scholes, A. G. M., Liloglou, T., Snijders, P. J. F., Hart, C. A., Jones, A. S., Woolgar, J. A., . . . Field, J. K. (1997). p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. INTERNATIONAL JOURNAL OF CANCER, 71(5), 796-799. doi:3.0.CO;2-6">10.1002/(SICI)1097-0215(19970529)71:5<796::AID-IJC17>3.0.CO;2-6
Allelotype of Barrett's adenocarcinoma: A search for novel tumour suppressor genes
Dolan, K., Garde, J., Walker, S. J., Sutton, R., & Field, J. K. (1997). Allelotype of Barrett's adenocarcinoma: A search for novel tumour suppressor genes. EUROPEAN JOURNAL OF CANCER, 33, 36. Retrieved from https://www.webofscience.com/
Allelotype of Barrett's adenocarcinoma; A search for novel tumour suppressor genes
Dolan, K., Garde, J., Swift, A., Gosney, J., Khan, S., Walker, S. J., . . . Field, J. K. (1997). Allelotype of Barrett's adenocarcinoma; A search for novel tumour suppressor genes. GUT, 40, F305. Retrieved from https://www.webofscience.com/
An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity
Rowley, H., Helliwell, T. R., Jones, A. S., Roland, N. J., Field, E. A., & Field, J. K. (1997). An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissues of the oral cavity. CLINICAL OTOLARYNGOLOGY, 22(1), 23-29. doi:10.1046/j.1365-2273.1997.00848.x
Apparently dominant cleft lip and palate - A study of microsatellite markers on chromosomes 2, 4 and 6.
Hibbert, S. A., Risk, J. M., & Field, J. K. (1997). Apparently dominant cleft lip and palate - A study of microsatellite markers on chromosomes 2, 4 and 6.. JOURNAL OF DENTAL RESEARCH, 76(5), 1039. Retrieved from https://www.webofscience.com/
Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (review)
Scully, C., & Field, J. K. (1997). Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (review). INTERNATIONAL JOURNAL OF ONCOLOGY, 10(1), 5-21. Retrieved from https://www.webofscience.com/
Loss of heterozygosity occurs at multiple sites in oesophageal adenocarcinoma
Dolan, K., Gosney, J., Walker, S. J., Sutton, R., & Field, J. K. (1997). Loss of heterozygosity occurs at multiple sites in oesophageal adenocarcinoma. GUT, 41, A255. Retrieved from https://www.webofscience.com/
Mandibular invasion in patients with oral and oropharyngeal squamous carcinoma
Jones, A. S., England, J., Hamilton, J., Helliwell, T. R., Field, J., Gerlinger, I., & Karkanevatos, T. (1997). Mandibular invasion in patients with oral and oropharyngeal squamous carcinoma. CLINICAL OTOLARYNGOLOGY, 22(3), 239-245. doi:10.1046/j.1365-2273.1997.00009.x
Microsatellite instability is rarely detected in oesophageal adenocarcinoma
Dolan, K., Gosney, J., Walker, S. J., Sutton, R., & Field, J. K. (1997). Microsatellite instability is rarely detected in oesophageal adenocarcinoma. GUT, 41, A255. Retrieved from https://www.webofscience.com/
Microsatellite instability is rarely detected in oesophageal adenocarcinoma
Dolan, K., Garde, J., Walker, S. J., Sutton, R., Gosney, J., & Field, J. K. (1997). Microsatellite instability is rarely detected in oesophageal adenocarcinoma. ONCOLOGY REPORTS, 4(6), 1319-1322. Retrieved from https://www.webofscience.com/
Oral tylosis: A re-appraisal
Field, E. A., Ellis, A., Friedmann, P. S., Leigh, I. M., & Field, J. K. (1997). Oral tylosis: A re-appraisal. ORAL ONCOLOGY, 33B(1), 55-57. doi:10.1016/S0964-1955(96)00052-8
p53 gene aberrations in non-small-cell lung carcinomas from a smoking population
Liloglou, T., Ross, H., Prime, W., Donnelly, R. J., Spandidos, D. A., Gosney, J. R., & Field, J. K. (1997). p53 gene aberrations in non-small-cell lung carcinomas from a smoking population. BRITISH JOURNAL OF CANCER, 75(8), 1119-1124. doi:10.1038/bjc.1997.193
1996
Erratum: Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival
Erratum: Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival (1996). British Journal of Cancer, 74(7), 1153. doi:10.1038/bjc.1996.507
Genomic instability in squamous cell carcinoma of the head and neck
Field, J. K. (1996). Genomic instability in squamous cell carcinoma of the head and neck. Anticancer Research, 16(4 C), 2421-2431.
Genomic instability in squamous cell carcinoma of the head and neck
Field, J. K. (1996). Genomic instability in squamous cell carcinoma of the head and neck. ANTICANCER RESEARCH, 16(4C), 2421-2431. Retrieved from https://www.webofscience.com/
Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC)
Kelsell, D. P., Risk, J. M., Leigh, I. M., Stevens, H. P., Ellis, A., Hennies, H. C., . . . Field, J. K. (1996). Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC). HUMAN MOLECULAR GENETICS, 5(6), 857-860. doi:10.1093/hmg/5.6.857
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck.
Snijders, P. J., Scholes, A. G., Hart, C. A., Jones, A. S., Vaughan, E. D., Woolgar, J. A., . . . Field, J. K. (1996). Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck.. International journal of cancer, 66(4), 464-469. doi:3.0.co;2-u">10.1002/(sici)1097-0215(19960516)66:4<464::aid-ijc9>3.0.co;2-u
Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck
Snijders, P. J. F., Scholes, A. G. M., Hart, C. A., Jones, A. S., Vaughan, E. D., Woolgar, J. A., . . . Field, J. K. (1996). Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinomas of the head and neck. INTERNATIONAL JOURNAL OF CANCER, 66(4), 464-469. doi:3.0.CO;2-U">10.1002/(SICI)1097-0215(19960516)66:4<464::AID-IJC9>3.0.CO;2-U
Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers
Rowley, H., Jones, A., Spandidos, D., & Field, J. (1996). Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers. In ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY Vol. 122 (pp. 497-501). Retrieved from https://www.webofscience.com/
Allelotype of non-small cell lung cancer
Neville, E. M., Stewart, M. P., Swift, A., Liloglou, T., Ross, H., Gosney, J. R., . . . Field, J. K. (1996). Allelotype of non-small cell lung cancer. INTERNATIONAL JOURNAL OF ONCOLOGY, 9(3), 533-539. Retrieved from https://www.webofscience.com/
Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival (vol 72, pg 1180, 1995)
Field, J. K., Kiaris, H., Risk, J. M., Tsiriyotis, C., Adamson, R., Zoumpourlis, V., . . . Jones, A. S. (1996). Allelotype of squamous cell carcinoma of the head and neck: Fractional allele loss correlates with survival (vol 72, pg 1180, 1995). BRITISH JOURNAL OF CANCER, 74(7), 1153. Retrieved from https://www.webofscience.com/
Close range mapping of the tylosis oesophageal cancer gene (TOGG) to chromosome 17q.
Risk, J. M., Kelsell, D. P., Bishop, D. T., Leigh, I. M., Ellis, A., & Field, J. K. (1996). Close range mapping of the tylosis oesophageal cancer gene (TOGG) to chromosome 17q.. JOURNAL OF DENTAL RESEARCH, 75(5), 1148. Retrieved from https://www.webofscience.com/
Early molecular biomarkers in lung cancer
Ross, H. L., Liloglou, T., Swift, A., Prime, W., Gosney, J., Donnelly, R. J., & Field, J. K. (1996). Early molecular biomarkers in lung cancer. In 2ND INTERNATIONAL CONGRESS ON LUNG CANCER (pp. 79-82). Retrieved from https://www.webofscience.com/
Fractional allele loss indicates distinct genetic populations in aerodigestive tract cancers.
Field, J. K., Kiaris, H., Neville, E., Swift, A., Liloglou, T., Risk, J. M., . . . Jones, A. S. (1996). Fractional allele loss indicates distinct genetic populations in aerodigestive tract cancers.. JOURNAL OF DENTAL RESEARCH, 75(5), 1148. Retrieved from https://www.webofscience.com/
Genomic instability in head and neck cancer.
Scholes, A. G., & Field, J. K. (1996). Genomic instability in head and neck cancer.. Current topics in pathology. Ergebnisse der Pathologie, 90, 201-222. doi:10.1007/978-3-642-80169-3_7
Identification of two novel target regions on the short arm of chromosome 9 in aerodigestive tract cancers.
Swift, A., Neville, E. M., Kiaris, H., Donnelly, R. J., & Field, J. K. (1996). Identification of two novel target regions on the short arm of chromosome 9 in aerodigestive tract cancers.. JOURNAL OF DENTAL RESEARCH, 75(5), 1193. Retrieved from https://www.webofscience.com/
Molecular basis of familial cleft lip and palate.
Hibbert, S. A., & Field, J. K. (1996). Molecular basis of familial cleft lip and palate.. Oral diseases, 2(3), 238-241. doi:10.1111/j.1601-0825.1996.tb00231.x
Polymorphisms in the promoter region of the WAF1/CIP1 gene
Liloglou, T., Risk, J. M., & Field, J. K. (1996). Polymorphisms in the promoter region of the WAF1/CIP1 gene. INTERNATIONAL JOURNAL OF ONCOLOGY, 9(3), 559-562. Retrieved from https://www.webofscience.com/
p53 gene mutations in SCCHN tumours correlate with stopped smokers.
Liloglou, T., Scholes, A., Spandidos, D. A., Jones, A. S., Vaughan, E. D., & Field, J. K. (1996). p53 gene mutations in SCCHN tumours correlate with stopped smokers.. JOURNAL OF DENTAL RESEARCH, 75(5), 1148. Retrieved from https://www.webofscience.com/
1995
ALLELOTYPE OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - FRACTIONAL ALLELE LOSS CORRELATES WITH SURVIVAL
FIELD, J. K., KIARIS, H., RISK, J. M., TSIRIYOTIS, C., ADAMSON, R., ZOUMPOURLIS, V., . . . JONES, A. S. (1995). ALLELOTYPE OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - FRACTIONAL ALLELE LOSS CORRELATES WITH SURVIVAL. BRITISH JOURNAL OF CANCER, 72(5), 1180-1188. doi:10.1038/bjc.1995.483
LOSS OF HETEROZYGOSITY AT 9P23 DEFINES A NOVEL LOCUS IN NONSMALL CELL LUNG-CANCER
NEVILLE, E. M., STEWART, M., MYSKOW, M., DONNELLY, R. J., & FIELD, J. K. (1995). LOSS OF HETEROZYGOSITY AT 9P23 DEFINES A NOVEL LOCUS IN NONSMALL CELL LUNG-CANCER. ONCOGENE, 11(3), 581-585. Retrieved from https://www.webofscience.com/
GENOMIC INSTABILITY ON CHROMOSOME-17 OCCURS IN BARRETTS CANCER
WRIGHT, T. A., SWIFT, A., KINGSNORTH, A. N., & FIELD, J. K. (1995). GENOMIC INSTABILITY ON CHROMOSOME-17 OCCURS IN BARRETTS CANCER. GASTROENTEROLOGY, 108(4), A554. Retrieved from https://www.webofscience.com/
2ND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA
JONES, A. S., MORAR, P., PHILLIPS, D. E., FIELD, J. K., HUSBAND, D., & HELLIWELL, T. R. (1995). 2ND PRIMARY TUMORS IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA. CANCER, 75(6), 1343-1353. doi:3.0.CO;2-T">10.1002/1097-0142(19950315)75:6<1343::AID-CNCR2820750617>3.0.CO;2-T
CHROMOSOME-18 - A POSSIBLE SITE FOR A TUMOR-SUPPRESSOR GENE DELETION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
ROWLEY, H., JONES, A. S., & FIELD, J. K. (1995). CHROMOSOME-18 - A POSSIBLE SITE FOR A TUMOR-SUPPRESSOR GENE DELETION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. CLINICAL OTOLARYNGOLOGY, 20(3), 266-271. doi:10.1111/j.1365-2273.1995.tb01864.x
DETECTION OF K-RAS MUTATIONS IN NONSMALL CELL LUNG-CARCINOMA
NEVILLE, E. M., ELLISON, G., KIARIS, H., STEWART, M., SPANDIDOS, D. A., FOX, J. C., & FIELD, J. K. (1995). DETECTION OF K-RAS MUTATIONS IN NONSMALL CELL LUNG-CARCINOMA. INTERNATIONAL JOURNAL OF ONCOLOGY, 7(3), 511-514. Retrieved from https://www.webofscience.com/
FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-17 AT 17Q11.2-Q12 IN BARRETTS ADENOCARCINOMA
SWIFT, A., RISK, J. M., KINGSNORTH, A. N., WRIGHT, T. A., MYSKOW, M., & FIELD, J. K. (1995). FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-17 AT 17Q11.2-Q12 IN BARRETTS ADENOCARCINOMA. BRITISH JOURNAL OF CANCER, 71(5), 995-998. doi:10.1038/bjc.1995.191
GENETIC-LINKAGE ANALYSIS OF APPARENTLY DOMINANT INHERITANCE OF CLEFT AND PALATE
HIBBERT, S. A., FIELD, J. K., LOVIUS, B. B. J., & WHITTAKER, J. (1995). GENETIC-LINKAGE ANALYSIS OF APPARENTLY DOMINANT INHERITANCE OF CLEFT AND PALATE. JOURNAL OF DENTAL RESEARCH, 74(3), 889. Retrieved from https://www.webofscience.com/
GENOMIC INSTABILITY, MUTATIONS AND EXPRESSION OF THE H-RAS GENE IN HEAD AND NECK-CANCER
KIARIS, H., LILOGLOU, T., SPANDIDOS, D. A., VAUGHAN, E. D., JONES, A. S., & FIELD, J. K. (1995). GENOMIC INSTABILITY, MUTATIONS AND EXPRESSION OF THE H-RAS GENE IN HEAD AND NECK-CANCER. JOURNAL OF DENTAL RESEARCH, 74(3), 859. Retrieved from https://www.webofscience.com/
HIGH-GRADE DYSPLASIA IN BARRETTS-ESOPHAGUS - WHEN SHOULD WE OPERATE
WRIGHT, T. A., GRAY, M. R., & KINGSNORTH, A. N. (1995). HIGH-GRADE DYSPLASIA IN BARRETTS-ESOPHAGUS - WHEN SHOULD WE OPERATE. In GASTROENTEROLOGY Vol. 108 (pp. A554). Retrieved from https://www.webofscience.com/
IDENTIFICATION OF A NOVEL TUMOR-SUPPRESSOR GENE IN BARRETTS CANCER
WRIGHT, T. A., SWIFT, A., KINGSNORTH, A. N., & FIELD, J. K. (1995). IDENTIFICATION OF A NOVEL TUMOR-SUPPRESSOR GENE IN BARRETTS CANCER. BRITISH JOURNAL OF SURGERY, 82(5), 702. Retrieved from https://www.webofscience.com/
Judging girls: decision making in parental consent to abortion cases.
Scarnecchia, S., & Field, J. K. (1995). Judging girls: decision making in parental consent to abortion cases.. Michigan journal of gender & law, 3(41), 75-123.
LOCALIZATION OF THE TYLOSIS ESOPHAGEAL CANCER GENE (TOCG) TO 17Q
RISK, J. M., WHITTAKER, J., BISHOP, D. T., LEIGH, I. M., ELLIS, A., & FIELD, J. K. (1995). LOCALIZATION OF THE TYLOSIS ESOPHAGEAL CANCER GENE (TOCG) TO 17Q. JOURNAL OF DENTAL RESEARCH, 74(3), 859. Retrieved from https://www.webofscience.com/
LOSS OF HETEROZYGOSITY OF THE ADENOMATOUS POLYPOSIS-COLI GENE IS A COMMON EVENT IN BARRETTS CANCERS
WRIGHT, T. A., FIELD, J., & KINGSNORTH, A. N. (1995). LOSS OF HETEROZYGOSITY OF THE ADENOMATOUS POLYPOSIS-COLI GENE IS A COMMON EVENT IN BARRETTS CANCERS. In GASTROENTEROLOGY Vol. 108 (pp. A554). Retrieved from https://www.webofscience.com/
MAPPING OF THE TYLOSIS CANCER GENE IN A LIVERPOOL PEDIGREE WITH PALMOPLANTAR KERATODERMA AND ESOPHAGEAL CANCER
FIELD, J. K., RISK, J. M., WHITTAKER, J., FRYER, A., ELLIS, A., SHAW, J. M., . . . LEIGH, I. M. (1995). MAPPING OF THE TYLOSIS CANCER GENE IN A LIVERPOOL PEDIGREE WITH PALMOPLANTAR KERATODERMA AND ESOPHAGEAL CANCER. JOURNAL OF MEDICAL GENETICS, 32(2), 143. Retrieved from https://www.webofscience.com/
MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., KIARIS, H., HOWARD, P., VAUGHAN, E. D., SPANDIDOS, D. A., & JONES, A. S. (1995). MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. BRITISH JOURNAL OF CANCER, 71(5), 1065-1069. doi:10.1038/bjc.1995.205
MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., KIARIS, H., HOWARD, P., VAUGHAN, E. D., SPANDIDOS, D. A., & JONES, A. S. (1995). MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. JOURNAL OF DENTAL RESEARCH, 74(3), 859. Retrieved from https://www.webofscience.com/
MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
KIARIS, H., HOWARD, P., VAUGHAN, E. D., SPANDIDOS, D. A., JONES, A. S., & FIELD, J. K. (1995). MICROSATELLITE INSTABILITY IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. JOURNAL OF MEDICAL GENETICS, 32(2), 143. Retrieved from https://www.webofscience.com/
MUTATIONS, EXPRESSION AND GENOMIC INSTABILITY OF THE H-RAS PROTOONCOGENE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
KIARIS, H., SPANDIDOS, D. A., JONES, A. S., VAUGHAN, E. D., & FIELD, J. K. (1995). MUTATIONS, EXPRESSION AND GENOMIC INSTABILITY OF THE H-RAS PROTOONCOGENE IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK. BRITISH JOURNAL OF CANCER, 72(1), 123-128. doi:10.1038/bjc.1995.287
THE ROLE OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN THE ETIOLOGY OF ORAL, HEAD AND NECK SQUAMOUS-CELL CARCINOMA
FIELD, J. K. (1995). THE ROLE OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN THE ETIOLOGY OF ORAL, HEAD AND NECK SQUAMOUS-CELL CARCINOMA. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 88(1), P35-P39. Retrieved from https://www.webofscience.com/
THE TREATMENT OF NODE-NEGATIVE SQUAMOUS-CELL CARCINOMA OF THE POSTCRICOID REGION
JONES, A. S., MCRAE, R. D., PHILLIPS, D. E., HAMILTON, J., FIELD, J. K., & HUSBAND, D. (1995). THE TREATMENT OF NODE-NEGATIVE SQUAMOUS-CELL CARCINOMA OF THE POSTCRICOID REGION. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 109(2), 114-119. doi:10.1017/S0022215100129433
1994
19th Sir peter freyer memorial lecture and surgical symposium 16th and 17th September 1994
McEvoy, D. A., Connolly, B., Donohue, V., O’Halpin, D., Rowley, H., O’Dywer, T. P., . . . McCarthy, P. M. (1994). 19th Sir peter freyer memorial lecture and surgical symposium 16th and 17th September 1994. Irish Journal of Medical Science, 163(9), 417-446. doi:10.1007/bf02975041
ALLELE LOSS ON CHROMOSOME-3 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK CORRELATES WITH POOR CLINICAL PROGNOSTIC INDICATORS
FIELD, J. K., TSIRIYOTIS, C., ZOUMPOURLIS, V., HOWARD, P., SPANDIDOS, D. A., & JONES, A. S. (1994). ALLELE LOSS ON CHROMOSOME-3 IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK CORRELATES WITH POOR CLINICAL PROGNOSTIC INDICATORS. INTERNATIONAL JOURNAL OF ONCOLOGY, 4(3), 543-549. Retrieved from https://www.webofscience.com/
DETECTION OF THE TUMOR-SUPPRESSOR GENE P53 IN NASOPHARYNGEAL CARCINOMA IN HONG-KONG CHINESE
PORTER, M. J., FIELD, J. K., LEE, J. C. K., LEUNG, S. F., LO, D., & VANHASSELT, C. A. (1994). DETECTION OF THE TUMOR-SUPPRESSOR GENE P53 IN NASOPHARYNGEAL CARCINOMA IN HONG-KONG CHINESE. ANTICANCER RESEARCH, 14(3B), 1357-1360. Retrieved from https://www.webofscience.com/
Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese.
Porter, M. J., Field, J. K., Lee, J. C., Leung, S. F., Lo, D., & Van Hasselt, C. A. (1994). Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese.. Anticancer research, 14(3B), 1357-1360.
EXPRESSION OF THE CELL-CELL ADHESION MOLECULE E-CADHERIN IN TONGUE CARCINOMA CELL-LINES
KINSELLA, A. R., BOWIE, G. L., FIELD, J. K., & JONES, A. S. (1994). EXPRESSION OF THE CELL-CELL ADHESION MOLECULE E-CADHERIN IN TONGUE CARCINOMA CELL-LINES. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 108(11), 957-961. doi:10.1017/S0022215100128622
LOSS OF HETEROZYGOSITY AND MICROSATELLITE INSTABILITY OF THE H-RAS GENE IN CANCER OF THE HEAD AND NECK
KIARIS, H., SPANDIDOS, D. A., JONES, A. S., & FIELD, J. K. (1994). LOSS OF HETEROZYGOSITY AND MICROSATELLITE INSTABILITY OF THE H-RAS GENE IN CANCER OF THE HEAD AND NECK. INTERNATIONAL JOURNAL OF ONCOLOGY, 5(3), 579-582. Retrieved from https://www.webofscience.com/
LOSS OF HETEROZYGOSITY OF THE APC GENE IS A COMMON EVENT IN ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS
WRIGHT, T. A., FIELD, J., DONNELEY, J. R., & KINGSNORTH, A. N. (1994). LOSS OF HETEROZYGOSITY OF THE APC GENE IS A COMMON EVENT IN ADENOCARCINOMA ARISING IN BARRETTS-ESOPHAGUS. In BRITISH JOURNAL OF SURGERY Vol. 81 (pp. 754). Retrieved from https://www.webofscience.com/
LOSS OF HETEROZYGOSITY ON CHROMOSOME-8 IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
KIARIS, H., JONES, A. S., SPANDIDOS, D. A., VAUGHAN, E. D., & FIELD, J. K. (1994). LOSS OF HETEROZYGOSITY ON CHROMOSOME-8 IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK. INTERNATIONAL JOURNAL OF ONCOLOGY, 5(6), 1243-1248. Retrieved from https://www.webofscience.com/
LOSS OF HETEROZYGOSITY STUDIES ON CHROMOSOME-17 IN HEAD-AND-NECK-CANCER USING MICROSATELLITE MARKERS
ADAMSON, R., JONES, A. S., & FIELD, J. K. (1994). LOSS OF HETEROZYGOSITY STUDIES ON CHROMOSOME-17 IN HEAD-AND-NECK-CANCER USING MICROSATELLITE MARKERS. ONCOGENE, 9(7), 2077-2082. Retrieved from https://www.webofscience.com/
MOLECULAR MECHANISMS IN LUNG CANCER
FIELD, J. K., STOCKER, C. J., NEVILLE, E. N., & TAYLOR, L. A. (1994). MOLECULAR MECHANISMS IN LUNG CANCER. In INTERNATIONAL CONGRESS FOR LUNG CANCER (pp. 29-34). Retrieved from https://www.webofscience.com/
P53 EXPRESSION AND MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - EXPRESSION CORRELATES WITH THE PATIENTS USE OF TOBACCO AND ALCOHOL
FIELD, J. K., ZOUMPOURLIS, V., SPANDIDOS, D. A., & JONES, A. S. (1994). P53 EXPRESSION AND MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - EXPRESSION CORRELATES WITH THE PATIENTS USE OF TOBACCO AND ALCOHOL. CANCER DETECTION AND PREVENTION, 18(3), 197-208. Retrieved from https://www.webofscience.com/
RAS ONCOGENES AS PROGNOSTIC INDICATORS IN THE DEVELOPMENT OF HUMAN TUMORS
SPANDIDOS, D. A., & FIELD, J. K. (1994). RAS ONCOGENES AS PROGNOSTIC INDICATORS IN THE DEVELOPMENT OF HUMAN TUMORS. In GTPASE-CONTROLLED MOLECULAR MACHINES Vol. 6 (pp. 121-127). Retrieved from https://www.webofscience.com/
THE DETECTION OF THE C-MYC AND RAS ONCOGENES IN NASOPHARYNGEAL CARCINOMA BY IMMUNOHISTOCHEMISTRY
PORTER, M. J., FIELD, J. K., LEUNG, S. F., LO, D., LEE, J. C. K., SPANDIDOS, D. A., & VANHASSELT, C. A. (1994). THE DETECTION OF THE C-MYC AND RAS ONCOGENES IN NASOPHARYNGEAL CARCINOMA BY IMMUNOHISTOCHEMISTRY. ACTA OTO-LARYNGOLOGICA, 114(1), 105-109. doi:10.3109/00016489409126025
THE LEVEL OF CERVICAL LYMPH-NODE METASTASES - THEIR PROGNOSTIC RELEVANCE AND RELATIONSHIP WITH HEAD AND NECK SQUAMOUS CARCINOMA PRIMARY SITES
JONES, A. S., ROLAND, N. J., FIELD, J. K., & PHILLIPS, D. E. (1994). THE LEVEL OF CERVICAL LYMPH-NODE METASTASES - THEIR PROGNOSTIC RELEVANCE AND RELATIONSHIP WITH HEAD AND NECK SQUAMOUS CARCINOMA PRIMARY SITES. CLINICAL OTOLARYNGOLOGY, 19(1), 63-69. doi:10.1111/j.1365-2273.1994.tb01150.x
THE TREATMENT OF EARLY SQUAMOUS-CELL CARCINOMA OF THE PIRIFORM FOSSA
JONES, A. S., WILDE, A., MCRAE, R. D., PHILLIPS, D. E., FIELD, J. K., & HUSBAND, D. G. (1994). THE TREATMENT OF EARLY SQUAMOUS-CELL CARCINOMA OF THE PIRIFORM FOSSA. CLINICAL OTOLARYNGOLOGY, 19(6), 485-490. doi:10.1111/j.1365-2273.1994.tb01274.x
TYLOSIS ASSOCIATED WITH CARCINOMA OF THE ESOPHAGUS AND ORAL LEUKOPLAKIA IN A LARGE LIVERPOOL FAMILY - A REVIEW OF 6 GENERATIONS
ELLIS, A., FIELD, J. K., FIELD, E. A., FRIEDMANN, P. S., FRYER, A., HOWARD, P., . . . WHITTAKER, J. (1994). TYLOSIS ASSOCIATED WITH CARCINOMA OF THE ESOPHAGUS AND ORAL LEUKOPLAKIA IN A LARGE LIVERPOOL FAMILY - A REVIEW OF 6 GENERATIONS. ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 30B(2), 102-112. Retrieved from https://www.webofscience.com/
TYLOSIS ESOPHAGEAL CANCER MAPPED
RISK, J. M., FIELD, E. A., FIELD, J. K., WHITTAKER, J., FRYER, A., ELLIS, A., . . . LEIGH, I. M. (1994). TYLOSIS ESOPHAGEAL CANCER MAPPED. NATURE GENETICS, 8(4), 319-321. doi:10.1038/ng1294-319
Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations.
Ellis, A., Field, J. K., Field, E. A., Friedmann, P. S., Fryer, A., Howard, P., . . . Whittaker, J. (1994). Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations.. European journal of cancer. Part B, Oral oncology, 30B(2), 102-112. doi:10.1016/0964-1955(94)90061-2
1993
THE ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., PAVELIC, Z. P., SPANDIDOS, D. A., STAMBROOK, P. J., JONES, A. S., & GLUCKMAN, J. L. (1993). THE ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 119(10), 1118-1122. Retrieved from https://www.webofscience.com/
EXPOSURE TO CIGARETTE-SMOKE AND EXPRESSION OF THE PROTEIN ENCODED BY THE P53-GENE IN BRONCHIAL-CARCINOMA
GOSNEY, J. R., BUTT, S. A., GOSNEY, M. A., FIELD, J. K., LAKE, R., COLBY, F., . . . HOFFMANN, D. (1993). EXPOSURE TO CIGARETTE-SMOKE AND EXPRESSION OF THE PROTEIN ENCODED BY THE P53-GENE IN BRONCHIAL-CARCINOMA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 686, 243-248. doi:10.1111/j.1749-6632.1993.tb39181.x
CYTOGENETIC ABERRATIONS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
FIELD, J. K., OWENS, W., PARLIARAS, J., JONES, A., & HOWARD, P. J. (1993). CYTOGENETIC ABERRATIONS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK. In JOURNAL OF CHEMOTHERAPY Vol. 5 (pp. 773-774). Retrieved from https://www.webofscience.com/
EXPOSURE TO CIGARETTE-SMOKE AND EXPRESSION OF THE PROTEIN ENCODED BY THE P53-GENE IN BRONCHIAL-CARCINOMA
GOSNEY, J. R., BUTT, S. A., GOSNEY, M. A., FIELD, J. K., LAKE, R., COLBY, F., . . . HOFFMANN, D. (1993). EXPOSURE TO CIGARETTE-SMOKE AND EXPRESSION OF THE PROTEIN ENCODED BY THE P53-GENE IN BRONCHIAL-CARCINOMA. In TOBACCO SMOKING AND NUTRITION Vol. 686 (pp. 243-248). doi:10.1111/j.1749-6632.1993.tb39181.x
EXPRESSION OF THE CELL-CELL ADHESION MOLECULE E-CADHERIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
BOWIE, G. L., CASLIN, A. W., ROLAND, N. J., FIELD, J., JONES, A. S., & KINSELLA, A. R. (1993). EXPRESSION OF THE CELL-CELL ADHESION MOLECULE E-CADHERIN IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. CLINICAL OTOLARYNGOLOGY, 18(3), 196-201. Retrieved from https://www.webofscience.com/
NON-SQUAMOUS MALIGNANCY IN LYMPH-NODES - THE OCCULT PRIMARY
JONES, A. S., PHILLIPS, D. E., COOK, J. A., FIELD, J. K., & GATI, I. (1993). NON-SQUAMOUS MALIGNANCY IN LYMPH-NODES - THE OCCULT PRIMARY. CLINICAL OTOLARYNGOLOGY, 18(4), 311-316. doi:10.1111/j.1365-2273.1993.tb00855.x
OVER-EXPRESSION OF P53-PROTEIN AND CIGARETTE-SMOKING IN BRONCHIAL-CARCINOMA
GOSNEY, J. R., GOSNEY, M. A., BUTT, S. A., & FIELD, J. K. (1993). OVER-EXPRESSION OF P53-PROTEIN AND CIGARETTE-SMOKING IN BRONCHIAL-CARCINOMA. INTERNATIONAL JOURNAL OF ONCOLOGY, 2(6), 1071-1074. Retrieved from https://www.webofscience.com/
P53 EXPRESSION IN END-STAGE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK PRIOR TO CHEMOTHERAPY TREATMENT - EXPRESSION CORRELATES WITH A VERY POOR CLINICAL OUTCOME
FIELD, J. K., MALLIRI, A., BUTT, S. A., GOSNEY, J. R., PHILLIPS, D., SPANDIDOS, D. A., & JONES, A. S. (1993). P53 EXPRESSION IN END-STAGE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK PRIOR TO CHEMOTHERAPY TREATMENT - EXPRESSION CORRELATES WITH A VERY POOR CLINICAL OUTCOME. INTERNATIONAL JOURNAL OF ONCOLOGY, 3(3), 431-435. Retrieved from https://www.webofscience.com/
PROGNOSTIC-SIGNIFICANCE OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN HUMAN MALIGNANCY
SPANDIDOS, D. A., LILOGLOU, T., & FIELD, J. K. (1993). PROGNOSTIC-SIGNIFICANCE OF ONCOGENES AND TUMOR-SUPPRESSOR GENES IN HUMAN MALIGNANCY. STEM CELLS, 11(3), 194-198. doi:10.1002/stem.5530110305
THE IMPACT OF MOLECULAR AND CELLULAR BIOLOGY IN TODAYS CLINICAL-PRACTICE IN HEAD AND NECK-CANCER
FIELD, J. K. (1993). THE IMPACT OF MOLECULAR AND CELLULAR BIOLOGY IN TODAYS CLINICAL-PRACTICE IN HEAD AND NECK-CANCER. In JOURNAL OF CHEMOTHERAPY Vol. 5 (pp. 774-775). Retrieved from https://www.webofscience.com/
1992
RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS - P53 OVER-EXPRESSION CORRELATES WITH A POOR PROGNOSIS
PAPADAKIS, E., MALLIRI, A., LINARDOPOULOS, S., KARAIOSSIFIDI, H., FIELD, J. K., & SPANDIDOS, D. A. (1992). RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS - P53 OVER-EXPRESSION CORRELATES WITH A POOR PROGNOSIS. INTERNATIONAL JOURNAL OF ONCOLOGY, 1(4), 403-413. Retrieved from https://www.webofscience.com/
MUTATIONS IN THE P53 GENE AT CODON 249 ARE RARE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., MALLIRI, A., JONES, A. J., & SPANDIDOS, D. A. (1992). MUTATIONS IN THE P53 GENE AT CODON 249 ARE RARE IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. INTERNATIONAL JOURNAL OF ONCOLOGY, 1(3), 253-256. Retrieved from https://www.webofscience.com/
Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck.
Owens, W., Field, J. K., Howard, P. J., & Stell, P. M. (1992). Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck.. European journal of cancer. Part B, Oral oncology, 28B(1), 17-21. doi:10.1016/0964-1955(92)90006-m
Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field, J. K. (1992). Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.. European journal of cancer. Part B, Oral oncology, 28B(1), 67-76. doi:10.1016/0964-1955(92)90016-t
RAS P21 EXPRESSION IN NEUROBLASTOMAS AND GANGLIO-NEUROBLASTOMAS - CORRELATION WITH PATIENTS PROGNOSIS
SPANDIDOS, D. A., ARVANITIS, D., & FIELD, J. K. (1992). RAS P21 EXPRESSION IN NEUROBLASTOMAS AND GANGLIO-NEUROBLASTOMAS - CORRELATION WITH PATIENTS PROGNOSIS. INTERNATIONAL JOURNAL OF ONCOLOGY, 1(1), 53-58. Retrieved from https://www.webofscience.com/
OVEREXPRESSION OF P53 GENE IN HEAD-AND-NECK CANCER, LINKED WITH HEAVY SMOKING AND DRINKING
FIELD, J. K., SPANDIDOS, D. A., & STELL, P. M. (1992). OVEREXPRESSION OF P53 GENE IN HEAD-AND-NECK CANCER, LINKED WITH HEAVY SMOKING AND DRINKING. LANCET, 339(8791), 502-503. doi:10.1016/0140-6736(92)91122-O
A PHASE-II STUDY OF CISPLATINUM VERSUS CISPLATINUM + NIFEDIPINE IN END-STAGE CARCINOMA OF THE HEAD AND NECK
JONES, A. S., PHILLIPS, D. E., & FIELD, J. K. (1992). A PHASE-II STUDY OF CISPLATINUM VERSUS CISPLATINUM + NIFEDIPINE IN END-STAGE CARCINOMA OF THE HEAD AND NECK. CLINICAL OTOLARYNGOLOGY, 17(6), 501-504. doi:10.1111/j.1365-2273.1992.tb01705.x
C-ERBB-2 EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., SPANDIDOS, D. A., YIAGNISIS, M., GOSNEY, J. R., PAPADIMITRIOU, K., & STELL, P. M. (1992). C-ERBB-2 EXPRESSION IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. ANTICANCER RESEARCH, 12(3), 613-619. Retrieved from https://www.webofscience.com/
EXPRESSION OF RAS RB1-PROTEIN AND P53-PROTEIN IN HUMAN BREAST-CANCER
SPANDIDOS, D. A., KARAIOSSIFIDI, H., MALLIRI, A., LINARDOPOULOS, S., VASSILAROS, S., TSIKKINIS, A., & FIELD, J. K. (1992). EXPRESSION OF RAS RB1-PROTEIN AND P53-PROTEIN IN HUMAN BREAST-CANCER. ANTICANCER RESEARCH, 12(1), 81-89. Retrieved from https://www.webofscience.com/
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer
Knight, L. J., Burrage, J., Bujac, S. R., Haggerty, C., Graham, A., Gibson, N. J., . . . Liloglou, T. (2009). Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer. INTERNATIONAL JOURNAL OF ONCOLOGY, 34(2), 465-471. doi:10.3892/ijo_00000171
LOW-LEVELS OF RAS P21 ONCOGENE EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
FIELD, J. K., YIAGNISIS, M., SPANDIDOS, D. A., GOSNEY, J. R., PAPADIMITRIOU, K., VAUGHAN, E. D., & STELL, P. M. (1992). LOW-LEVELS OF RAS P21 ONCOGENE EXPRESSION CORRELATES WITH CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 18(2), 168-176. Retrieved from https://www.webofscience.com/
MULTIPLE CYTOGENETIC ABERRATIONS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK
OWENS, W., FIELD, J. K., HOWARD, P. J., & STELL, P. M. (1992). MULTIPLE CYTOGENETIC ABERRATIONS IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK. ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 28B(1), 17-21. doi:10.1016/0964-1955(92)90006-M
Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck
Owens, W., Field, J. K., Howard, P. J., & Stell, P. M. (1992). Multiple cytogenetic aberrations in squamous cell carcinomas of the head and neck. European Journal of Cancer. Part B: Oral Oncology, 28(1), 17-21. doi:10.1016/0964-1955(92)90006-M
ONCOGENES AND TUMOR-SUPPRESSOR GENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K. (1992). ONCOGENES AND TUMOR-SUPPRESSOR GENES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. ORAL ONCOLOGY, 28B(1), 67-76. Retrieved from https://www.webofscience.com/
Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck
Field, J. K. (1992). Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. European Journal of Cancer. Part B: Oral Oncology, 28(1), 67-76. doi:10.1016/0964-1955(92)90016-T
1991
ELEVATED P53 EXPRESSION CORRELATES WITH A HISTORY OF HEAVY SMOKING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., SPANDIDOS, D. A., MALLIRI, A., GOSNEY, J. R., YIAGNISIS, M., & STELL, P. M. (1991). ELEVATED P53 EXPRESSION CORRELATES WITH A HISTORY OF HEAVY SMOKING IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. BRITISH JOURNAL OF CANCER, 64(3), 573-577. doi:10.1038/bjc.1991.352
EXPRESSION OF C-MYC ONCOPROTEIN IN DISSEMINATED SMALL-CELL BRONCHIAL-CARCINOMA VARIES WITH METASTATIC SITE
BUTT, S. A., & GOSNEY, J. R. (1991). EXPRESSION OF C-MYC ONCOPROTEIN IN DISSEMINATED SMALL-CELL BRONCHIAL-CARCINOMA VARIES WITH METASTATIC SITE. In JOURNAL OF PATHOLOGY Vol. 164 (pp. A350). Retrieved from https://www.webofscience.com/
EXPRESSION OF P53 PROTEIN AND CIGARETTE-SMOKING IN BRONCHIAL-CARCINOMA
GOSNEY, J. R., BUTT, S. A., GOSNEY, M. A., FIELD, J. K., & LYE, M. D. W. (1991). EXPRESSION OF P53 PROTEIN AND CIGARETTE-SMOKING IN BRONCHIAL-CARCINOMA. JOURNAL OF PATHOLOGY, 164(4), A350. Retrieved from https://www.webofscience.com/
EXPRESSION OF RAS P21 ONCOPROTEIN IN SMALL-CELL BRONCHIAL-CARCINOMA IS ASSOCIATED WITH SHORTENED SURVIVAL
BUTT, S. A., GOSNEY, J. R., GOSNEY, M. A., FIELD, J. K., & LYE, M. D. W. (1991). EXPRESSION OF RAS P21 ONCOPROTEIN IN SMALL-CELL BRONCHIAL-CARCINOMA IS ASSOCIATED WITH SHORTENED SURVIVAL. JOURNAL OF PATHOLOGY, 164(4), A350. Retrieved from https://www.webofscience.com/
IMMUNOHISTOCHEMICAL ANALYSIS OF THE EXPRESSION OF THE C-MYC ONCOPROTEIN IN HUMAN STOMACH CANCERS
SPANDIDOS, D. A., KARAYIANNIS, M., YIAGNISIS, M., PAPDIMITRIOU, K., & FIELD, J. K. (1991). IMMUNOHISTOCHEMICAL ANALYSIS OF THE EXPRESSION OF THE C-MYC ONCOPROTEIN IN HUMAN STOMACH CANCERS. DIGESTION, 50(3-4), 127-134. doi:10.1159/000200752
P53 EXPRESSION IN CYTOLOGIC SPECIMENS FROM BENIGN AND MALIGNANT BREAST-LESIONS
KOUTSELINI, H., MALLIRI, A., FIELD, J. K., & SPANDIDOS, D. A. (1991). P53 EXPRESSION IN CYTOLOGIC SPECIMENS FROM BENIGN AND MALIGNANT BREAST-LESIONS. ANTICANCER RESEARCH, 11(4), 1415-1420. Retrieved from https://www.webofscience.com/
Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
Arvanitis, D., Malliri, A., Antoniou, D., Linardopoulos, S., Field, J. K., & Spandidos, D. A. (1991). Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.. In vivo (Athens, Greece), 5(4), 317-321.
The alloimmune response against pancreatic islets is generated by both direct and indirect pathways.
Stock, P. G., Ascher, N. L., Chen, S., Field, J., Bach, F. H., & Sutherland, D. E. (1991). The alloimmune response against pancreatic islets is generated by both direct and indirect pathways.. In Transplantation proceedings Vol. 23 (pp. 819-820).
1990
RAS, C-MYC AND C-ERBB-2 ONCOPROTEIN EXPRESSION IN NON-AIDS MEDITERRANEAN KAPOSIS-SARCOMA
SPANDIDOS, D. A., KALOTERAKIS, A., YIAGNISIS, M., VARATSOS, A., & FIELD, J. K. (1990). RAS, C-MYC AND C-ERBB-2 ONCOPROTEIN EXPRESSION IN NON-AIDS MEDITERRANEAN KAPOSIS-SARCOMA. ANTICANCER RESEARCH, 10(6), 1619-1625. Retrieved from https://www.webofscience.com/
EVALUATION OF THE RAS AND MYC ONCOPROTEINS IN BENIGN GASTRIC-LESIONS
KARAYIANNIS, M., YIAGNISIS, M., PAPADIMITRIOU, K., FIELD, J. K., & SPANDIDOS, D. A. (1990). EVALUATION OF THE RAS AND MYC ONCOPROTEINS IN BENIGN GASTRIC-LESIONS. ANTICANCER RESEARCH, 10(5A), 1127-1133. Retrieved from https://www.webofscience.com/
EXPRESSION OF RAS P21 AND MYC P62 ONCOPROTEINS IN SMALL-CELL AND NON-SMALL-CELL CARCINOMA OF THE LUNG
SPANDIDOS, D. A., ZAKINTHINOS, S., PETRAKI, C., SOTSIOU, F., YIAGNISIS, M., DIMOPOULOS, A. M., . . . FIELD, J. K. (1990). EXPRESSION OF RAS P21 AND MYC P62 ONCOPROTEINS IN SMALL-CELL AND NON-SMALL-CELL CARCINOMA OF THE LUNG. ANTICANCER RESEARCH, 10(5A), 1105-1114. Retrieved from https://www.webofscience.com/
C-MYC ONCOPROTEIN IN BRONCHIAL-CARCINOMA - EXPRESSION IN ALL MAJOR MORPHOLOGICAL TYPES
GOSNEY, J. R., FIELD, J. K., GOSNEY, M. A., LYE, M. D. W., SPANDIDOS, D. A., & BUTT, S. A. (1990). C-MYC ONCOPROTEIN IN BRONCHIAL-CARCINOMA - EXPRESSION IN ALL MAJOR MORPHOLOGICAL TYPES. ANTICANCER RESEARCH, 10(3), 623-628. Retrieved from https://www.webofscience.com/
Evaluation of the ras and myc oncoproteins in benign gastric lesions
Karayiannis, M., Yiagnisis, M., Papadimitriou, K., Field, J. K., & Spandidos, D. A. (1990). Evaluation of the ras and myc oncoproteins in benign gastric lesions. Anticancer Research, 10(5 A), 1127-1134.
Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung
Spandidos, D. A., Zakinthinos, S., Petraki, C., Sotsiou, F., Yiagnisis, M., Dimopoulos, A. M., . . . Field, J. K. (1990). Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung. Anticancer Research, 10(5 A), 1105-1114.
IMMUNOCYTOCHEMICAL STUDY OF RAS ONCOPROTEIN IN CYTOLOGIC SPECIMENS OF PRIMARY LUNG-TUMORS
KOUTSELINI, H., KAPPATOU, G., YIAGNISIS, M., FIELD, J. K., & SPANDIDOS, D. A. (1990). IMMUNOCYTOCHEMICAL STUDY OF RAS ONCOPROTEIN IN CYTOLOGIC SPECIMENS OF PRIMARY LUNG-TUMORS. ANTICANCER RESEARCH, 10(3), 597-604. Retrieved from https://www.webofscience.com/
RELATIONSHIP BETWEEN C-MYC ONCOPROTEIN EXPRESSION AND MORPHOLOGY IN BRONCHIAL-CARCINOMA
BUTT, S. A., GOSNEY, J. R., GOSNEY, M. A., FIELD, J. K., & LYE, M. D. W. (1990). RELATIONSHIP BETWEEN C-MYC ONCOPROTEIN EXPRESSION AND MORPHOLOGY IN BRONCHIAL-CARCINOMA. JOURNAL OF PATHOLOGY, 161(4), A347. Retrieved from https://www.webofscience.com/
THE ROLE OF RAS AND MYC ONCOGENES IN HUMAN SOLID TUMORS AND THEIR RELEVANCE IN DIAGNOSIS AND PROGNOSIS
FIELD, J. K., & SPANDIDOS, D. A. (1990). THE ROLE OF RAS AND MYC ONCOGENES IN HUMAN SOLID TUMORS AND THEIR RELEVANCE IN DIAGNOSIS AND PROGNOSIS. ANTICANCER RESEARCH, 10(1), 1-22. Retrieved from https://www.webofscience.com/
1989
ELEVATED EXPRESSION OF THE C-MYC ONCOPROTEIN CORRELATES WITH POOR PROGNOSIS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
FIELD, J. K., SPANDIDOS, D. A., STELL, P. M., VAUGHAN, E. D., EVAN, G. I., & MOORE, J. P. (1989). ELEVATED EXPRESSION OF THE C-MYC ONCOPROTEIN CORRELATES WITH POOR PROGNOSIS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA. ONCOGENE, 4(12), 1463-1468. Retrieved from https://www.webofscience.com/
Does Candida have a role in oral epithelial neoplasia?
Field, E. A., Field, J. K., & Martin, M. V. (1989). Does Candida have a role in oral epithelial neoplasia?. Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 27(5), 277-294.
C-MYC ONCOGENE EXPRESSION AND PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
FIELD, J. K., STELL, P. M., & MOORE, J. P. (1989). C-MYC ONCOGENE EXPRESSION AND PROGNOSIS IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK. In JOURNAL OF DENTAL RESEARCH Vol. 68 (pp. 570). Retrieved from https://www.webofscience.com/
C-MYC ONCOPROTEIN EXPRESSION IN POTENTIALLY MALIGNANT LESIONS OF THE OROFACIAL REGION
FIELD, E. A., TYLDESLEY, W. R., VAUGHAN, E. D., STELL, P. M., MOORE, J. P., & FIELD, J. K. (1989). C-MYC ONCOPROTEIN EXPRESSION IN POTENTIALLY MALIGNANT LESIONS OF THE OROFACIAL REGION. In JOURNAL OF DENTAL RESEARCH Vol. 68 (pp. 598). Retrieved from https://www.webofscience.com/
DOES CANDIDA HAVE A ROLE IN ORAL EPITHELIAL NEOPLASIA
FIELD, E. A., FIELD, J. K., & MARTIN, M. V. (1989). DOES CANDIDA HAVE A ROLE IN ORAL EPITHELIAL NEOPLASIA. JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 27(5), 277-294. Retrieved from https://www.webofscience.com/
HIGH-LEVELS OF C-MYC PROTEIN IN HUMAN-BREAST TUMORS DETERMINED BY A SENSITIVE ELISA TECHNIQUE
SPANDIDOS, D. A., FIELD, J. K., AGNANTIS, N. J., EVAN, G. I., & MOORE, J. P. (1989). HIGH-LEVELS OF C-MYC PROTEIN IN HUMAN-BREAST TUMORS DETERMINED BY A SENSITIVE ELISA TECHNIQUE. ANTICANCER RESEARCH, 9(4), 821-826. Retrieved from https://www.webofscience.com/
RAS-ONCOPROTEINS, C-MYC-ONCOPROTEINS AND C-ERBB-2-ONCOPROTEINS IN HUMAN-BREAST CANCER
SPANDIDOS, D. A., YIAGNISIS, M., PAPADIMITRIOU, K., & FIELD, J. K. (1989). RAS-ONCOPROTEINS, C-MYC-ONCOPROTEINS AND C-ERBB-2-ONCOPROTEINS IN HUMAN-BREAST CANCER. ANTICANCER RESEARCH, 9(5), 1385-1393. Retrieved from https://www.webofscience.com/
THE CORRELATION OF PLOIDY WITH C-MYC ONCOGENE EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
FORSTER, G., COOKE, L. D., COOKE, T. G., STELL, P. M., & FIELD, J. K. (1989). THE CORRELATION OF PLOIDY WITH C-MYC ONCOGENE EXPRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA. In JOURNAL OF DENTAL RESEARCH Vol. 68 (pp. 598). Retrieved from https://www.webofscience.com/
ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
Spandidos, D. A., Yiagnisis, M., Papadimitriou, K., & Field, J. K. (1989). ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.. Anticancer research, 9(5), 1385-1393.
1988
A PHYSICAL AND MICROBIOLOGICAL EVALUATION OF THE RE-USE OF NON-STERILE GLOVES
MARTIN, M. V., DUNN, H. M., FIELD, E. A., FIELD, J. K., HIBBERT, S. A., MCGOWAN, P., & WARDLE, I. (1988). A PHYSICAL AND MICROBIOLOGICAL EVALUATION OF THE RE-USE OF NON-STERILE GLOVES. BRITISH DENTAL JOURNAL, 165(9), 321-324. doi:10.1038/sj.bdj.4806611
TIME, STEAM, TEMPERATURE (TST) CONTROL INDICATORS TO MEASURE ESSENTIAL STERILIZATION CRITERIA FOR AUTOCLAVES IN GENERAL DENTAL PRACTICE AND THE COMMUNITY DENTAL SERVICE
FIELD, E. A., FIELD, J. K., & MARTIN, M. V. (1988). TIME, STEAM, TEMPERATURE (TST) CONTROL INDICATORS TO MEASURE ESSENTIAL STERILIZATION CRITERIA FOR AUTOCLAVES IN GENERAL DENTAL PRACTICE AND THE COMMUNITY DENTAL SERVICE. BRITISH DENTAL JOURNAL, 164(6), 183-186. doi:10.1038/sj.bdj.4806396
1987
EXPRESSION OF ONCOGENES IN HUMAN-TUMORS WITH SPECIAL REFERENCE TO THE HEAD AND NECK REGION
FIELD, J. K., & SPANDIDOS, D. A. (1987). EXPRESSION OF ONCOGENES IN HUMAN-TUMORS WITH SPECIAL REFERENCE TO THE HEAD AND NECK REGION. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 16(3), 97-107. doi:10.1111/j.1600-0714.1987.tb01474.x
ONCOGENE EXPRESSION IN PLEOMORPHIC SALIVARY ADENOMA
FIELD, J. K., LAMOTHE, A., & SPANDIDOS, D. A. (1987). ONCOGENE EXPRESSION IN PLEOMORPHIC SALIVARY ADENOMA. In JOURNAL OF DENTAL RESEARCH Vol. 66 (pp. 877). Retrieved from https://www.webofscience.com/
1986
CLINICAL RELEVANCE OF ONCOGENE EXPRESSION IN HEAD AND NECK TUMORS
FIELD, J. K., LAMOTHE, A., & SPANDIDOS, D. A. (1986). CLINICAL RELEVANCE OF ONCOGENE EXPRESSION IN HEAD AND NECK TUMORS. ANTICANCER RESEARCH, 6(4), 595-600. Retrieved from https://www.webofscience.com/
C-MYC EXPRESSION IS ELEVATED IN TNM STAGE-III AND STAGE-IV SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK REGION
FIELD, J. K., LAMOTHE, A., & SPANDIDOS, D. A. (1986). C-MYC EXPRESSION IS ELEVATED IN TNM STAGE-III AND STAGE-IV SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK REGION. In JOURNAL OF DENTAL RESEARCH Vol. 65 (pp. 525). Retrieved from https://www.webofscience.com/
1985
MULTIPLE TRANSCRIPTIONAL ACTIVATION OF CELLULAR ONCOGENES IN HUMAN HEAD AND NECK SOLID TUMORS
SPANDIDOS, D. A., LAMOTHE, A., & FIELD, J. K. (1985). MULTIPLE TRANSCRIPTIONAL ACTIVATION OF CELLULAR ONCOGENES IN HUMAN HEAD AND NECK SOLID TUMORS. ANTICANCER RESEARCH, 5(2), 221-224. Retrieved from https://www.webofscience.com/
ELEVATED EXPRESSION OF MULTIPLE ONCOGENES IN HEAD AND NECK TUMORS
FIELD, J. K., SPANDIDOS, D. A., & LAMOTHE, A. (1985). ELEVATED EXPRESSION OF MULTIPLE ONCOGENES IN HEAD AND NECK TUMORS. In JOURNAL OF DENTAL RESEARCH Vol. 64 (pp. 695). Retrieved from https://www.webofscience.com/
TRANSCRIPTIONAL ACTIVATION OF HA-RAS KI-RAS AND MYC CELLULAR ONCOGENES IN HUMAN HEAD AND NECK SOLID TUMORS
LAMOTHE, A., FIELD, J. K., STELL, P. M., & SPANDIDOS, D. A. (1985). TRANSCRIPTIONAL ACTIVATION OF HA-RAS KI-RAS AND MYC CELLULAR ONCOGENES IN HUMAN HEAD AND NECK SOLID TUMORS. In CLINICAL OTOLARYNGOLOGY Vol. 10 (pp. 120). Retrieved from https://www.webofscience.com/
1984
SEX-DIFFERENCES IN SEXUAL NEEDS AND DESIRES
DENNEY, N. W., FIELD, J. K., & QUADAGNO, D. (1984). SEX-DIFFERENCES IN SEXUAL NEEDS AND DESIRES. ARCHIVES OF SEXUAL BEHAVIOR, 13(3), 233-245. doi:10.1007/BF01541650
1983
SERUM REGULATION OF THE ESTROGEN RESPONSIVENESS OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7
PAGE, M. J., FIELD, J. K., EVERETT, N. P., & GREEN, C. D. (1983). SERUM REGULATION OF THE ESTROGEN RESPONSIVENESS OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7. CANCER RESEARCH, 43(3), 1244-1250. Retrieved from https://www.webofscience.com/
1982
A MICROCOMPUTER PROGRAM FOR ANALYSIS OF NUCLEIC-ACID HYBRIDIZATION DATA
GREEN, S., FIELD, J. K., GREEN, C. D., & BEYNON, R. J. (1982). A MICROCOMPUTER PROGRAM FOR ANALYSIS OF NUCLEIC-ACID HYBRIDIZATION DATA. NUCLEIC ACIDS RESEARCH, 10(4), 1411-1420. doi:10.1093/nar/10.4.1411
1981
EFFECTS OF OESTROGENS ON THE COMPLEXITY OF POLY (A) RNA FROM RAT UTERUS
FIELD, J. K., GREEN, S., & GREEN, C. D. (1981). EFFECTS OF OESTROGENS ON THE COMPLEXITY OF POLY (A) RNA FROM RAT UTERUS. Biochemical Society Transactions, 9(2), 153P. doi:10.1042/bst009153pb
1978
The Response to Hormones and Anti-Hormones of Human Breast Tumour Cells Grown in Continuous Culture
Page, M. J., Field, J. K., & Green, C. D. (1978). The Response to Hormones and Anti-Hormones of Human Breast Tumour Cells Grown in Continuous Culture. BIOCHEMICAL SOCIETY TRANSACTIONS, 6, 1318-1319. doi:10.1042/bst0061318
1976
FURTHER STUDY OF INHERITANCE OF RACING PERFORMANCE IN THOROUGHBRED HORSES
FIELD, J. K., & CUNNINGHAM, E. P. (1976). FURTHER STUDY OF INHERITANCE OF RACING PERFORMANCE IN THOROUGHBRED HORSES. JOURNAL OF HEREDITY, 67(4), 247-248. doi:10.1093/oxfordjournals.jhered.a108721